Updated on 2023/10/11

写真a

 
HASHIGUCHI Teruto
 
Organization
Research Field in Medicine and Health Sciences, Medical and Dental Sciences Area Graduate School of Medical and Dental Sciences Advanced Therapeutics Course Cardiovascular and Respiratory Disorders Professor
Research Field in Medicine and Health Sciences, Medical and Dental Sciences Area Faculty of Medicine
Title
Professor

Degree

  • 博士(医学) ( 2002.7   鹿児島大学 )

Research Interests

  • 脈管新生●血管新生●リンパ管新生●VEGF●リンパ節●POEMS症候群●ペプチドーム

  • Blood Coagulation

Research Areas

  • Others / Others  / HIV感染症

  • Others / Others  / 神経内科

  • Others / Others  / 血栓止血

  • Others / Others  / 臨床検査

  • Life Science / Neurology

Research History

  • Kagoshima University   Professor

    2011.4

  • Kagoshima University

    2011.4

  • - 鹿児島大学医学部臨床検査医学講座 助教授

    2002

  • - Kagoshima University School of Medicine,

    2002

  • Kagoshima University   Faculty of Medicine

    2000 - 2002

  • Yamagata University School of Medicine,

    1992 - 1994

  • Yamagata University   Faculty of Medicine

    1992 - 1994

  • Washington State University

    1991 - 1992

  • 米国ワシントン州立大学留学

    1991 - 1992

  • Molecular Patho-Biochemisty, Assistant

▼display all

Professional Memberships

  • 日本病態栄養学会

    2015.10

  • 日本臨床化学会

    2015.10

  • 日本エイズ学会

    2015.10

  • 日本血栓止血学会

    2015.10

  • 日本感染症学会

    2015.10

  • 日本糖尿病学会

    2015.10

  • 日本臨床検査医学会

    2015.10

  • 日本血液学会

    2015.10

  • 日本動脈硬化学会

    2015.10

  • 日本内科学会

    2015.10

  • 日本内分泌学会

    2015.10

  • 日本神経学会

    2015.10

  • 日本血液学会

  • 日本臨床検査医学会

  • 日本糖尿病学会

  • 日本神経学会

  • 日本分泌学会

▼display all

 

Papers

  • Kawasaki H., Fudamoto K., Yamamoto M., Iwaanakuchi T., Yoshida T., Hashiguchi T., Uto Y. .  Verification of the relationship between the sequential organ failure assessment score and the length of intensive care unit and hospital stay in terms of medical resources input .  Medicine (United States)102 ( 35 )   2023.9

     More details

    Language:Japanese   Publisher:Medicine (United States)  

    This study aimed to clarify the relationship between the sequential organ failure assessment (SOFA) score and the length of intensive care unit (ICU) and hospital stays and verify whether the SOFA score can indicate the optimal length of ICU stay. Medical resource input was evaluated as the medical treatment score, converted by volume, within 2 days after ICU admission. After classifying emergency patients into surgical and nonsurgical categories, the relationship between medical resources, SOFA score, and ICU and hospital stay lengths was analyzed. Medical resource input was high when the SOFA score was high after ICU admission. A positive correlation was confirmed between the SOFA score and length of ICU stay in surgical and nonsurgical patients. Nonsurgical patients are more likely to be discharged within the diagnosis procedure combination hospital stages I and II if medical resources are high in the initial stages of ICU admission. The SOFA score affects medical resource input and the length of ICU stay. The early input of medical resources after ICU admission reduces the length of hospital stay in the diagnosis procedure combination, suggesting that the SOFA score is a valuable indicator of the optimal length of ICU stay.

    DOI: 10.1097/MD.0000000000034632

    Scopus

  • Yamakuchi M., Okawa M., Takenouchi K., Bibek A., Yamada S., Inoue K., Higurashi K., Tabaru A., Tanoue K., Oyama Y., Higashi S., Fujisaki C., Kanda H., Terasaki H., Sakamoto T., Soga Y., Hashiguchi T. .  VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals .  PLoS ONE18 ( 4 April )   2023.4

     More details

    Language:Japanese   Publisher:PLoS ONE  

    Vascular endothelial growth factor A (VEGF-A) plays pivotal roles in regulating tumor angiogenesis as well as physiological vascular function. The major VEGF-A isoforms, VEGFA121 and VEGF-A165, in serum, plasma, and platelets have not been exactly evaluated due to the lack of the appropriate assay system. Antibodies against human VEGF-A121 and VEGF-A165 (hVEGF-A121 and hVEGF-A165) were successfully produced and Enzyme-Linked ImmunoSorbent Assay (ELISA) for hVEGF-A121 and hVEGF-A165 were separately created by these monoclonal antibodies. The measurement of recombinant hVEGF-A121 and hVEGF-A165 by the created ELISA showed no cross-reaction between hVEGF-A121 and hVEGF-A165 in conditioned media from HEK293 cells transfected with either hVEGFA121 or hVEGF-A165 expression vector. The levels of VEGF-A121 and VEGF-A165 in serum, plasma, and platelets from 59 healthy volunteers proved that VEGF-A121 level was higher than VEGF-A165 in both plasma and serum in all the cases. VEGF-A121 or VEGFA165 in serum represented higher level than that in plasma. In contrast, the level of VEGFA165 was higher than VEGF-A121 in platelets. The newly developed ELISAs for hVEGFA121 and hVEGF-A165 revealed different ratios of VEGF isoforms in serum, plasma, and platelets. Measuring these isoforms in combination provides useful information as biomarkers for diseases involving VEGF-A121 and VEGF-A165. Copyright:

    DOI: 10.1371/journal.pone.0284131

    Scopus

  • Oda Y, Ito T, Yamada Y, Koga T, Nagasato T, Ohnishi-Wada T, Hosokawa K, Fukase H, Hashiguchi T, Maruyama I .  Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System. .  Thrombosis journal19 ( 1 ) 88   2021.11

     More details

    Language:English   Publisher:Thrombosis Journal  

    Background: Rupture of an atherosclerotic plaque and subsequent exposure of the subendothelial prothrombotic matrix to blood cause arterial thrombosis. Circulating platelets play an indispensable role in the growth of arterial thrombi partially owing to their unique ability to adhere to the subendothelial matrix and to aggregate to each other under flow conditions. Recently, the Total Thrombus-formation Analysis System (T-TAS) was developed for ex vivo analysis of the thrombogenic potential of whole blood samples under flow conditions. Despite the potential clinical utility of the T-TAS in assessing the risk for thrombosis and bleeding, reference intervals for T-TAS analysis in healthy individuals have not been determined. Methods: In total, 122 whole blood samples were collected from healthy volunteers ranging in age from 25 to 45 years. T-TAS analysis and hematological, physiological, and lifestyle assessments were conducted in these subjects. Whole blood samples anticoagulated with hirudin were perfused into a collagen-coated microchip (PL chip). The time to 10 kPa and the area under the flow pressure curve up to 10 min (AUC10) were analyzed as representative variables for thrombogenic potential. Reference intervals, which were defined as 2.5–97.5 percentiles, were determined. Additionally, univariate and multivariate analyses were performed to identify factors associated with the AUC10 in the T-TAS. Results: The time to 10 kPa and the AUC10 widely varied, even in healthy volunteers. The reference intervals were 1.50–4.02 min and 223.4–456.8, respectively, at a shear rate of 1500 s− 1. Univariate and multivariate analyses showed that platelet counts were most significantly associated with the AUC10 of the T-TAS. The presence of one or more cardiovascular risk factors of a high body mass index, a high pulse pressure, high fasting serum glucose levels, high low-density lipoprotein-cholesterol levels, a history of smoking, and no habitual exercise, had the second largest effect on the AUC10 of the T-TAS. Conclusions: Healthy volunteers who had any cardiovascular risk factors showed augmented thrombogenicity, even in artificial uniform capillaries, compared with those without any risk factors in the T-TAS.

    DOI: 10.1186/s12959-021-00341-3

    Scopus

    PubMed

  • Mukaihara Kosuke, Yamakuchi Munekazu, Kanda Hideaki, Shigehisa Yoshiya, Arata Kenichi, Matsumoto Kazuhisa, Takenouchi Kazunori, Oyama Yoko, Koriyama Toyoyasu, Hashiguchi Teruto, Imoto Yutaka .  冠動脈バイパス術後の血小板内VEGF-Aと血清中マイクロRNA-126の評価(Evaluation of VEGF-A in platelet and microRNA-126 in serum after coronary artery bypass grafting) .  Heart and Vessels36 ( 11 ) 1635 - 1645   2021.11冠動脈バイパス術後の血小板内VEGF-Aと血清中マイクロRNA-126の評価(Evaluation of VEGF-A in platelet and microRNA-126 in serum after coronary artery bypass grafting)

     More details

    Language:English   Publisher:シュプリンガー・ジャパン(株)  

    冠動脈バイパス術(CABG)の治療期間を通じ、血管内皮細胞増殖因子A(VEGF-A)とマイクロRNA(miR)-126が示す役割を評価した。2013年7月~2014年3月に当大学病院を含む2施設でCABGを施行した患者67名(男性率95%、平均66±3歳)から全血を採取して解析に用いた。CABG施行の3日後には血小板数が減少していたが、こうした動的変化はオフポンプCABGを受けた症例よりも従来法でのCABG例の方がより大きく生じていた。同一数の血小板に含まれるVEGF-AのレベルはCABGの3日後に上昇し、血清中のVEGF-Aレベルは7日後に上昇した。血清中のmiR-126-3pのレベルはCABG施行後、急速に上昇し、次いで施行前の水準を下回るまでに低下した。CABGの7日後の時点では、末梢動脈疾患(PAD)であった患者群(全集団の12%)での血小板内VEGF-Aレベルは、PAD非罹患の群に比べ上昇していた。逆にCABGから7日後の血清中miR-126-3pレベルは、非PAD群よりもPAD群の方が低かった。こうした結果から、PADでみられる内皮機能障害に起因してmiR-126-3pの血清中レベルは低下し、そのため血小板内VEGF-Aレベルが上昇するという機序が存在し、これがCABG後の合併症と密接に関係していると考えられた。

  • Maenosono Ryuichi, Mizukami Naoko, Ichiki Hitoshi, Oketani Naoya, Namino Fuminori, Masamoto Izumi, Yuasa Toshinori, Yamakuchi Munekazu, Ohishi Mitsuru, Hashiguchi Teruto .  発作性心房細動に対するカテーテルアブレーション後の心房細動再発予測因子候補としての全心房伝導時間 電気的心房リモデリングと構造的心房リモデリングの時間経過との関連(Total atrial conduction time as a possible predictor of atrial fibrillation recurrence after catheter ablation for paroxysmal atrial fibrillation: relationship between electrical atrial remodeling and structural atrial remodeling time courses) .  Journal of Medical Ultrasonics48 ( 3 ) 295 - 306   2021.7発作性心房細動に対するカテーテルアブレーション後の心房細動再発予測因子候補としての全心房伝導時間 電気的心房リモデリングと構造的心房リモデリングの時間経過との関連(Total atrial conduction time as a possible predictor of atrial fibrillation recurrence after catheter ablation for paroxysmal atrial fibrillation: relationship between electrical atrial remodeling and structural atrial remodeling time courses)

     More details

    Language:English   Publisher:シュプリンガー・ジャパン(株)  

    心房細動アブレーション後に認められる、心房細動再発と全心房伝導時間(PA-TDI duration)との関連について検討した。対象患者は、発作性心房細動に対し高周波アブレーションが施行された患者209例と心房細動再発に対し2回目のアブレーションが施行された患者75例とした。心房の電気的リモデリングを表す体表面心電図上のP波始点から、遠位側冠動脈洞(CS)の心房電位までの時間(PA-CSd duration)、右房の電気的リモデリングを表すP波始点から、近位CS心房電位までの時間(PA-CSp duration)と左房の電気的リモデリングを反映する、近位から遠位CSまでの伝導時間(CSp-CSd duration)を調査した。また、左房の構造的リモデリングマーカーとしては、左房容積係数(LAVI)を測定した。その結果、PA-TDI durationはPA-CSd durationと正相関が認められ、心房細動再発患者では、2回目アブレーションのPA-TDI duration、PA-CSd durationおよびCSp-CSd durationが1回目に比べ有意に長かったが、1回目と2回目のアブレーションのLAVIとPA-CSp durationでは有意差はみられなかった。以上より、発作性心房細動患者に対する心房細動アブレーション後のPA-TDI duration延長は、左房の電気的リモデリング進行と考えられることから、アブレーション後の心房細動再発予測に有用と判断された。

  • Maenosono R, Mizukami N, Ichiki H, Oketani N, Namino F, Masamoto I, Yuasa T, Yamakuchi M, Ohishi M, Hashiguchi T .  Total atrial conduction time as a possible predictor of atrial fibrillation recurrence after catheter ablation for paroxysmal atrial fibrillation: relationship between electrical atrial remodeling and structural atrial remodeling time courses. .  Journal of medical ultrasonics (2001)48 ( 3 ) 295 - 306   2021.4

     More details

    Language:English   Publisher:Journal of Medical Ultrasonics  

    Purpose: Recently, the estimated total atrial conduction time measured using tissue Doppler imaging (PA-TDI duration) has been reported as a more accurate predictor of atrial fibrillation (AF) recurrence after catheter ablation than left atrial volume index (LAVI). The PA-TDI duration is considered to reflect electrical and structural remodeling in the right atrium (RA) and left atrium (LA). We sought to investigate the association between AF recurrence and PA-TDI duration after AF ablation. Methods: We studied 209 patients who underwent radiofrequency ablation for paroxysmal AF and 75 patients who underwent second ablation for AF recurrence. We assessed the duration from the onset of the P wave on the surface electrocardiogram to the atrial electrogram in distal coronary sinus (CS) (PA-CSd duration) indicating electrical remodeling of the atrium, the PA-CS proximal duration (PA-CSp duration) representing electrical remodeling of RA, and the conduction time in CS (proximal to distal) (CSp-CSd duration) reflecting electrical remodeling of LA. We also measured LAVI as a marker of structural remodeling of LA. Results: The PA-TDI duration had a positive correlation with PA-CSd duration. In the patients with AF recurrence, PA-TDI duration, PA-CSd duration, and CSp-CSd duration in the second ablation were significantly longer than those in the first (p < 0.01, respectively), whereas there was no significant difference in LAVI and PA-CSp duration between the first and second ablation sessions. Conclusion: A prolonged PA-TDI duration after AF ablation may indicate advanced electrical remodeling of LA, and may predict AF recurrence after ablation in patients with paroxysmal AF.

    DOI: 10.1007/s10396-021-01090-6

    Scopus

    PubMed

  • 橋口 照人 .  特集 2つのルーチン検査値で患者の病態を考えてみよう フィブリノゲンとD-dimer .  治療103 ( 1 ) 74 - 78   2021.1

     More details

    Publisher:(株)南山堂  

    DOI: 10.15104/j00821.2021134621

  • Mukaihara K. .  Evaluation of VEGF-A in platelet and microRNA-126 in serum after coronary artery bypass grafting .  Heart and Vessels36 ( 11 ) 1635 - 1645   2021

     More details

    Language:English   Publisher:Heart and Vessels  

    Platelet functions are thought to contribute to clinical outcomes after heart surgery. This study was conducted to assess the pivotal roles of vascular endothelial growth factor-A (VEGF-A) and microRNA-126 (miR-126) during coronary artery bypass grafting (CABG). Whole blood was collected for platelet isolation from 67 patients who underwent CABG surgery between July 2013 and March 2014. VEGF-A and miR-126 levels in serum, plasma, and platelets were measured at various time points and compared with clinical characteristics. The platelet count was decreased at 3 days after CABG. This dynamic change in platelet count was larger after conventional coronary artery bypass (CCAB) than off-pump coronary artery bypass (OPCAB). VEGF-A in the same number of platelets (IP-VEGF-A) was increased at 3 days after CABG, followed by an increase of VEGF-A in serum (S-VEGF-A) at 7 days after surgery. The miR-126-3p level in serum (S-miR-126-3p) increased rapidly after CABG and then decreased below preoperative levels. The IP-VEGF-A level on day 7 after CABG in patients with peripheral artery disease (PAD), who suffered from endothelial dysfunction, was higher compared with patients without PAD. Conversely, S-miR-126-3p on day 7 after surgery was lower in patients with PAD than in patients without PAD. Low levels of S-miR-126-3p due to endothelial dysfunction may lead to high IP-VEGF-A, which is closely related to complications after CABG.

    DOI: 10.1007/s00380-021-01855-6

    Scopus

    PubMed

  • Kanda H. .  Dynamic changes in platelets caused by shear stress in aortic valve stenosis .  Clinical Hemorheology and Microcirculation77 ( 1 ) 71 - 81   2021

     More details

    Language:English   Publisher:Clinical Hemorheology and Microcirculation  

    BACKGROUND AND OBJECTIVE: Turbulent blood flow in patients with aortic valve stenosis (AS) results in morphological and functional changes in platelets and coagulation factors. The aim of this study is to determine how shear stress affects platelets and coagulation factors. METHODS: We retrospectively evaluated data from 78 patients who underwent AVR to treat AS between March 2008 and July 2017 at Kagoshima University Hospital. RESULTS: Platelet (PLT) count obviously decreased at three days after AVR, and increased above preoperative levels at the time of discharge. In contrast, platelet distribution width (PDW), mean platelet volume (MPV), and platelet large cell ratio (P-LCR) increased three days after AVR, then decreased to below preoperative levels. No differences were evident between groups with higher (HPPG > 100 mmHg) and lower (LPPG < 100 mmHg) peak pressure gradients (PPG) before AVR, whereas PLT count, PDW, MPV and P-LCR improved more in the HPPG group. Plateletcrit (PCT), which represents the total volume of platelets, increased after AVR due to decreased shear stress. High increasing rate of PCT was associated with lower PLT count, higher PDW and lower fibrinogen. CONCLUSION: Shear stress affects PLT count, PDW, and fibrinogen in patients with AS.

    DOI: 10.3233/CH-200928

    Scopus

    PubMed

  • 矢坂 正弘, 橋口 照人 .  抗血栓療法部会 .  日本血栓止血学会誌32 ( 6 ) 792 - 793   2021

     More details

    Language:Japanese   Publisher:一般社団法人 日本血栓止血学会  

    DOI: 10.2491/jjsth.32.792

  • Furukawa Y. .  Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis .  Journal of Infection and Chemotherapy26 ( 2 ) 279 - 281   2020.2

     More details

    Language:English   Publisher:Journal of Infection and Chemotherapy  

    We report an AIDS patient with a high HIV RNA copy number in the plasma who was successfully treated for prolonged Mycobacterium avium bacteremia and other complications. An HIV-infected patient with high fever, anemia, high alkaline phosphatase, cystic lung lesions, hepatitis B virus infection and Kaposi's sarcoma was referred to our hospital. PCR of the blood revealed Mycobacterium avium bacteremia and the time to blood culture positivity was 8 days. The HIV-1 RNA copy number in the plasma was more than ten million copies/ml and the CD4-positive T cell count was 21 cells/μL. Although the high fever resolved five days after therapy for Mycobacterium avium was started, the fever recurred just before starting anti-retroviral therapy (ART) including dolutegravir. The patient experienced repeated but self-limiting bouts of severe inflammation. Mycobacteremia was intermittently detected up to 79 days, suggesting that the recurrent episodes of inflammation were due to the intermittent dissemination of mycobacteria, and that persistent treatment is needed. Five months after the beginning of ART, the HIV-1 RNA copy number in the plasma was still 28,000 copies/ml. An HIV drug-resistance test revealed sensitivity to all anti-retroviral drugs. Eleven months after the initiation of ART, the HIV RNA copy number in the plasma decreased to 45 copies/mL and the CD4-positive T cell count recovered to 205 cells/μL. Our case also suggests that dolutegravir can be effective in cases with prolonged high levels of HIV RNA. Our findings emphasize that prompt diagnosis and persistent therapy for mycobacterial infection are important for successful treatment.

    DOI: 10.1016/j.jiac.2019.08.012

    Scopus

    PubMed

  • Namino F. .  Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation .  Clinical and Applied Thrombosis/Hemostasis25   1076029619851570   2019.5

     More details

    Language:English   Publisher:Clinical and Applied Thrombosis/Hemostasis  

    Atrial fibrillation (AF) is the most common cardiac arrhythmia in the world and has a high risk of thromboembolism. The most effective approach, catheter ablation, requires evaluation by electrocardiography. The aim of our study was to investigate novel clinical markers that predict restoration of sinus rhythm (SR) after catheter ablation. Seventy-eight consecutive patients with AF underwent catheter ablation and were separated into 2 groups: restored SR and recurrent AF. The levels of 4 blood proteins (serum or plasma) and 3 mature microRNAs (miRNAs) and their primary miRNAs (pri-miRNAs) in serum were measured before and after ablation, and the associations between each parameter were analyzed statistically. Soluble thrombomodulin (s-TM) and plasminogen activator inhibitor-1 (PAI-1) levels increased above baseline after ablation in both the restored SR (s-TM 11.55 [2.92] vs 13.75 [3.38], P <.001; PAI-1 25.74 [15.25] vs 37.79 [19.56], P <.001) and recurrent AF (s-TM 10.28 [2.78] vs 11.67 [3.37], P <.001; PAI-1 26.16 [15.70] vs 40.74 [22.55], P <.001) groups. Levels of C-reactive protein and asymmetric dimethylarginine were not significantly changed. Pri-miR-126 levels significantly decreased after ablation in the recurrent AF group, but the other miRNAs and pri-miRNAs did not. The measurement of s-TM and pri-miR-126 in blood was a useful tool to reflect the condition of AF patients with catheter ablation.

    DOI: 10.1177/1076029619851570

    Scopus

    PubMed

  • 橋口 照人 .  増刊号 検査項目と異常値からみた-緊急・重要疾患レッドページ 1章 全身疾患 血栓傾向 .  臨床検査63 ( 4 ) 364 - 365   2019.4増刊号 検査項目と異常値からみた-緊急・重要疾患レッドページ 1章 全身疾患 血栓傾向

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1542201927

  • Koriyama T. .  Legionella pneumophila infection-mediated regulation of RICTOR via miR-218 in U937 macrophage cells .  Biochemical and Biophysical Research Communications508 ( 2 ) 608 - 613   2019.1

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    Background: Inhalation of aerosolized Legionella pneumophila, a Gram-negative bacterium, can cause severe pneumonia. During infection, L. pneumophila replicates intracellularly in macrophages. The involvement of host microRNAs (miRNAs) in L. pneumophila infection is not fully understood. Methods: The human macrophage-like cell line U937 was infected with L. pneumophila. The levels of miRNA and messenger RNA (mRNA) were measured using reverse transcriptase polymerase chain reaction. Release of lactate dehydrogenase was used to evaluate cytotoxicity. The expression of RICTOR and related proteins was examined by western blotting of cell lysates. Results: L. pneumophila infection upregulated the expression of miR-218 and the host genes SLIT2 and SLIT3 in U937 cells. The expression of RICTOR, a component of the mechanistic target of rapamycin complex 2 (mTORC2), decreased during L. pneumophila infection. RICTOR protein expression was inhibited by the overexpression of miR-218, whereas knockdown of miR-218 restored the downregulation of RICTOR by L. pneumophila. L. pneumophila infection induced the expression of the proinflammatory cytokines IL-6 and TNF-alpha, which was modulated by knockdown of miR-218 or RICTOR. Conclusions: Our study revealed the involvement of miR-218 in regulating the inflammatory response of macrophages against L. pneumophila infection. These findings suggest potential novel roles for miR-218 and RICTOR as therapeutic targets of L. pneumophila infection.

    DOI: 10.1016/j.bbrc.2018.11.093

    Scopus

    PubMed

  • Aryal B. .  Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study .  Cancer Biomarkers26 ( 1 ) 51 - 61   2019

     More details

    Language:English   Publisher:Cancer Biomarkers  

    BACKGROUND AND AIMS: A striking difference has been observed in structure and functional properties between plasma and platelet von Willebrand factor (VWF). While the existing evidence has revealed a clinical relevance of plasma VWF-Ag in liver regeneration (LR) and different cancers, this study was designed to explore the properties of intra-platelet (IP) and serum VWF-Ag in patients with hepatocellular carcinoma (HCC) undergoing partial hepatectomy. METHODS: A total of 40 patients undergoing partial hepatectomy were prospectively recruited from 3 institutions. VWF-Ag concentrations were evaluated mainly in serum and platelet extracts. Patients were followed-up for postoperative liver dysfunction and HCC recurrence. RESULTS: We observed a post-resection increase in the concentration of VWF-Ag in serum and platelet. Patients with postoperative liver dysfunction had substantially reduced serum and IP VWF-Ag concentrations. After a 2-year follow-up, patients with higher post-resection serum and IP VWF-Ag concentrations were found to develop early HCC recurrence. Likewise, IP VWF-Ag was able to independently predict post-resection early HCC recurrence. CONCLUSION: This multicenter, prospective, pilot study demonstrates a bivalent property of IP VWF in LR and oncological outcome; low preoperative VWF appeared to have a negative association on post-resection liver dysfunction, whereas, patients with higher post-resection VWF-Ag concentrations were found to have early HCC recurrence.

    DOI: 10.3233/CBM-190168

    Scopus

    PubMed

  • Aryal B. .  Predictive value of diminished serum PDGF-BB after curative resection of hepatocellular cancer .  Journal of Oncology2019   1925315   2019

     More details

    Language:English   Publisher:Journal of Oncology  

    Purpose. Platelet derived growth factor-BB (PDGF-BB) has emerged as one of the key cytokines in malignant transformation of different cells. PDGF-BB also exhibits a potent mitogenic effect on liver cells; studies have advocated clinical implications of monitoring serum PDGF-BB (sPDGF-BB) in patients with liver disease. We thus investigated the predictive relevance of perioperative sPDGF-BB after curative resection of hepatocellular carcinoma (HCC). Methods. We evaluated perioperative sPDGF-BB in a prospective homogenous cohort of 40 patients diagnosed with HCC. During the first two-year follow-up, patients were evaluated every three months for postresection HCC recurrence. Results. Patients who developed recurrence during two-year follow-up were found to have lower concentration of sPDGF-BB than those without recurrence in both pre- and postoperative settings (P < 0.05 and P < 0.001, resp.). We validated that the reduced postoperative sPDGF-BB (< 2133.29 pg/mL) was associated with an increased incidence of postresection HCC recurrence [area under curve (AUC) > 0.8, 95% confidence interval (CI) = 0.68 - 0.94, P < 0.001]; furthermore, we were able to demonstrate that postoperative sPDGF-BB was an independent predictor of HCC recurrence (hazard ratio = 5.64, 95% CI = 1.56 - 20.30, P < 0.01). Conclusions. These findings provide a new insight into an association between diminished perioperative sPDGF-BB and HCC recurrence. Patients with low perioperative sPDGF-BB progressed early HCC recurrence. Therefore, evaluating perioperative sPDGF-BB may provide useful clinical information to characterize patients with postresection HCC recurrence.

    DOI: 10.1155/2019/1925315

    Scopus

    PubMed

  • Aryal B, Yamakuchi M, Hashiguchi T, Imoto Y .  Intra-platelet Serotonin as a Biomarker in HCC Recurrence: When Time Matters. .  Journal of Cancer10 ( 11 ) 2384 - 2385   2019

     More details

    Language:English   Publisher:Journal of Cancer  

    DOI: 10.7150/jca.30696

    Scopus

    PubMed

  • Aryal B. .  Therapeutic implication of platelets in liver regeneration –hopes and hues .  Expert Review of Gastroenterology and Hepatology12 ( 12 ) 1219 - 1228   2018.12

     More details

    Language:English   Publisher:Expert Review of Gastroenterology and Hepatology  

    DOI: 10.1080/17474124.2018.1533813

    Scopus

    PubMed

  • Yamakuchi M, Hashiguchi T .  Endothelial Cell Aging: How miRNAs Contribute? .  Journal of clinical medicine7 ( 7 )   2018.7

     More details

    Language:English   Publisher:Journal of Clinical Medicine  

    Endothelial cells (ECs) form monolayers and line the interior surfaces of blood vessels in the entire body. In most mammalian systems, the capacity of endothelial cells to divide is limited and endothelial cells are prone to be senescent. Aging of ECs and resultant endothelial dysfunction lead to a variety of vascular diseases such as atherosclerosis, diabetes mellites, hypertension, and ischemic injury. However, the mechanism by which ECs get old and become senescent and the impact of endothelial senescence on the vascular function are not fully understood. Recent research has unveiled the crucial roles of miRNAs, which are small non-coding RNAs, in regulating endothelial cellular functions, including nitric oxide production, vascular inflammation, and anti-thromboformation. In this review, how senescent-related miRNAs are involved in controlling the functions of ECs will be discussed.

    DOI: 10.3390/jcm7070170

    Scopus

    PubMed

  • Ohno Sachi, Kohjitani Atsushi, Miyata Masaaki, Tohya Akina, Yamashita Kaoru, Hashiguchi Teruto, Ohishi Mitsuru, Sugimura Mitsutaka .  Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia .  International Heart Journal59 ( 3 ) 559 - 565   2018.5

     More details

    Language:English   Publisher:International Heart Journal Association  

    <p>Endothelial dysfunction is observed in several cardiovascular diseases, where endothelium-dependent vasodilation is impaired by oxidative stress. However, the time course of endothelial function during the perioperative period of a minor-to-moderate surgery, and the effects of atherosclerotic risk factors and employed general anesthetics on recovery of endothelial function, are unknown. Endothelial function of 30 patients was evaluated as the reactive hyperemia index (RHI) of reactive hyperemia peripheral arterial tonometry. RHI was measured on day before surgery (control), immediately after surgery (Day 0), day after surgery (Day 1), and day 4 after surgery (Day 4) in patients with no functional limitations who were scheduled for oral and maxillofacial surgery of around 3 hours. Sevoflurane- or propofol-based anesthesia supplemented with an opioid analgesic remifentanil was employed. The control RHI was 2.26 ± 0.64. The RHI significantly decreased to the lowest level on Day 0 (1.52 ± 0.28), recovered on Day 1 (2.07 ± 0.58), and improved further on Day 4 (2.55 ± 0.83). Multiple linear regression analysis revealed that recovery of the RHI from Day 0 to Day 4 was impaired by diabetes mellitus (<i>P</i> = 0.0313), obesity (BMI ≥ 25; <i>P</i> = 0.0166), hyperuricemia (uric acid ≥ 6.0 mg/dL; <i>P</i> = 0.0416) and sevoflurane-based anesthesia (<i>P</i> = 0.0308). These findings suggest that endothelial function as evaluated by the RHI is severely suppressed on the day of a minor-to-moderate surgery, and that it improves until the 4th postoperative day on average. Recovery of endothelial function is impaired by diabetes mellitus, obesity, hyperuricemia, and sevoflurane-based anesthesia.</p>

    DOI: 10.1536/ihj.17-143

    Scopus

    PubMed

  • Ohno Sachi, Kohjitani Atsushi, Miyata Masaaki, Tohya Akina, Yamashita Kaoru, Hashiguchi Teruto, Ohishi Mitsuru, Sugimura Mitsutaka .  小~中等度手術後の血管内皮機能の回復は糖尿病、肥満、高尿酸血症、セボフルランベースの麻酔によって障害される(Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia) .  International Heart Journal59 ( 3 ) 559 - 565   2018.5小~中等度手術後の血管内皮機能の回復は糖尿病、肥満、高尿酸血症、セボフルランベースの麻酔によって障害される(Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia)

     More details

    Language:English   Publisher:(一社)インターナショナルハートジャーナル刊行会  

    小~中等度手術の周術期における血管内皮機能の時間経過と、アテローム動脈硬化症の危険因子および全身麻酔が血管内皮機能の回復に及ぼす影響を調べた。3時間程度の口腔および顎顔面手術を行い、レミフェンタニルを追加したセボフルランまたはプロポフォールベースの麻酔を行った18歳以上の患者を対象とした。血管内皮機能は反応性充血末梢動脈圧力測定の反応性充血指標(RHI)によって手術前日、手術直後、1、4日後に評価した。30例(男性13例、女性17例、平均48.3±18.4歳)のデータ解析を行った。平均RHIは手術前日が2.26±0.64で、手術直後に1.52±0.28と最も低く、術後1日では2.07±0.58と回復し、4日目には更に改善して2.55±0.83となった。重回帰分析により、RHIの術後の改善は糖尿病、肥満、高尿酸血症、セボフルランベースの麻酔によって障害されることが示された。

  • Higashi Y. .  High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice .  Experimental Dermatology27 ( 2 ) 178 - 184   2018.2

     More details

    Language:English   Publisher:Experimental Dermatology  

    Psoriasis, a chronic inflammatory skin disease, is closely related to systemic metabolism. An elevated body mass index (BMI) is a risk factor for psoriasis; inflammasomes are activated by adipose tissue macrophages in obese subjects. We hypothesized that hyperlipidaemia is involved in the pathogenesis of psoriasis and examined the role of a high-fat diet (HFD) in the development of psoriasis in imiquimod (IMQ)-treated mice. The body weight and serum level of cholesterol were significantly higher in mice fed an HFD than in a regular diet (RD). HFD mice had higher psoriasis skin scores, and the number of neutrophils infiltrating into the lesional skin was elevated. IL-17A mRNA expression was significantly increased in the skin of IMQ-treated HFD mice; the expression of IL-22, IL-23 and TNF-α mRNA was not enhanced. Caspase-1 and IL-1β were activated in the skin of IMQ-treated HFD mice, and their serum level of IL-17A, TNF-α and IL-1β was significantly upregulated. Our findings strongly suggest that hyperlipidaemia is involved in the development and progression of psoriasis via systemic inflammation and inflammasome activation.

    DOI: 10.1111/exd.13484

    Scopus

    PubMed

  • Takagi K. .  IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424/503 in vitro .  Cellular Signalling42   270 - 280   2018.1

     More details

    Language:English   Publisher:Cellular Signalling  

    Pulmonary arterial hypertension (PAH) has a major effect on life expectancy with functional degeneracy of the lungs and right heart. Interleukin-13 (IL-13), one of the type 2 cytokines mainly associated with allergic diseases, has recently been reported to be associated with Schistosomiasis-associated PAH which shares pathological features with other forms of PAH, such as idiopathic PAH and connective tissue disease-associated PAH. But a direct pathological role of IL-13 in the development of PAH has not been explored. We examined the effects of recombinant human IL-13 on the function of primary human pulmonary artery endothelial cells (HPAECs) to examine how IL-13 influences exacerbation of PAH. IL-13 increased the expression of Rictor, which is a key molecule of mammalian target of rapamycin complex 2. Treatment of IL-13 induced HPAEC migration via Rictor. Rictor was directly regulated by both miR-424 and 503 (miR-424/503). Therefore, IL-13 increases Rictor level by regulating miR-424/503, causing the increase of HPAEC migration. Since enhancement of HPAEC migration in the lung is thought to be associated with PAH, these data suggest that IL-13 takes some roles in exacerbating PAH.

    DOI: 10.1016/j.cellsig.2017.10.019

    Scopus

    PubMed

  • Aryal B. .  Deciphering platelet kinetics in diagnostic and prognostic evaluation of hepatocellular carcinoma .  Canadian Journal of Gastroenterology and Hepatology2018   9142672   2018

     More details

    Language:English   Publisher:Canadian Journal of Gastroenterology and Hepatology  

    Liver pathophysiology can, directly and indirectly, impose morphological or biochemical abnormalities of the platelets. Conversely, platelets are also able to regulate the promitogenic and profibrotic signals on liver pathobiology. Platelet contribution to the liver pathophysiology is typically facilitated by the platelet-derived growth factors that are sequestered in different subsets of alpha and dense granules, and the release of these growth factors is synchronized according to the stage and type of liver disease or injury. Thus, platelets harbor clinically relevant information with potential diagnostic and prognostic implications in liver diseases. Hepatocellular carcinoma (HCC) largely influences the platelet kinetics, and a growing body of evidence has recognized its association with HCC occurrence or prognosis. This narrative review summarizes the progress made on implicating platelet as a diagnostic and prognostic tool for HCC; the review also dissects the contradictory results from earlier studies and reflects how combining platelet-based information may enable more reliable test for diagnostic and prognostic evaluation of HCC.

    DOI: 10.1155/2018/9142672

    Scopus

    PubMed

  • 橋口 照人 .  採血から検査結果の解釈まで .  日本血栓止血学会誌29 ( 6 ) 545 - 549   2018

     More details

    Language:Japanese   Publisher:一般社団法人 日本血栓止血学会  

    DOI: 10.2491/jjsth.29.545

  • Panta S. .  Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner .  Biochemical and Biophysical Research Communications483 ( 2 ) 803 - 809   2017.2

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    In the course of studying crosstalk between inflammation and angiogenesis, high doses of pro-inflammatory factors have been reported to induce apoptosis in cells. Under normal circumstances also the pro-inflammatory cytokines are being released in low doses and are actively involved in cell signaling pathways. We studied the effects of low grade inflammation in growth factor induced angiogenesis using tumor necrosis factor alfa (TNFα) and vascular endothelial growth factor A (VEGF) respectively. We found that low dose of TNFα can inhibit VEGF induced angiogenesis in human umbilical vein endothelial cells (HUVECs). Low dose of TNFα induces mild upregulation and moreover nuclear localization of tumor suppressor protein 53 (P53) which causes decrease in inhibitor of DNA binding-1 (Id1) expression and shuttling to the cytoplasm. In absence of Id1, HUVECs fail to upregulate β3-integrin and cell migration is decreased. Connecting low dose of TNFα induced p53 to β3-integrin through Id1, we present additional link in cross talk between inflammation and angiogenesis.

    DOI: 10.1016/j.bbrc.2016.12.096

    Scopus

    PubMed

  • Yoshihara N, Terasaki H, Shirasawa M, Kawano H, Sonoda S, Yamaguchi M, Hashiguchi T, Hisatomi T, Ishibashi T, Sakamoto T .  PERMEABILITY AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO. .  Retina (Philadelphia, Pa.)37 ( 1 ) 179 - 190   2017.1

     More details

    Language:English   Publisher:Retina  

    Purpose: To determine the effects of bevacizumab, ranibizumab, and aflibercept on the permeability and the effects of anti-vascular endothelial growth factor (VEGF) on highly polarized retinal pigment epithelial cells (RPECs) in vitro. Methods: Highly polarized RPECs were cultured in the upper chamber of a Transwell system. Anti-VEGF antibodies were added to the upper chamber, and the concentrations of the drugs in the lower chambers were measured. The permeability rates of the three anti- VEGF drugs through the RPEC layer and the concentration of VEGF in each chamber were determined. Results: The permeability of aflibercept was significantly lower by about 40% than that of bevacizumab through the RPEC layer (P < 0.05). Ranibizumab was significantly more permeable through the RPECs than bevacizumab (180% of bevacizumab, P < 0.05). Although VEGF was almost absent in the upper chamber after exposure to the 3 antibodies, it was decreased more significantly with aflibercept than with bevacizumab in the lower chamber (2.8% vs. 65.8% of control; P < 0.01). Ranibizumab also decreased the VEGF level compared with bevacizumab (31.7% vs. 65.8% of control; P < 0.01). Conclusion: The greater reduction of the amount of VEGF in the lower chamber by aflibercept and ranibizumab than bevacizumab may explain why aflibercept and ranibizumab are more effective than bevacizumab against type 1 choroidal neovascularization.

    DOI: 10.1097/IAE.0000000000001117

    Scopus

    PubMed

  • Aryal B. .  Post-resection exhaustion of intra-platelet serotonin: Also an indicator of early hepatocellular carcinoma recurrence? .  Journal of Cancer8 ( 19 ) 3984 - 3991   2017

     More details

    Language:English   Publisher:Journal of Cancer  

    Purpose: Serotonin (5-hydroxytryptamine, 5-HT) is well known for its growth stimulatory effect on several types of carcinoma and tumor cells. Since a large portion of 5-HT is stored and transported by platelets, the aim of this study was to assess the influence of platelet-sequestered 5-HT on post-resection hepatocellular carcinoma (HCC) recurrence. Methods: This pilot study was conducted in a cohort of forty patients diagnosed with HCC undergoing partial hepatectomy. 5-HT levels in serum, plasma and intra-platelet (IP) were monitored preoperatively and four weeks after liver resection. The patients were followed every three months after the surgery. Results: Follow-up was standardized to a fixed length of time. Fifteen patients (37.5%) developed HCC recurrence during 18 months follow-up. Patients with recurrence had significantly reduced serum and IP 5-HT levels at four weeks of liver resection (P = 0.003 and P = 0.014 respectively). Accordingly, in the Cox regression hazard model, serum and IP 5-HT were able to independently predict the recurrence (hazard ratio = 0.1, 95% confidence interval = 0.01 - 0.75 and hazard ratio = 0.1, 95% confidence interval = 0.01 - 0.89 respectively). The optimal cut-off value of 42.77 ng/ml for serum [area under the curve (AUC): 0.78, P = 0.003] and 0.3117 ng per 106 platelets (AUC: 0.733, P = 0.015), on receiver operating characteristic (ROC) curve corresponded to maximum sensitivity and specificity of prediction. The disease free interval was significantly worse in patients with low serum and IP 5-HT (P = 0.001 and P = 0.029 respectively). Conclusion: IP 5-HT monitored during early follow-up, after liver resection may represent a useful marker of early HCC recurrence.

    DOI: 10.7150/jca.20971

    Scopus

    PubMed

  • Maenosono Ryuichi, Yuasa Toshinori, Kisanuki Akira, Ohishi Mitsuru, Hashiguchi Teruto, Mizukami Naoko, Oketani Naoya, Iriki Yasuhisa, Yunoue Shingo, Kobayashi Saori, Nakamura Yukimi, Oozono Nanase, Takasaki Kunikazu .  Relationship between Total Atrial Conduction Time and Recurrence of Atrial Fibrillation after Complex Fractionated Atrial Electrogram Ablation of Paroxysmal Atrial Fibrillation .  Japanese Journal of Medical Ultrasound Technology42 ( 4 ) 399 - 409   2017

     More details

    Language:Japanese   Publisher:Japanese Society of Sonographers  

    <p><b>Purpose</b>: Recently, it has been reported that an index of the total atrial conduction time derived by tissue Doppler imaging (PA-TDI duration) has a superior accuracy for prediction of atrial fibrillation (AF) recurrence compared with the left atrial volume index (LAVI) after pulmonary vein isolation (PVI). We performed catheter ablation targeting complex fractionated atrial electrograms (CFAE ablation) on patients with AF and explored the independent predictor of AF recurrence after CFAE ablation.</p><p><b>Subjects and methods</b>: Our study included 160 patients with paroxysmal AF who underwent AF ablation (CFAE ablation or CFAE ablation+PVI) for the first time. Of these, 107 patients in whom a measurement of PA-TDI duration was possible were divided into no recurrence and recurrence groups. Univariable and multivariable Cox proportional hazards analyses were performed to investigate predictors of AF recurrence after AF ablation. The receiver operator characteristics (ROC) curve was calculated to evaluate the performance of possible independent predictors of AF recurrence after AF ablation was obtained by multivariate analysis. The time-dependent changes of PA-TDI duration and LAVI were observed to investigate the predictors of AF recurrence after AF ablation.</p><p><b>Results</b>: The left atrial dimension (LAD) was significantly larger in the recurrence group than in the no recurrence group (41.1±5.4 mm to 38.1±5.1 mm, p<0.01). In the multivariate analysis, the left atrial volume (LAV) and LAD were suggested as independent predictors of AF recurrence after AF ablation. However, the ROC curve analyses demonstrated that LAV and LAD had low accuracy of predicting AF recurrence after AF ablation (area under the curve: LAV, 0.609; LAD, 0.659). There were no significant differences in PA-TDI duration or LAVI in both strategies before ablation between the recurrence and the no recurrence groups. Six months after the ablation, the PA-TDI duration in the recurrence group was significantly longer than before ablation with both strategies (CFAE ablation: 142.9±18.5 ms to 155.4±17.6 ms, p<0.01; CFAE ablation+PVI: 135.6±20.3 ms to 155.1±21.8 ms, p<0.01), and PA-TDI duration in the no recurrence group with CFAE ablation was significantly shorter than before ablation (141.8±23.3 ms to 131.1±23.9 ms, p=0.011). However, there was no significant difference in LAVI between the recurrence and no recurrence groups for both strategies.</p><p><b>Conclusion</b>: The data obtained before ablation could not predict AF recurrence after CFAE ablation for patients with paroxysmal AF. However, longer PA-TDI duration at the 6-month followup may predict AF recurrence after CFAE ablation for paroxysmal AF.</p>

    DOI: 10.11272/jss.42.399

  • HASHIGUCHI Teruto .  Basic concept for evaluating coagulation and fibrinolysis data .  Rinsho Ketsueki58 ( 10 ) 2096 - 2103   2017

     More details

    Language:Japanese   Publisher:The Japanese Society of Hematology  

    <p>"Fibrin is insoluble in blood" is the most important concept to accept the coagulation system. Essentially, blood coagulation is a process to convert blood from soluble to insoluble. Fibrinolysis is another process to convert insoluble protein to soluble protein again. The blood coagulation cascade requires calcium ion and efficiently acts on platelet phospholipid membranes. On the other hand, the fibrinolysis system efficiently acts on fibrin. Unlike other vitamin K-dependent coagulation factors, thrombin can be released from the coagulation site to the systemic circulation and has multiple biological effects regulated through thrombin receptors. Thrombin is captured by thrombomodulin on endothelial cells or anti-thrombin. Low level of coagulation and fibrinolysis idling are always working even under healthy conditions because of shear stress on injured vessels. Measurement of coagulation times, such as PT and APTT, is the basic method used by numerous clinics in coagulation-related examinations. Measurement of coagulation factor activity by one method is based on the concept that excess amounts of coagulation factors circulate in the blood. Under DIC conditions, excess pathological protease activity yields a huge amount of peptides in the blood in addition to coagulation and fibrinolysis markers.</p>

    DOI: 10.11406/rinketsu.58.2096

    PubMed

  • Namino Fuminori, Yamakuchi Munekazu, Iriki Yasuhisa, Maenosono Ryuichi, Oketani Naoya, Ohishi Mitsuru, Maruyama Ikuro, Hashiguchi Teruto .  心房細動アブレーション治療における血管内皮機能への影響の解明 CAVIの新たな有用性の探索(Comparison between cardio-ankle vascular index and biomarkers of endothelial function in patients with atrial fibrillation underwent catheter ablation) .  福田記念医療技術振興財団情報 ( 29 ) 103 - 112   2016.12心房細動アブレーション治療における血管内皮機能への影響の解明 CAVIの新たな有用性の探索(Comparison between cardio-ankle vascular index and biomarkers of endothelial function in patients with atrial fibrillation underwent catheter ablation)

     More details

    Language:English   Publisher:(公財)福田記念医療技術振興財団  

    カテーテルアブレーションを施行した心房細動(AF)患者を対象に、術前と術後6ヵ月後の心臓足首血管指数(CAVI)を比較し、CAVIが内皮障害のマーカーとなりうるか検討した。カテーテルアブレーションを施行したAF患者101名(男81名、女20名、平均年齢61.8±8.6歳)を対象とした。6ヵ月後に来院しなかった23名は除いた。78名のうち、洞調律(SR)に回復した患者は33名、AFが再発した患者は45名であった。ベースライン時のCAVIについて、SR回復群とAF再発群との間に有意差はなかった。6ヵ月後のCAVIは両群ともベースライン時と差がなかった。CAVIは年齢と強い相関があり、左室駆出分画と弱い相関がみられた。内皮細胞のバイオマーカーである血清トロンボモデュリン濃度は、SR回復群の方がベースライン時は高値で、両群とも6ヵ月後は上昇していた。ベースライン時の血漿プラスミノーゲンアクチベーターインヒビター1濃度は両群間で差はなく、両群とも6ヵ月後に上昇していた。primary-miR-126とmature miR-126はAF再発群で6ヵ月後に低下し、内皮機能の新しいバイオマーカーとなり得ると考えられた。

  • Kawamura Hideki, Tokuda Koichi, Imuta Naoko, Kubota Tomohiro, Koriyama Toyoyasu, Miyanohara Hiroaki, Hashiguchi Teruto, Kawano Yoshifumi, Nishi Junichiro .  Epidemiological Analysis of Nosocomial MRSA Outbreaks Using Phage Open-Reading Frame Typing in a Tertiary-Care Hospital .  Japanese Journal of Infectious Diseases69 ( 6 ) 523 - 524   2016.11

     More details

    Language:English   Publisher:National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee  

    Pulsed-field gel electrophoresis (PFGE) is a reliable method for analyzing outbreaks of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA); however, it is time-consuming and technically demanding. A new strain-differentiation method for MRSA, namely phage open reading frame (ORF) typing (POT), is a rapid PCR-based technique, in which the ORFs of lysogenized phage genomes in MRSA are amplified. The aim of this study was to evaluate the utility of the POT method for epidemiological analysis of nosocomial MRSA outbreaks. Forty-four strains from 12 episodes of 3 or more nosocomial MRSA infections in 1 ward within a 4-week period were characterized using PFGE and POT methods. The strains were classified into 16 distinct types using POT and 19 subtypes using PFGE. We defined an outbreak as 3 or more new MRSA infections caused by strains with indistinguishable genetic patterns. The identification of 11 (91.7%) episodes by PFGE, including 4 outbreaks and 7 sporadic events, was consistent with the results of POT analysis. These results suggest that POT is a useful epidemiological tool for evaluating nosocomial MRSA outbreaks.

    DOI: 10.7883/yoken.JJID.2015.320

    Scopus

    PubMed

  • Kawamura Hideki, Tokuda Koichi, Imuta Naoko, Kubota Tomohiro, Koriyama Toyoyasu, Miyanohara Hiroaki, Hashiguchi Teruto, Kawano Yoshifumi, Nishi Junichiro .  phage open-reading frame typingを用いた三次医療施設におけるMRSA院内アウトブレイクの疫学的解析(Epidemiological Analysis of Nosocomial MRSA Outbreaks Using Phage Open-Reading Frame Typing in a Tertiary-Care Hospital) .  Japanese Journal of Infectious Diseases69 ( 6 ) 523 - 524   2016.11phage open-reading frame typingを用いた三次医療施設におけるMRSA院内アウトブレイクの疫学的解析(Epidemiological Analysis of Nosocomial MRSA Outbreaks Using Phage Open-Reading Frame Typing in a Tertiary-Care Hospital)

     More details

    Language:English   Publisher:国立感染症研究所  

    三次医療施設におけるMRSA院内アウトブレイクを疫学的に解析するためのphage open-reading frame typing(POT)の有用性を評価した。4週間以内の1病棟のMRSA新規感染症例が3例以上の場合をアウトブレイクと定義し、12エピソード由来の44株について、POT型とPFGEパターンを比較した。44株は16POT型に分類された。最頻度のPOT型は207-117の20株で、PFGEのA型(n=12)、E型(n=6)、I型(n=1)、K1型(n=1)から成っていた。2番目に頻度が高かったのは207-113型の4株で、PFGEのA(n=1)、E1(n=1)、E2(n=1)、I(n=1)から成っていた。4エピソードはPFGEとPOTによりアウトブレイクと特定された。7エピソードはPFGEとPOTのどちらでもアウトブレイクと特定されなかった。PFGEによる、アウトブレイク4と散発例7を含む11エピソード特定率(91.7%)は、POT解析による成績と一致した。POTはMRSA院内アウトブレイクの評価に有用であることが示唆された。

  • Shimizu T, Yamakuchi M, Biswas KK, Aryal B, Yamada S, Hashiguchi T, Maruyama I .  HMGB1 is secreted by 3T3-L1 adipocytes through JNK signaling and the secretion is partially inhibited by adiponectin. .  Obesity (Silver Spring, Md.)24 ( 9 ) 1913 - 21   2016.9

     More details

    Language:English   Publisher:Obesity  

    Objective: Obesity is a chronic inflammatory disease, and adipocytes contribute to obesity-associated inflammation by releasing inflammatory mediators. High mobility group box 1 (HMGB1), a highly conserved DNA-binding protein, mainly localized to cell nuclei, has been recently recognized as an innate pro-inflammatory mediator when released extracellularly. It was hypothesized that HMGB1 is an adipocytokine that acts as an innate pro-inflammatory mediator in white adipose tissue (WAT) of patients with obesity and is associated with insulin resistance. Additionally, it was hypothesized that HMGB1 secretion is regulated by adiponectin. Methods: 3T3-L1 cells were differentiated into mature adipocytes. After tumor necrosis factor-α (TNF-α) stimulation, HMGB1 in culture media was measured. Localizations of HMGB1 in 3T3-L1 adipocytes and human WAT were examined by immunostaining. Results: HMGB1 was secreted from TNF-α-induced 3T3-L1 adipocytes through JNK signaling. HMGB1-activated MAP kinases (ERK1/2, JNK) and suppressed insulin-stimulated Akt phosphorylation in 3T3-L1 adipocytes. The cytoplasm in 3T3-L1 adipocytes and adipocytes of WAT from a patient with obesity was intensely stained with HMGB1. Adiponectin partially inhibited TNF-α-induced HMGB1 secretion from 3T3-L1 adipocytes. Conclusions: These findings suggest that HMGB1 is a pro-inflammatory adipocytokine involved in WAT inflammation and insulin resistance in patients with obesity, which may contribute to the progression of metabolic syndrome, and that adiponectin protects against HMGB1-induced adipose tissue inflammation.

    DOI: 10.1002/oby.21549

    Scopus

    PubMed

  • 竹岡 啓子, 日高 洋, 菱沼 昭, 池田 勝義, 大久保 滋夫, 土屋 逹行, 橋口 照人, 古田 耕, 堀田 多恵子, 松下 一之, 松本 祐之, 村上 正巳, 前川 真人, 日本臨床検査医学会標準化委員会 .  甲状腺刺激ホルモン(TSH)のハーモナイゼーション .  臨床病理64 ( 4 ) 375 - 379   2016.4甲状腺刺激ホルモン(TSH)のハーモナイゼーション

     More details

    Language:Japanese   Publisher:(一社)日本臨床検査医学会  

    甲状腺刺激ホルモン(TSH)のハーモナイゼーションについて検討した。アーキテクトTSH、エクルーシスTSH、ルミパルスTSH-III、Eテスト「TOSOH」II(TSH)について検討した。NIBSC81/565調製液の濃度に対して、ルミパルスの測定値が最も低く平均94.3%、エクルーシスの測定値も平均97.1%と低値であった。アーキテクトは平均106.1%と高値、Eテスト「TOSOH」は平均118.7%と最も高値であった。臨床検査精度管理調査用試料では、ルミパルス、アーキテクト、Eテスト「TOSOH」の3試薬で比較し、ルミパルスが低値、Eテスト「TOSOH」が高値となった。エクルーシスは4試薬の中で最も高値を示した。各試薬での測定値とAPTMとの差は換算することにより減少した。また、試薬による測定値の変動も換算することにより減少した。

  • Hashiguchi T. .  Iron metabolism regulated by erythropoietin and clinical application for myelodysplastic syndrome .  Japanese Journal of Clinical Chemistry45 ( 2 ) 117 - 119   2016.4

     More details

    Language:Japanese   Publisher:Japanese Journal of Clinical Chemistry  

    Scopus

  • Aryal B, Shimizu T, Kadono J, Furoi A, Komokata T, Inoue M, Ikeda S, Fukukura Y, Nakamura M, Yamakuchi M, Hashiguchi T, Imoto Y .  A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans. .  PloS one11 ( 3 ) e0150446   2016

     More details

    Language:English   Publisher:PLoS ONE  

    Background Liver regeneration (LR) involves an early inductive phase characterized by the proliferation of hepatocytes, and a delayed angiogenic phase distinguished by the expansion of nonparenchymal compartment. The interest in understanding the mechanism of LR has lately shifted from the proliferation and growth of parenchymal cells to vascular remodeling during LR. Angiogenesis accompanied by LR exerts a pivotal role to accomplish the process. Vascular endothelial growth factor (VEGF) has been elucidated as the most dynamic regulator of angiogenesis. From this perspective, platelet derived/Intra-platelet (IP) VEGF-A should be associated with LR. Material and Methods Thirty-seven patients diagnosed with hepatocellular carcinoma and undergoing partial hepatectomy (PH) were enrolled in the study. Serum and IP VEGF-A was monitored preoperatively and at four weeks of PH. Liver volumetry was determined on computer models derived from computed tomography (CT) scan. Results Serum and IP VEGF-A was significantly elevated at four weeks of PH. Preoperative IP VEGF-A was higher in patients with advanced cancer and vascular invasion. Postoperative IP VEGF-A was higher after major liver resection. There was a statistically significant correlation between postoperative IP VEGF-A and the future remnant liver volume. Moreover, the soluble vascular endothelial growth factor receptor-1 (sVEGFR1) was distinctly downregulated suggesting a fine-Tuned angiogenesis at the later phase of LR. Conclusion IP VEGF-A is overexpressed during later phase of LR suggesting its implications in inducing angiogenesis during LR.

    DOI: 10.1371/journal.pone.0150446

    Scopus

    PubMed

  • HASHIGUCHI Teruto .  Extrinsic coagulation cascade and diversity of prothrombin time .  Japanese Journal of Thrombosis and Hemostasis27 ( 6 ) 631 - 635   2016

     More details

    Language:Japanese   Publisher:The Japanese Society on Thrombosis and Hemostasis  

    DOI: 10.2491/jjsth.27.631

  • 竹之下 友寿, 政元 いずみ, 谷口 眞由美, 田畑 仁美, 高味 聡子, 橋口 照人, 西川 拓朗, 河野 嘉文 .  MLL関連ALLにおけるneural-glial antigen 2(NG2)抗原使用の有用性について .  Cytometry Research25 ( 2 ) 21 - 26   2015.10MLL関連ALLにおけるneural-glial antigen 2(NG2)抗原使用の有用性について

     More details

    Language:Japanese   Publisher:(一社)日本サイトメトリー学会  

    症例1は15歳男子で、38℃台の発熱を認め、日中は解熱する熱型で推移した。数日前から眼瞼周囲に紫斑を認め、救急外来で末梢血に異常を認め、救急搬送された。10万を超える白血球の異常増加、リンパ芽球様異常細胞増加、貧血、血小板減少を認めた。細胞形態は好中球と同等の大きさで細胞質は好塩基性に富み、N/C比が大きく、核網微細で大きな核小体を認め一部にブレブを認めた。LDHの高度上昇を認め、Dダイマーが高値であった。CD10陰性、CD15陽性、CD34一部陽性の結果から混合血統白血病(MLL)関連急性リンパ性白血病(ALL)を疑い神経膠抗原2(NG2)抗体を用い追加検査を行った結果、NG2強陽性となり、MLL関連ALL疑いと報告できた。症例2は5歳男児で、鼻出血を繰り返し、左足の紫斑に気付き、2日後から39℃台の発熱を認め、紫斑が増加した。急性白血病が疑われ緊急入院した。リンパ芽球様異常細胞増加、貧血、血小板減少を認めた。骨髄検査でNCC 55.9万/mm3、MgK 12.5/mm3、Blasts 97.0%、LDH高度上昇を認めた。骨髄血のFISH検査ではMLLスプリットシグナルは99.0%であった。NG2抗体を用いたMRD追跡を行った。MLLスプリットシグナル陽性率とNG2の陽性率は同様の変化をしていた。

  • Ichinose A., Osaki T., Souri M., Matsushita T., Urano T., Ieko M., Tamai Y., Ito T., Kawamae K., Yamamoto M., Madoiwa S., Kurosawa H., Ogawa Y., Yatomi Y., Hanafusa N., Kawasugi K., Ishida F., Kitajima I., Asakura H., Hosono N., Mouri H., Kobayashi T., Wada H., Miyata S., Kashiwagi H., Ikeda M., Yukawa M., Higasa S., Hato T., Okamoto K., Okamura T., Uchiba M., Hashiguchi T., Maruyama I. .  Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies .  Haemophilia21 ( 5 ) 653 - 658   2015.9

     More details

    Language:Japanese   Publisher:Haemophilia  

    Introduction: Autoimmune haemophilia-like disease (or haemorrha-philia) due to anti-factor XIII (FXIII; F13 to avoid confusion with FVIII or FXII) antibodies (termed AH13) is a severe bleeding disorder. Although AH13 is thought to be rare, 'the number of its diagnosed patients' has recently increased in Japan. However, its prevalence remains unknown. Aim: To improve understanding of this disease, we examined and diagnosed 32 'new' Japanese patients with AH13. Methods: The presence of antibodies against F13-A subunit and/or F13-B subunit was confirmed by using a dot blot test and enzyme-linked immunosorbent assays. Results: Most of our patients had autoantibodies against the F13-A subunit (88%). A predominance of men (59%) was observed. The mean age and residual F13 activity of our AH13 cohort were 71.7 years and 10.5% of normal, respectively, and 53% of cases were idiopathic. Autoimmune disorders and malignancies were the leading underlying disease (both 16%). Intramuscular and subcutaneous bleeding were the leading symptoms (both 72%). Most of our patients were treated with F13 concentrates (72%) to arrest bleeding and with prednisolone (81%) to eradicate anti-F13 autoantibodies. Cyclophosphamide and rituximab (both 25%) were also administered. The mortality of AH13 was high (22%), and haemorrhage was the major cause of death (71%). Moreover, 13% of our AH13 patients were diagnosed after haemorrhagic death. Conclusion: Physicians/haematologists must raise the awareness of AH13 as a life-threatening disease. This report represents the only experience of a nationwide survey, and may contribute to a diagnosis on potentially overlooked non-Japanese AH13 patients in other countries in the world.

    DOI: 10.1111/hae.12677

    Scopus

  • Ochiai R, Sugiura Y, Otsuka K, Katsuragi Y, Hashiguchi T .  Coffee bean polyphenols ameliorate postprandial endothelial dysfunction in healthy male adults. .  International journal of food sciences and nutrition66 ( 3 ) 350 - 4   2015.5

     More details

    Language:Japanese   Publisher:International Journal of Food Sciences and Nutrition  

    To reveal the effect of coffee bean polyphenols (CBPs) on blood vessels, this study aimed to investigate the effect of CBPs on acute postprandial endothelial dysfunction. Thirteen healthy non-diabetic men (mean age, 44.9±1.4 years) consumed a test beverage (active: containing CBPs, placebo: no CBPs) before a 554-kcal test meal containing 14g of protein, 30g of fat and 58g of carbohydrates. Then, a crossover analysis was performed to investigate the time-dependent changes in flow-mediated dilation (FMD) in the brachial artery. In the active group, the postprandial impairment of FMD was significantly improved, the two-hour postprandial nitric oxide metabolite levels were significantly increased and the six-hour postprandial urinary 8-epi-prostaglandin F2α levels were significantly reduced compared to the placebo group. The test meal increased the levels of blood glucose, insulin and triglycerides in both groups with no significant intergroup differences. These findings indicate that CBPs intake ameliorates postprandial endothelial dysfunction in healthy men.

    DOI: 10.3109/09637486.2015.1007453

    Scopus

    PubMed

  • Ikeda K, Ichihara K, Hashiguchi T, Hidaka Y, Kang D, Maekawa M, Matsumoto H, Matsushita K, Okubo S, Tsuchiya T, Furuta K, Committee for Standardization, The Japanese Society of Laboratory Medicine (JSLM). .  Evaluation of the short-term stability of specimens for clinical laboratory testing. .  Biopreservation and biobanking13 ( 2 ) 135 - 43   2015.4

     More details

    Language:Japanese   Publisher:Biopreservation and Biobanking  

    Background: A major concern in both the laboratory-medicine and research communities is the quality of human specimens for analysis. However, there is insufficient scientific evidence regarding optimal conditions for handling and storing routine specimens, especially those in liquid form. Thus, we investigated the stability of clinically relevant samples stored under various conditions. Materials and Methods: Ten clinical laboratories in Japan conducted analyses of the stability of post-clinical (left over after analysis) test samples in relation to temperature and storage duration. We examined serum, whole blood, and urine samples submitted to each laboratory for routine testing. In this study, at least 5 samples for each of 35 tests were analyzed at each laboratory. After completion of routine testing, specimens with sufficient residual volume and values between LL-R/2 (lower limit of reference interval) and UL+R/2 (upper limit) were divided into 300 μL aliquots, where R=UL - LL. Aliquots of serum specimens were stored at either room temperature (23°C), 4°C, -20°C, or -80°C without light exposure. Aliquots of whole blood and urine specimens were stored at either 23°C or 4°C. The storage time was either 1, 3, or 7 days. Average differences between pre- and post-storage test results were evaluated for each laboratory test by two-way ANOVA. F-values for between-day variations were used for judging the statistical significance of storage-related changes in test values, whereas the ratio of between-day SD to between-individual SD (one-fourth of reference interval) was used to indicate the practical significance of the change. Results and Conclusion: Sample denaturation is clearly temperature- and storage-duration dependent for almost all analytes. In general, specimens were most susceptible to denaturation at 23°C, then 4°C, -20°C, and -80°C. This study confirmed the accumulated routine, practice-based, detailed knowledge regarding specimen stability and will help to ensure the reliability of laboratory test results.

    DOI: 10.1089/bio.2014.0072

    Scopus

    PubMed

  • Namino F, Iriki Y, Maenosono R, Ichiki H, Okui H, Yoshimura A, Oketani N, Matsushita M, Ohishi M, Hashiguchi T .  The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation. .  Journal of arrhythmia31 ( 1 ) 6 - 11   2015.2

     More details

    Language:English   Publisher:Journal of Arrhythmia  

    Background Complex fractionated atrial electrogram (CFAE)-targeted catheter ablation (CFAE ablation) requires a high rate of atrial fibrillation (AF) termination to provide good outcomes. We determined the optimal settings of CFAE software. Methods In our 430 consecutive patients, AF was terminated in 97 (234/242) and 79% (149/188) of patients with paroxysmal and persistent AF, respectively, by CFAE ablation combined with (31%) or without (69%) pulmonary vein isolation, occasionally with nifekalant infusion. We analyzed 109 consecutive patients who underwent CFAE ablation to determine the optimal settings for comparing subjective versus objective decisions by the CFAE software on CARTO3. We compared three settings: the default setting (0.05-0.15 mV, 50-120 ms) and two modified settings (#1: 0.05-0.30 mV, 40-70 ms, #2: 0.05-0.13 mV, 10-20 ms). We retrospectively analyzed 11,425 points during left atrial mapping before ablation and 10,306 points that were subjectively detected and ablated as CFAE points. An interval confidence level ≥6 denoted a site with CFAE. Results With the default setting, the accuracy, sensitivity, specificity, positive productive value, and negative productive values were 67, 42, 77, 48, and 73%, respectively. With modified setting #1, the values were 78, 55, 87, 74, and 77%, respectively, versus 64, 82, 60, 53, and 91%, respectively, for modified setting #2. Conclusion These data suggest that setting #1 was generally superior to the default setting, whereas setting #2 was optimal for excluding areas not requiring ablation. The optimal CFAE software setting was a voltage of 0.05-0.30 mV and an interval parameter of 40-70 ms.

    DOI: 10.1016/j.joa.2014.04.006

    Scopus

    PubMed

  • Namino Fuminori, Iriki Yasuhisa, Maenosono Ryuichi, Ichiki Hitoshi, Okui Hideki, Yoshimura Akino, Oketani Naoya, Matsushita Masakaze, Ohishi Mitsuru, Hashiguchi Teruto .  心房細動に対する基質アブレーションにおけるcomplex fractionated atrial electrogramソフトウェアの最適設定(The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation) .  Journal of Arrhythmia31 ( 1 ) 6 - 11   2015.2心房細動に対する基質アブレーションにおけるcomplex fractionated atrial electrogramソフトウェアの最適設定(The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation)

     More details

    Language:English   Publisher:(一社)日本不整脈心電学会  

    Complex fractionated atrial electrogram(CFAE)アブレーションを施行した持続性心房細動患者109例(男性87例、女性22例、平均59±10歳)のデータを解析し、CFAEソフトウェアにより主観的および客観的決定を比較するための最適設定について検討した。デフォルト設定(0.05~0.15mV、50~120ms)と2つの修正設定(#1:0.05~0.30mV、40~70ms、#2:0.05~0.13mV、10~20ms)を比較した。アブレーション前の左房マッピング時の11425ポイント、またCFAEポイントとして主観的に検出され焼灼された10300ポイントを後方視的に分析した。デフォルト設定の精度、感度、特異度、陽性的中率、陰性的中率はそれぞれ67%、42%、77%、48%、73%であった。修正設定#1の場合はそれぞれ78%、55%、87%、74%、77%、修正設定#2の場合はそれぞれ64%、82%、60%、53%、91%であった。結論として、修正設定#1は全般的にデフォルト設定より優れており、設定#2はアブレーションを必要としない領域を除外するために最適であった。最適なCFAEソフトウェア設定は0.05~0.30mVの電圧および40~70msの間隔パラメータであった。

  • TAKENOSHITA Tomohisa, MASAMOTO Izumi, TANIGUCHI Mayumi, TABATA Hitomi, TAKAMI Satoko, HASHIGUCHI Teruto, NISHIKAWA Takuro, KAWANO Yoshifumi .  Regarding the utility of the neural-glial antigen 2 (NG2) in MLL-related ALL .  Cytometry Research25 ( 2 ) 21 - 26   2015

     More details

    Language:Japanese   Publisher:Japan Cytometry Society  

    <p>We have recognized the appearance of NG2 antigen in MLL rearrangement-positive ALL. However, it is not clear why NG2 antigen appears in MLL rearrangement-positive ALL. The appearance of NG2 is not distinctive, but it is believed to be useful in MRD detection of MLL rearrangement-positive ALL. Using NG2, we are able to confirm the suspected connection with MLL-related ALL (case 1). And we tried to track the course of MRD in the ALL case (case 2). B cellprecursor acute lymphoblastic leukemia (BCPALL) was initially suspected in case 1. However, positive results for CD79a, CD19 and negative results for CD66c led us to use chondroitin sulfate proteoglycan-type neural-glial antigen 2 antibody (NG2 antibody), with a focus on negative CD10, positive CD15 and partially positive CD34 findings. Positive findings for NG2 confirmed the case 1 as mixed lineage leukemia (MLL)-related ALL. In addition, we confirmed the activity of an idioblast rate by visual observation and the positive rate of the MLL split signal. Tracking of the NG2 positive rate in the course of ALL was effective for the detection of MRD in the case 2.</p>

    DOI: 10.18947/cytometryresearch.25.2_21

  • Amitani M, Cheng KC, Asakawa A, Amitani H, Kairupan TS, Sameshima N, Shimizu T, Hashiguchi T, Inui A .  Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors. .  PeerJ3 ( 8 ) e1105 - 15   2015

     More details

    Language:English   Publisher:PeerJ  

    Objective. Allantoin is the primary active compound in yams (Dioscorea spp.). Recently, allantoin has been demonstrated to activate imidazoline 3 (I3) receptors located in pancreatic tissues. Thus, the present study aimed to investigate the role of allantoin in the effect to improve damage induced in pancreatic β-cells by streptozotocin (STZ) via the I3 receptors. Research Design andMethods. The effect of allantoin on STZ-induced apoptosis in pancreatic β-cells was examined using the ApoTox-Glo triplex assay, live/dead cell double staining assay, flow cytometric analysis, and Western blottings. The potential mechanism was investigated using KU14R: an I3 receptor antagonist, and U73122: a phospholipase C (PLC) inhibitor. The effects of allantoin on serum glucose and insulin secretion were measured in STZ-treated rats. Results. Allantoin attenuated apoptosis and cytotoxicity and increased the viability of STZ-induced β-cells in a dose-dependent manner; this effect was suppressed by KU14R and U73112. Allantoin decreased the level of caspase-3 and increased the level of phosphorylated B-cell lymphoma 2 (Bcl-2) expression detected by Western blotting. The improvement in β-cells viability was confirmed using flow cytometry analysis. Daily injection of allantoin for 8 days in STZ-treated rats significantly lowered plasma glucose and increased plasma insulin levels. This action was inhibited by treatment with KU14R. Conclusion. Allantoin ameliorates the damage of β-cells induced by STZ. The blockade by pharmacological inhibitors indicated that allantoin can activate the I3 receptors through a PLC-related pathway to decrease this damage. Therefore, allantoin and related analogs may be effective in the therapy for β-cell damage.

    DOI: 10.7717/peerj.1105

    Scopus

    PubMed

  • 古城 剛, 田淵 智久, 松下 昌風, 橋口 照人 .  異常値をひもとく・21 高アミラーゼ血症を伴う多発性骨髄腫 .  臨床検査58 ( 13 ) 1663 - 1668   2014.12異常値をひもとく・21 高アミラーゼ血症を伴う多発性骨髄腫

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1542200127

  • Hatanaka M., Higashi Y., Fukushige T., Baba N., Kawai K., Hashiguchi T., Su J., Zeng W., Chen X., Kanekura T. .  Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts .  Anticancer Research34 ( 12 ) 7091 - 7096   2014.12

     More details

    Language:Japanese   Publisher:Anticancer Research  

    Background: Cluster of differentiation 147 (CD147)/basigin on the malignant tumor cell surface is critical for tumor proliferation, invasiveness, metastasis, and angiogenesis. CD147 expressed on malignant melanoma cells can induce tumor cell invasion by stimulating the production of matrix metalloproteinases (MMPs) by surrounding fibroblasts. Membrane vesicles, microvesicles and exosomes have attracted attention, as vehicles of functional molecules and their association with CD147 has been reported. Cleaved CD147 fragments released from tumor cells were reported to interact with fibroblasts. We investigated the intercellular mechanisms by which CD147 stimulates fibroblasts to induce MMP2 activity. Materials and Methods: CD147 was knockeddown using short hairpin RNA (shRNA). The stimulatory effect of CD147 in cell culture supernatants, microvesicles, and exosomes on the enzymatic activity of MMP2 was examined by gelatin zymography. Results: Supernatants from A375 control cells induced increased enzymatic activity of fibroblasts; such activity was significantly lower in CD147 knock-down cells. Conclusion: Cleaved CD147 plays a pivotal role in stimulating fibroblasts to induce MMP2 activity.

    Scopus

  • Kawano H, Sakamoto T, Ito T, Miyata K, Hashiguchi T, Maruyama I .  Hyaluronan protection of corneal endothelial cells against extracellular histones after phacoemulsification. .  Journal of cataract and refractive surgery40 ( 11 ) 1885 - 93   2014.11

     More details

    Language:English   Publisher:Journal of Cataract and Refractive Surgery  

    PURPOSE: To determine the effect of histones on corneal endothelial cells generated during cataract surgery. SETTING: Kagoshima University Hospital, Kagoshima, Japan. DESIGN: Experimental study. METHODS: Standard phacoemulsification was performed on enucleated pig eyes. Histones in the anterior segment of the eye were determined by immunohistochemistry. Cultured human corneal endothelial cells were exposed to histones for 18 hours, and cell viability was determined by 2-(2-methoxy-4-nitrophenyl)-3-(4-nitro-phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt assay. The concentration of interleukin-6 (IL-6) in the culture medium of human corneal endothelial cells was measured using enzyme-linked immunosorbent assay. The effects of signal inhibitors U0126, SB203580, and SP600125 were evaluated. The protective effect of hyaluronan against histones was evaluated in human corneal endothelial cells with and without hyaluronan. RESULTS: Cellular debris containing histones was observed in the anterior chamber of pig eyes after phacoemulsification. Exposure of human corneal endothelial cells to 50 mg/mL of histones or more led to cytotoxic effects. The IL-6 concentration was significantly increased dose dependently after exposure of human corneal endothelial cells to histones (P<.01). The histoneinduced IL-6 production was significantly decreased by extracellular signal-regulated kinases 1/2 and p-38 mitogen-activated protein kinase inhibitors (P<.01). Co-incubation of hyaluronan and histones caused formation of histone aggregates, decreased the cytotoxic effects of the histones, and blocked the increase in IL-6 (P<.01). CONCLUSIONS: Histones were released extracellularly during phacoemulsification and exposure of human corneal endothelial cells to histones increased the IL-6 secretion. The intraoperative use of hyaluronan may decrease the cytotoxic effects of histones released during cataract surgery. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned.

    DOI: 10.1016/j.jcrs.2014.07.026

    Scopus

    PubMed

  • Furukawa Y, Hashiguchi T, Minami R, Yamamoto M, Takashima H .  Exacerbation of microcytic anemia associated with cessation of anti-retroviral therapy in an HIV-1-infected patient with beta thalassemia. .  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy20 ( 6 ) 387 - 9   2014.6

     More details

    Language:English   Publisher:Journal of Infection and Chemotherapy  

    We report a patient with Japanese minor β thalassemia and HIV-1 infection. The patient showed prolonged anemia, which was originally attributed to chronic parvovirus B19 infection. Twelve years later, the patient presented with exacerbation of microcytic anemia following cessation of anti-retroviral therapy; the exacerbation resolved when anti-retroviral therapy was resumed. Sequencing of the β globin gene revealed heterozygosity for a four-nucleotides deletion at codon 41/42 and minor β thalassemia was confirmed. Because HIV-1-infected patients frequently show anemia due to nutritional deficiencies, opportunistic infections, AIDS-related malignancies, drug treatment and a direct effect of HIV-1 on the bone marrow, it is likely to overlook other causes of anemia. Thalassemia should be considered in the differential diagnosis of anemia even in HIV-1 infected patients, when microcytic anemia without iron deficiency is observed. Our case suggested that active HIV infection may have worsened β thalassemia, and early introduction of anti-retroviral therapy is beneficial for the recovery of anemia. © 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.jiac.2014.01.008

    Scopus

    PubMed

  • Furukawa Yoshitaka, Hashiguchi Teruto, Minami Rumi, Yamamoto Masahiro, Takashima Hiroshi .  βサラセミアを呈するHIV-1感染患者における抗レトロウイルス療法の中断に伴う小球性貧血の増悪(Exacerbation of microcytic anemia associated with cessation of anti-retroviral therapy in an HIV-1-infected patient with beta thalassemia) .  Journal of Infection and Chemotherapy20 ( 5-6 ) 387 - 389   2014.6βサラセミアを呈するHIV-1感染患者における抗レトロウイルス療法の中断に伴う小球性貧血の増悪(Exacerbation of microcytic anemia associated with cessation of anti-retroviral therapy in an HIV-1-infected patient with beta thalassemia)

     More details

    Language:English   Publisher:エルゼビア・ジャパン(株)  

    症例は40代前半の男性(2000年3月時点)で、2ヵ月前から重度貧血が続いており、ニューモシスチス肺炎のため入院した。血漿中HIV-1 RNAコピー数とCD4陽性T細胞数からAIDSと診断された。骨髄液のPCRによりパルボウイルスB19感染による重度貧血が疑われた。HIV RNAが減少したため2000年5月に退院した。抗レトロウイルス治療を中断していたが、2012年3月に疲労感のため来院した。4日後に抗レトロウイルス療法を再開し、24日後に増悪は改善した。1年後にヘモグロビンが上昇し、血漿中HIV RNAコピー数の完全阻害が見られた。血漿中鉄濃度と不飽和鉄結合能から患者の小球性貧血は鉄欠乏によるものではないことが示唆された。βグロビン鎖遺伝子のDNA配列決定により、1アリルにおいてコドン41/42で4ヌクレオチドの欠損がある異型接合性が明らかになり、軽症βサラセミアと診断された。

  • Kawano H, Ito T, Yamada S, Hashiguchi T, Maruyama I, Hisatomi T, Nakamura M, Sakamoto T .  Toxic effects of extracellular histones and their neutralization by vitreous in retinal detachment. .  Laboratory investigation; a journal of technical methods and pathology94 ( 5 ) 569 - 85   2014.5Toxic effects of extracellular histones and their neutralization by vitreous in retinal detachment.

     More details

    Language:English  

    DOI: 10.1038/labinvest.2014.46

    PubMed

  • Kohjitani Atsushi, Miyata Masaaki, Iwase Yoko, Ohno Sachi, Tohya Akina, Manabe Yozo, Hashiguchi Teruto, Sugiyama Kazuna .  自律神経系と光電式指尖容積脈波の2次微分波との関連(Associations between the Autonomic Nervous System and the Second Derivative of the Finger Photoplethysmogram Indices) .  Journal of Atherosclerosis and Thrombosis21 ( 5 ) 501 - 508   2014.5自律神経系と光電式指尖容積脈波の2次微分波との関連(Associations between the Autonomic Nervous System and the Second Derivative of the Finger Photoplethysmogram Indices)

     More details

    Language:English   Publisher:(一社)日本動脈硬化学会  

    168名の患者(18~89歳)について、手術前日に座位で光電式指尖容積脈波の2次微分波(SDPTG)と心拍数変動(HRV)を測定した。SDPTG指数(b/a、c/a、d/a、e/a)とHRV指数(周波数分析、時間帯分析)を求めた。c/aとアテローム性硬化に基づく状態や危険因子との関連性についても評価した。SDPTG指数c/aは低周波成分(LF)と高周波成分(HF)と正の関連を示した。重回帰分析を行ったところ、LF、HF、心拍数はc/aの独立決定因子であった。c/a値は高血圧、糖尿病、高脂血症の患者で有意に低く、c/aの低値は血清トリグリセリドと総コレステロール濃度と有意に関連した。c/aの低下は末梢血管運動の圧反射反応の低下、心臓の副交感神経活性の低下と関連し、さらに高血圧、糖尿病、高脂血症のようなアテローム性硬化の基礎となる状態と関連すると考えられた。

  • Takenouchi K, Shrestha B, Yamakuchi M, Yoshinaga N, Arimura N, Kawaguchi H, Nagasato T, Feil R, Kawahara K, Sakamoto T, Maruyama I, Hashiguchi T .  Upregulation of non-β cell-derived vascular endothelial growth factor A increases small clusters of insulin-producing cells in the pancreas. .  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association122 ( 5 ) 308 - 15   2014.5Upregulation of non-β cell-derived vascular endothelial growth factor A increases small clusters of insulin-producing cells in the pancreas.

     More details

    Language:English  

    DOI: 10.1055/s-0034-1371811

    PubMed

  • Ochiai R, Sugiura Y, Shioya Y, Otsuka K, Katsuragi Y, Hashiguchi T .  Coffee polyphenols improve peripheral endothelial function after glucose loading in healthy male adults. .  Nutrition research (New York, N.Y.)34 ( 2 ) 155 - 9   2014.2

     More details

    Language:English   Publisher:Nutrition Research  

    Brewed coffee is a widely consumed beverage, and many studies have examined its effects on human health. We investigated the vascular effects of coffee polyphenols (CPPs), hypothesizing that a single ingestion of CPP during glucose loading would improve endothelial function. To test this hypothesis, we conducted a randomized acute clinical intervention study with crossover design and measured reactive hyperemia index (RHI) to assess the acute effects of a 75-g glucose load with CPP in healthy, nondiabetic adult men. Blood glucose and insulin levels were elevated after glucose loading with and without CPP, with no significant differences between treatments. The RHI did not significantly decrease after glucose loading without CPP. With CPP, however, RHI significantly (P < .05) increased over baseline after glucose loading. The difference between treatments was statistically significant (P < .05). No significant changes were observed in an oxidative stress marker after glucose loading with or without CPP. These findings suggest that a single ingestion of CPP improves peripheral endothelial function after glucose loading in healthy subjects. © 2014 Elsevier Inc.

    DOI: 10.1016/j.nutres.2013.11.001

    Scopus

    PubMed

  • Kohjitani Atsushi, Miyata Masaaki, Iwase Yoko, Ohno Sachi, Tohya Akina, Manabe Yozo, Hashiguchi Teruto, Sugiyama Kazuna .  Associations between the Autonomic Nervous System and the Second Derivative of the Finger Photoplethysmogram Indices .  Journal of Atherosclerosis and Thrombosis21 ( 5 ) 501 - 8   2014

     More details

    Language:English   Publisher:Japan Atherosclerosis Society  

    <b><i>Aim</i></b>: The indices of the second derivative of the finger photoplethysmogram(SDPTG) denote stiffness of large arteries, peripheral vascular resistance and vascular aging. However, the association between the autonomic nervous activity and the SDPTG indices has not yet been elucidated.<br>
    <b><i>Methods</i></b>: The SDPTG and heart rate variability(HRV) were consecutively measured in the sitting position on the day before surgery in 168 patients 18-89 years of age. The relationships between the SDPTG indices(b/a, c/a, d/a and e/a) and HRV indices(power spectral analysis and time domain analysis parameters) were analyzed. The relationships between c/a and atherosclerosis-based conditions and risk factors for atherosclerosis were also evaluated.<br>
    <b><i>Results</i></b>: The SDPTG index b/a was negatively associated and the d/a index was positively associated with the low-frequency(LF)(<i>R</i>=<b>−</b>0.44 and 0.42, respectively) and high-frequency(HF) components(<i>R</i>=<b>−</b>0.31 and 0.35, respectively). The SDPTG index c/a was also positively associated with the LF(<i>R</i>=0.40) and HF(<i>R</i>=0.44) components. A multivariate regression analysis showed that the LF, HF and heart rate were independent determinants of the c/a. Furthermore, the c/a values were significantly lower in the patients with hypertension, diabetes mellitus and hyperlipidemia than in those without these diseases, and a reduced c/a was significantly associated with increased serum triglyceride and total cholesterol concentrations.<br>
    <b><i>Conclusions</i></b>: These findings suggest that a decrease in c/a is associated with a reduced baroreflex response of the peripheral vasomotor activity and a decreased cardiac parasympathetic activity. Furthermore, a decrease in c/a was found to be associated with atherosclerosis-based conditions, such as hypertension, diabetes mellitus and hyperlipidemia.

    DOI: 10.5551/jat.19877

    Scopus

    PubMed

  • Arata Hitoshi, Okubo Ryuichi, Watanabe Osamu, Takashima Hiroshi, Hashiguchi Teruto .  10. Novel Development of Biomarker in Nervous Disease .  Nihon Naika Gakkai Zasshi102 ( 12 ) 3174 - 82   2013.12

     More details

    Language:Japanese   Publisher:The Japanese Society of Internal Medicine  

    DOI: 10.2169/naika.102.3174

    Scopus

    PubMed

  • Shrestha C, Ito T, Kawahara K, Shrestha B, Yamakuchi M, Hashiguchi T, Maruyama I .  Saturated fatty acid palmitate induces extracellular release of histone H3: a possible mechanistic basis for high-fat diet-induced inflammation and thrombosis. .  Biochemical and biophysical research communications437 ( 4 ) 573 - 8   2013.8Saturated fatty acid palmitate induces extracellular release of histone H3: a possible mechanistic basis for high-fat diet-induced inflammation and thrombosis.

     More details

    Language:English  

    DOI: 10.1016/j.bbrc.2013.06.117

    PubMed

  • Nakahara M, Ito T, Kawahara K, Yamamoto M, Nagasato T, Shrestha B, Yamada S, Miyauchi T, Higuchi K, Takenaka T, Yasuda T, Matsunaga A, Kakihana Y, Hashiguchi T, Kanmura Y, Maruyama I .  Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. .  PloS one8 ( 9 ) e75961   2013

     More details

    Language:English   Publisher:PLoS ONE  

    Introduction:Recent studies have shown that histones, the chief protein component of chromatin, are released into the extracellular space during sepsis, trauma, and ischemia-reperfusion injury, and act as major mediators of the death of an organism. This study was designed to elucidate the cellular and molecular basis of histone-induced lethality and to assess the protective effects of recombinant thrombomodulin (rTM). rTM has been approved for the treatment of disseminated intravascular coagulation (DIC) in Japan, and is currently undergoing a phase III clinical trial in the United States.Methods:Histone H3 levels in plasma of healthy volunteers and patients with sepsis and DIC were measured using enzyme-linked immunosorbent assay. Male C57BL/6 mice were injected intravenously with purified histones, and pathological examinations were performed. The protective effects of rTM against histone toxicity were analyzed both in vitro and in mice.Results:Histone H3 was not detectable in plasma of healthy volunteers, but significant levels were observed in patients with sepsis and DIC. These levels were higher in non-survivors than in survivors. Extracellular histones triggered platelet aggregation, leading to thrombotic occlusion of pulmonary capillaries and subsequent right-sided heart failure in mice. These mice displayed symptoms of DIC, including thrombocytopenia, prolonged prothrombin time, decreased fibrinogen, fibrin deposition in capillaries, and bleeding. Platelet depletion protected mice from histone-induced death in the first 30 minutes, suggesting that vessel occlusion by platelet-rich thrombi might be responsible for death during the early phase. Furthermore, rTM bound to extracellular histones, suppressed histone-induced platelet aggregation, thrombotic occlusion of pulmonary capillaries, and dilatation of the right ventricle, and rescued mice from lethal thromboembolism.Conclusions:Extracellular histones cause massive thromboembolism associated with consumptive coagulopathy, which is diagnostically indistinguishable from DIC. rTM binds to histones and neutralizes the prothrombotic action of histones. This may contribute to the effectiveness of rTM against DIC. © 2013 Nakahara et al.

    DOI: 10.1371/journal.pone.0075961

    Scopus

    PubMed

  • Yamashita A., Nishihira K., Matsuura Y., Ito T., Kawahara K., Hatakeyama K., Hashiguchi T., Maruyama I., Yagi H., Matsumoto M., Fujimura Y., Kitamura K., Shibata Y., Asada Y. .  Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus .  Atherosclerosis224 ( 2 ) 511 - 514   2012.10

     More details

    Language:Japanese   Publisher:Atherosclerosis  

    To examine the presence of CD34-positive cells and intranuclear factors in acute coronary thrombi, we compared thrombi in patients with type 2 diabetes mellitus (DM, n = 21) and without DM (n = 29). Immunohistochemical staining revealed the constitutive presence of platelets, fibrin, erythrocytes, neutrophils, extracellular high-mobility group box 1 (HMGB-1), and histone H3 in all thrombi. There were significantly more oval or flat CD34-positive cells and significantly larger HMGB-1-positive areas in the thrombi from patients with DM. The flat CD34-positive cells expressed ecto-nucleoside triphosphate diphosphohydrolase (a platelet aggregation inhibitor). The number of CD34-positive cells was negatively correlated with the serum levels of glucose and hemoglobin A1c, whereas the HMGB-1-positive area was positively correlated with the levels of serum glucose. The paucity of CD34-positive cells and the high levels of HMGB-1 expression in acute coronary thrombi from patients with type 2 DM could facilitate thrombus formation. © 2012 Elsevier Ireland Ltd.

    DOI: 10.1016/j.atherosclerosis.2012.07.027

    Scopus

  • MAENOSONO Ryuichi, OKETANI Naoya, ISHIDA Sanemasa, IRIKI Yasuhisa, ICHIKI Hitoshi, OKUI Hideki, NINOMIYA Yuichi, HAMASAKI Shuichi, NAMINO Fuminori, MATSUSHITA Masakaze, TEI Chuwa, HASHIGUCHI Teruto .  Effectiveness of esophagus detection by three-dimensional electroanatomicla mapping to avoid esophageal injury during ablation of atrial fibrillation .    60 ( 1 ) 119 - 125   2012.8

     More details

    Language:English  

  • Maenosono R, Oketani N, Ishida S, Iriki Y, Ichiki H, Okui H, Ninomiya Y, Hamasaki S, Namino F, Matsushita M, Tei C, Hashiguchi T .  Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation. .  Journal of cardiology60 ( 2 ) 119 - 25   2012.8

     More details

    Language:English   Publisher:Journal of Cardiology  

    Aims: Esophageal-left atrial (LA) fistula during atrial fibrillation (AF) ablation is a fatal event. We explored the relation of the esophagus-to-ablated point distance and esophageal temperature rise. Methods: Consecutive patients (n=106) underwent complex fractionated atrial electrogram-guided AF ablation using CartoMerge; the pulmonary veins were isolated in 23 patients. Maximum radiofrequency (RF) power near the esophagus was 15. W. Ablated points with esophageal temperature rise (monitored with a probe) to ≥38.0. °C were tagged; if ≥39.0 °C, RF was discontinued. Results: Of 1647 ablated points near the esophagus, 274 were associated with a temperature rise to 38.0-38.9 °C and 241 points to ≥39.0 °C. Distances (mm) from points to esophagus were 5.1. ± 0.6 (no rise), 4.2 ± 3.1 (38.0-38.9 °C), 2.9 ± 2.5 (≥39.0 °C). Altogether, 15.5% of points in the upper LA posterior wall, 41.5% in the middle, and 30.2% in the lower caused rises to ≥38.0 °C; 8.7%, 24.6%, and 11.0% caused rises to ≥39.0 °C. The middle wall was most affected (p<0.01), as shown by multiple logistic regression analysis (both temperatures). Points causing a rise increased significantly as distance decreased (p<0.001). The odds ratio for rise to ≥38.0. °C compared with <4.0 to >5.0 mm distance was 2.28 (p=0.004). The longest distance for ≥38.0 °C rise was 18.5 mm. Conclusion: Distance is an important predictor of esophageal temperature rise. The middle LA posterior wall is most vulnerable. A dose of 15. W is too high for ablation, especially <4.0. mm from the esophagus. Points >20.0. mm away are relatively safe. © 2012 Japanese College of Cardiology.

    DOI: 10.1016/j.jjcc.2012.02.009

    Scopus

    PubMed

  • Maenosono Ryuichi, Oketani Naoya, Ishida Sanemasa, Iriki Yasuhisa, Ichiki Hitoshi, Okui Hideki, Ninomiya Yuichi, Hamasaki Shuichi, Namino Fuminori, Matsushita Masakaze, Tei Chuwa, Hashiguchi Teruto .  心房細動アブレーション中の食道傷害を避けるための三次元電気解剖学的マッピングによる食道探知の有用性(Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation) .  Journal of Cardiology60 ( 1-2 ) 119 - 125   2012.8心房細動アブレーション中の食道傷害を避けるための三次元電気解剖学的マッピングによる食道探知の有用性(Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation)

     More details

    Language:English   Publisher:(一社)日本心臓病学会  

    心房細動(AF)アブレーション中の合併症である食道-左房瘻は致死的事故である。食道と心房アブレーション部位との間の距離と食道温度上昇との関係を検討した。CartoMergeを使用し複合分画化心房電位図ガイド下で106例の患者のAFアブレーションを行った。23例では肺動脈隔離を施行した。食道近位でアブレーションした1647ヶ所の中で274ヶ所では上昇した。食道とアブレーション部位との距離が5.1±0.6mmのときは食道温度は上昇しなかった。距離が食道温度上昇の予測因子で、左房後壁中部アブレーションが最も危険であった。

  • 橋口 照人, 一瀬 白帝 .  今月の主題 新規経口抗凝固薬の光と影 新旧経口抗凝固薬の薬理学的特徴に基づいた使用上の注意 APTTと内因系凝固機能 .  medicina49 ( 6 ) 1008 - 1011   2012.6今月の主題 新規経口抗凝固薬の光と影 新旧経口抗凝固薬の薬理学的特徴に基づいた使用上の注意 APTTと内因系凝固機能

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1402105993

  • Tada K, Kawahara K, Matsushita S, Hashiguchi T, Maruyama I, Kanekura T .  MK615, a Prunus mume Steb. Et Zucc ('Ume') extract, attenuates the growth of A375 melanoma cells by inhibiting the ERK1/2-Id-1 pathway. .  Phytotherapy research : PTR26 ( 6 ) 833 - 8   2012.6

     More details

    Language:English   Publisher:Phytotherapy Research  

    The Japanese apricot, a commonly consumed food called 'Ume' in Japan, has been used for a traditional Japanese medicine for centuries. MK615, an extract of compounds from 'Ume', has strong antitumorigenic and antiinflammatory effects including the induction of apoptosis and autophagy, and inhibition of cytokine production mediated via the inhibition of MAPKs signaling including ERK-1/2, JNK and p38MAPK. The inhibitor of DNA binding 1 (Id-1), a basic helix-loop-helix (bHLH) transcription factor family, is essential for DNA binding and the transcriptional regulation of various proteins that play important roles in the development, progression and invasion of tumors. In melanoma, Id-1 is constitutively expressed in the late and early stages, suggesting it as a therapeutic target in patients with melanoma. This study reports that MK615 profoundly reduced both the mRNA- and protein expression levels of Id-1 and inhibited cell growth in A375 melanoma cells. MK615 markedly inhibited the phosphorylation of ERK1/2, which is associated with Id-1 protein expression in A375 cells. Id-1-specific RNAi induced the death of A375 cells. Moreover, the expression of Bcl-2 was decreased by both MK615 and Id-1-specific RNAi in A375 cells. The results suggest that MK615 is a potential therapeutic agent for treating malignant melanoma. Copyright © 2011 John Wiley & Sons, Ltd.

    DOI: 10.1002/ptr.3645

    Scopus

    PubMed

  • KODAMA Yuichi, OKAMOTO Yasuhiro, HASHIGUCHI Teruto, SHINKODA Yuichi, NISHIKAWA Takuro, TANABE Takayuki, KAWANO Yoshifumi .  Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children .    95 ( 5 ) 494 - 499   2012.5

     More details

    Language:English  

  • Kodama Yuichi, Okamoto Yasuhiro, Hashiguchi Teruto, Shinkoda Yuichi, Nishikawa Takuro, Tanabe Takayuki, Kawano Yoshifumi .  血小板数およびヘマトクリット値で補正した血管内皮増殖因子は小児再生不良性貧血の臨床経過と関連する(Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children) .  International Journal of Hematology95 ( 5 ) 494 - 499   2012.5血小板数およびヘマトクリット値で補正した血管内皮増殖因子は小児再生不良性貧血の臨床経過と関連する(Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children)

     More details

    Language:English   Publisher:(一社)日本血液学会  

    健常成人の血小板からの血管内皮増殖因子(VEGF)放出量をin vitroで測定し、血清中のVEGF濃度、血小板数および/またはヘマトクリット値で補正したVEGF濃度との相関を調べた。血小板数とヘマトクリット値の両者で補正した値(補正VEGF)がVEGF放出量と最も強く相関した。次に、再生不良性貧血(AA)の小児患者11名の補正VEGFを測定した。AA患児の補正VEGFは年齢が一致する対照よりも有意に高かった。更に、2年以上治療を要しなかったAA患児の補正VEGFは早期に治療を要したAA患児よりも高かった。以上のデータは、VEGFを増やし、AAの疾患進行を遅らせるための代償機構が働いていることを示唆する。補正VEGFはAAの臨床予後を予測するために有用である。

  • Kodama Y, Okamoto Y, Hashiguchi T, Shinkoda Y, Nishikawa T, Tanabe T, Kawano Y .  Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children. .  International journal of hematology95 ( 5 ) 494 - 9   2012.5Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children.

     More details

    Language:English  

    DOI: 10.1007/s12185-012-1074-1

    PubMed

  • Kikuchi Kiyoshi, Kawahara Ko-ichi, Matsuda Fumiyo, Ito Takashi, Morimoto Yoko, Tancharoen Salunya, Miura Naoki, Takeshige Nobuyuki, Orito Kimihiko, Yamashita Shin, Uchikado Hisaaki, Miyagi Naohisa, Shiomi Naoto, Kuramoto Terukazu, Tokutomi Takashi, Shigemori Minoru, Sakamoto Rokudai, Kikuchi Chiemi, Iida Narumi, Yoshida Yoshihiro, Hashiguchi Teruto, Maruyama Ikuro, Morioka Motohiro, Tanaka Eiichiro .  Effect of edaravone on HMGB1 in neuronal cells under ischemic conditions .  Neurotraumatology34 ( 2 ) 225 - 227   2011.12

     More details

    Language:Japanese   Publisher:The Japan Society of Neurotraumatology  

    DOI: 10.32187/neurotraumatology.34.2_225

  • Shirasawa M, Arimura N, Otsuka H, Sonoda S, Hashiguchi T, Sakamoto T .  Intravitreous VEGF-A in eyes with massive vitreous hemorrhage. .  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie249 ( 12 ) 1805 - 10   2011.12

     More details

    Language:English   Publisher:Graefe's Archive for Clinical and Experimental Ophthalmology  

    Purpose/background Although vascular endothelial growth factor (VEGF) is abundant in serum, the intraocular concentration of VEGF in eyes with massive vitreous hemorrhage (VH) is not well-known. The present study was conducted to elucidate the effects of a massive VH on intravitreous VEGF concentration. Methods Vitreous samples were obtained during vitrectomy: 12 samples from eyes with epiretinal membrane without diabetic retinopathy (DR), and nine samples from massive VH with no DR, such as age-related macular degeneration, rhegmatogenous VH, Terson's syndrome and macroaneurysm rupture. Twelve samples were obtained from proliferative DR. VEGF was measured with an enzymelinked immunosorbent assay (ELISA). Samples incubated with or without heparin were also examined for the release of VEGF binding to the vitreous body. The localization of VEGF and type II collagen in the vitreous was evaluated from immunohistochemistry. Results The concentration of VEGF was significantly higher in eyes with proliferative DR (821 ± 949 pg/ml) than in non-DR with massive VH (2.75 ± 7.5 pg/ml, P<0.01, chi-square test) or non-DR with no VH (less than detectable level, P<0.01, chi-square test) There was no statistically significant difference between eyes with massive VH and non-diabetic eyes without VH. Treatment with heparin did not significantly affect the concentration of vitreous VEGF. VEGF was localized mainly in the clot from the results of an immunohistochemical analysis. Conclusions Even with a massive VH, diffusible VEGF does not increase significantly in the liquid phase and is principally present in a clot. VH alone should not be an indication for vitrectomy from the point of view of VEGFrelated pathology. © Springer-Verlag 2011.

    DOI: 10.1007/s00417-011-1795-5

    Scopus

    PubMed

  • Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H .  Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. .  Oncology reports26 ( 5 ) 1227 - 33   2011.11

     More details

    Language:English   Publisher:Oncology Reports  

    The fucosylated fraction of α-fetoprotein (AFP-L3) is a specific marker for hepatocellular carcinoma (HCC). However, conventional AFP-L3% (c-AFP-L3%) has not always been reliable in cases with low serum α-fetoprotein (AFP) levels. In this study, we evaluated the clinical utility of a newly developed assay, highly sensitive AFP-L3% (hs-AFP-L3%). Subjects included 74 patients with benign liver disease (BLD), including chronic hepatitis and cirrhosis, and 94 with HCC. Serum hs-AFP-L3% was significantly higher than c-AFP-L3% in patients with early-stage HCC (solitary or <20 mm in diameter). Additionally, hs-AFP-L3% was significantly increased in patients with well-differentiated HCC. In patients with serum AFP <20 ng/ml, the sensitivities of c-AFP-L3% and hs-AFP-L3% were 12.5 and 44.6%, respectively, at a cut-off value of 5%. In 59 BLD patients with serum AFP <20 ng/ml, the HCC-positive rate in patients with hs-AFP-L3% =5% was significantly higher compared to those with hs-AFP-L3% <5% during the follow-up period (median, 35 months; range, 5-48 months). Importantly, none of the BLD patients with both serum AFP <20 ng/ml and hs-AFP-L3% <5% developed HCC. These results indicated that hs-AFP-L3% is useful for early detection of HCC in BLD patients, even for those with serum AFP <20 ng/ml. Furthermore, since hs-AFP-L3% increases before HCC is detectable by various advanced imaging modalities, this assay may help identify BLD patients with a higher risk of HCC.

    DOI: 10.3892/or.2011.1425

    Scopus

    PubMed

  • Kawamura H, Nishi J, Imuta N, Tokuda K, Miyanohara H, Hashiguchi T, Zenmyo M, Yamamoto T, Ijiri K, Kawano Y, Komiya S .  Quantitative analysis of biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA) strains from patients with orthopaedic device-related infections. .  FEMS immunology and medical microbiology63 ( 1 ) 10 - 5   2011.10

     More details

    Language:English   Publisher:FEMS Immunology and Medical Microbiology  

    Biofilms play a pivotal role in medical device-related infections. However, epidemiological analysis of biofilm formation and genotyping among clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients with orthopaedic infections has rarely been reported. A total of 168 MRSA strains were examined: 23 strains from patients with device-related infection (the device group); 55 from patients with device-non-related infection (the nondevice group); and 90 from asymptomatic nasal carriers (the colonization group). Pulsed-field gel electrophoresis analysis and five genotyping methods including agr typing were performed. Biofilm formation was quantified using a microtitre plate assay. The device group had a significantly higher incidence of agr-2 than the colonization group (78.3% vs. 34.4%, P=0.001). The biofilm index of the agr-2 (0.523 ± 0.572) strains was significantly higher than those of agr-1 (0.260 ± 0.418, P<0.0001) and agr-3 (0.379 ± 0.557, P=0.045). The prevalence of strong biofilm formers in the device group (43.5%) was significantly higher than that in the nondevice group (12.7%, P=0.003) and the colonization group (20.0%, P=0.020). agr-2 MRSA strains may be more likely to cause orthopaedic device infection because of their strong biofilm formation ability. © 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd.

    DOI: 10.1111/j.1574-695X.2011.00821.x

    Scopus

    PubMed

  • Yoshinaga N, Arimura N, Otsuka H, Kawahara K, Hashiguchi T, Maruyama I, Sakamoto T .  NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway. .  Laboratory investigation; a journal of technical methods and pathology91 ( 9 ) 1277 - 90   2011.9

     More details

    Language:English   Publisher:Laboratory Investigation  

    Intraocular neovascularization is the leading cause of severe visual loss and anti-vascular endothelial growth factor (VEGF) therapy is currently performed for choroidal neovascularization (CNV). Despite its potent anti-angiogenic effect, there are concerns about its long-term safety. Non-steroidal anti-inflammatory drugs (NSAIDs) are common therapeutic agents used for treating inflammatory diseases, and their anti-stress effects are attracting attention now. We studied the effects of topical NSAIDs on CNV, focusing on anti-stress proteins. Cultured retinal pigment epithelium (RPE) cells were treated with NSAIDs: bromfenac, indomethacin, or vehicle control. Transcription factor NF-E2-related factor 2 (Nrf2) and its downstream anti-oxidant protein heme oxygenase (HO)-1 were assessed using western blot and immunohistochemistry. As a result, NSAIDs induced translocation of Nrf2 into the nucleus and the robust expression of HO-1 in a dose-and time-dependent manner. Flow cytometric analysis revealed that bromfenac inhibited H 2 O 2-induced apoptosis in cultured RPE cells. Next, we studied the effects of topical bromfenac on laser-induced CNV model in rat. The expressions of Nrf2 and HO-1, infiltrations of ED-1-positive macrophages at CNV lesions and size were analyzed. VEGF in the ocular fluid of these rats was also measured using enzyme-linked immunosorbent assay. Rats administered an inhibitor of HO-1 stannic mesoporphyrin (SnMP) were also studied. The results showed that topical bromfenac led to translocation of Nrf2 and induction of HO-1 in CNV lesions and that the number of infiltrating macrophages at the CNV lesion decreased. The sizes of CNV lesions were significantly smaller in bromfenac-treated rats than control CNV, and the effects were diminished by SnMP. VEGF increased in the ocular fluid after laser treatment and was inhibited by bromfenac and SnMP canceling these effects. NSAIDs inhibit CNV through the novel anti-stress protein HO-1-dependent pathway, indicating its potential therapeutic value for various intraocular angiogenic diseases including CNV. © 2011 USCAP, Inc All rights reserved.

    DOI: 10.1038/labinvest.2011.101

    Scopus

    PubMed

  • Kikuchi K., Kawahara K.I., Uchikado H., Miyagi N., Kuramoto T., Miyagi T., Morimoto Y., Ito T., Tancharoen S., Miura N., Takenouchi K., Oyama Y., Shrestha B., Matsuda F., Yoshida Y., Arimura S., Mera K., Tada K.I., Yoshinaga N., Maenosono R., Ohno Y., Hashiguchi T., Maruyama I., Shigemori M. .  Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction (Review) .  Experimental and Therapeutic Medicine2 ( 5 ) 771 - 775   2011.9

     More details

    Language:Japanese   Publisher:Experimental and Therapeutic Medicine  

    Edaravone was originally developed as a potent free radical scavenger and has been widely used to treat cerebral infarction in Japan since 2001. Several free radical scavengers have been developed and some of them have progressed to clinical trials for the treatment of cerebral infarction. One such scavenger, edaravone, has been approved by the regulatory authority in Japan for the treatment of patients with cerebral infarction. Of particular interest is the ability of edaravone to diffuse into the central nervous system in various neurologic diseases. Aside from its hydroxyl radical scavenging effect, edaravone has been found to have beneficial effects on inflammation, matrix metalloproteinases, nitric oxide production and apoptotic cell death. Concordantly, edaravone has been found to have neuroprotective effects in a number of animal models of disease, including stroke, spinal cord injury, traumatic brain injury, neurodegenerative diseases and brain tumors. The proven safety of edaravone following 9 years of use as a free radical scavenger suggests that it may have potential for development into an effective treatment of multiple neurologic conditions in humans.

    DOI: 10.3892/etm.2011.281

    Scopus

  • Araki Y., Nonaka D., Tajima A., Maruyama M., Nitto T., Ishikawa H., Yoshitake H., Yoshida E., Kuronaka N., Asada K., Yanagida M., Nojima M., Yoshida K., Takamori K., Hashiguchi T., Maruyama I., Lee L.J., Tanaka K. .  Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: Its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertension .  Proteomics11 ( 13 ) 2727 - 2737   2011.7

     More details

    Language:Japanese   Publisher:Proteomics  

    We have recently developed a new target plate (BLOTCHIP®) for MALDI-MS. An advantage of this procedure is that it does not require the lowering of protein concentrations in test samples prior to analysis. Accordingly, this new technology enables the detection of peptides present in blood samples, including those that would otherwise be adsorbed to abundant blood proteins and would thus escape detection. Using this technology, we analyzed the peripheral blood of patients with pregnancy-induced hypertension (PIH; the most common serious complication of pregnancy) to test a potential utility of the technology for monitoring of the pathophysiological status. In the present study, we found 23 characteristic peptides for PIH in the blood serum of pregnant women. Offline LC-MALDI MS/MS identified 7 of the 23 peptides as fragments derived from kininogen-1 (three peptides), fibrinogen-α, complement component C4-A/B, α-2-HS-glycoprotein and inter-α-trypsin inhibitor heavy chain H4. 2-D scatter plots with combinations of the peptides found in the present study can be grouped for pregnant women with/without PIH, which would be satisfactory reflected for their status. Additionally, the levels of most of these peptides found were significantly decreased by albumin/IgG depletion prior to BLOTCHIP® analysis in accordance with conventional proteomics procedures. These results indicated that BLOTCHIP® analysis can be applied for discovery study of PIH biomarker candidates. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

    DOI: 10.1002/pmic.201000753

    Scopus

  • Meng X, Kawahara KI, Miyanohara H, Yoshimoto Y, Yoshinaga K, Noma S, Kikuchi K, Morimoto Y, Ito T, Oyama Y, Yoshinaga N, Shrestha B, Chandan B, Mera K, Tada KI, Miura N, Ono Y, Takenouchi K, Maenosono R, Nagasato T, Hashiguchi T, Maruyama I .  1,5-Anhydro-D-fructose: A natural antibiotic that inhibits the growth of gram-positive bacteria and microbial biofilm formation to prevent nosocomial infection. .  Experimental and therapeutic medicine2 ( 4 ) 625 - 628   2011.7

     More details

    Language:Japanese   Publisher:Experimental and Therapeutic Medicine  

    Nosocomial infections caused by microbial opportunistic infections or microbial biofilms may occur during hospitalization and increase patient morbidity, mortality and health care costs. Artificial antibiotic agents were initially used to prevent infection; however, the high prevalence of nosocomial infections has resulted in their excessive use, which has led to microbial resistance to these agents. The increase in microbial resistance to antibiotics and the development of antibiotic agents may be the cause of the production of other microbial resistance. Thus, natural compounds that have no adverse side effects would be a preferred treatment modality. Recently, the monosaccharide 1,5-anhydro-D-fructose (1,5-AF), a natural plant compound derived from starch, has been found to have multifunctional properties, including antioxidant, antiplatelet aggregation by thrombin and anti-inflammatory activities. The results of the present study demonstrate that 1,5-AF suppressed the growth of coagulase negative staphylococci on the hands as well as the growth of Staphylococcus epidermidis, which is a cause of opportunistic infections. Furthermore, 1,5-AF suppressed bio film formation by the methicillin resistant Staphylococcus aureus. In conclusion, 1,5-AF is a natural compound that may be effective in preventing nosocomial infections, without causing adverse side effects.

    DOI: 10.3892/etm.2011.245

    Scopus

    PubMed

  • HASHIGUCHI Teruto .  Vascular function and idling .  Japanese Journal of Thrombosis and Hemostasis22 ( 1 ) 11 - 17   2011

     More details

    Language:Japanese   Publisher:The Japanese Society on Thrombosis and Hemostasis  

    DOI: 10.2491/jjsth.22.11

  • Kikuchi Kiyoshi, Kawahara Ko-ichi, Uchikado Hisaaki, Miyagi Naohisa, Kuramoto Terukazu, Miyagi Tomoya, Morimoto Yoko, Ito Takashi, Tancharoen Salunya, Miura Naoki, Miyata Kei, Kikuchi Chiemi, Sakamoto Rokudai, Shiomi Naoto, Hashiguchi Teruto, Maruyama Ikuro, Tokutomi Takashi, Shigemori Minoru .  Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced apoptosis in ischemic neuronal injury in PC12 cells .  Neurotraumatology33 ( 2 ) 241 - 243   2010.12Reviewed

     More details

    Language:Japanese   Publisher:The Japan Society of Neurotraumatology  

    DOI: 10.32187/neurotraumatology.33.2_241

  • Kikuchi K., Kawahara K.I., Miyagi N., Uchikado H., Kuramoto T., Morimoto Y., Tancharoen S., Miura N., Takenouchi K., Oyama Y., Shrestha B., Matsuda F., Yoshida Y., Arimura S., Mera K., Tada K.I., Yoshinaga N., Maenosono R., Ohno Y., Hashiguchi T., Maruyama I., Shigemori M. .  Edaravone: A new therapeutic approach for the treatment of acute stroke .  Medical Hypotheses75 ( 6 ) 583 - 585   2010.12

     More details

    Language:Japanese   Publisher:Medical Hypotheses  

    Acute stroke, including acute ischemic stroke (AIS) and acute hemorrhagic stroke, (AHS) is a common medical problem with particular relevance to the demographic changes in industrialized societies. In recent years, treatments for AIS have emerged, including thrombolysis with tissue plasminogen activator (t-PA). Although t-PA is the most effective currently available therapy, it is limited by a narrow therapeutic time window and side effects, and only 3% of all AIS patients receive thrombolysis. Edaravone was originally developed as a potent free radical scavenger and, since 2001, has been widely used to treat AIS in Japan. It was shown that edaravone extended the narrow therapeutic time window of t-PA in rats. The therapeutic time window is very important for the treatment of AIS, and early edaravone treatment is more effective. Thus, more AIS patients might be rescued by administering edaravone with t-PA. Meanwhile, edaravone attenuates AHS-induced brain edema, neurologic deficits and oxidative injury in rats. Although edaravone treatment is currently only indicated for AIS, it does offer neuroprotective effects against AHS in rats. Therefore, we hypothesize that early administration of edaravone can rescue AHS patients as well as AIS patients. Taken together, our findings suggest that edaravone should be immediately administered on suspicion of acute stroke, including AIS and AHS. © 2010 Elsevier Ltd.

    DOI: 10.1016/j.mehy.2010.07.038

    Scopus

  • Otsuka H, Arimura N, Sonoda S, Nakamura M, Hashiguchi T, Maruyama I, Nakao S, Hafezi-Moghadam A, Sakamoto T .  Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment. .  The American journal of pathology177 ( 5 ) 2268 - 77   2010.11

     More details

    Language:English   Publisher:American Journal of Pathology  

    Stromal cell-derived factor-1 (SDF-1) causes chemotaxis of CXCR4-expressing bone marrow-derived cells. SDF-1 is involved in the pathogenesis of various vascular diseases, including those of the eye. However, the role of SDF-1 in neuronal diseases is not completely understood. Here, we show higher SDF-1 levels in the vitreous humor of patients with retinal detachment (RD) compared with normal patients. SDF-1 correlated positively with the duration as well as the extent of RD. Furthermore, SDF-1 correlated significantly with levels of interleukin-6 and interleukin-8, but not with vascular endothelial growth factor. Western blot analysis results showed significant SDF-1 up-regulation in detached rat retinas compared with normal animals. Immunohistochemistry data showed that SDF-1 was co-localized with the glial cells of the detached retina. SDF-1 blockade with a neutralizing antibody increased photoreceptor cell loss and macrophage accumulation in the subretinal space. The retinal precursor cell line R28 expressed CXCR4. SDF-1 rescued serum starvation-induced apoptosis in R28 cells and enhanced their ability to participate in wound closure in a scratch assay. Our results indicate a surprising, protective role for SDF-1 in RD. This effect may be mediated directly or indirectly through other cell types. Copyright © American Society for Investigative Pathology.

    DOI: 10.2353/ajpath.2010.100134

    Scopus

    PubMed

  • Mera K, Kawahara K, Tada K, Kawai K, Hashiguchi T, Maruyama I, Kanekura T .  ER signaling is activated to protect human HaCaT keratinocytes from ER stress induced by environmental doses of UVB. .  Biochemical and biophysical research communications397 ( 2 ) 350 - 4   2010.6

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    Proteins are folded properly in the endoplasmic reticulum (ER). Various stress such as hypoxia, ischemia and starvation interfere with the ER function, causing ER stress, which is defined by the accumulation of unfolded protein (UP) in the ER. ER stress is prevented by the UP response (UPR) and ER-associated degradation (ERAD). These signaling pathways are activated by three major ER molecules, ATF6, IRE-1 and PERK. Using HaCaT cells, we investigated ER signaling in human keratinocytes irradiated by environmental doses of ultraviolet B (UVB). The expression of Ero1-Lα, an upstream signaling molecule of ER stress, decreased at 1-4 h after 10 mJ/cm2 irradiation, indicating that the environmental dose of UVB-induced ER stress in HaCaT cells, without growth retardation. Furthermore, expression of intact ATF6 was decreased and it was translocated to the nuclei. The expression of XBP-1, a downstream molecule of IRE-1, which is an ER chaperone whose expression is regulated by XBP-1, and UP ubiquitination were induced by 10 mJ/ cm2 UVB at 4 h. PERK, which regulates apoptosis, was not phosphorylated. Our results demonstrate that UVB irradiation generates UP in HaCaT cells and that the UPR and ERAD systems are activated to protect cells from UVB-induced ER stress. This is the first report to show ER signaling in UVB-irradiated keratinocytes. © 2010 Elsevier Inc.

    DOI: 10.1016/j.bbrc.2010.05.128

    Scopus

    PubMed

  • Oyama Y, Hashiguchi T, Taniguchi N, Tancharoen S, Uchimura T, Biswas KK, Kawahara K, Nitanda T, Umekita Y, Lotz M, Maruyama I .  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. .  Laboratory investigation; a journal of technical methods and pathology90 ( 6 ) 853 - 66   2010.6

     More details

    Language:English   Publisher:Laboratory Investigation  

    Granulomatous nephritis can be triggered by diverse factors and results in kidney failure. However, despite accumulating data about granulomatous inflammation, pathogenetic mechanisms in nephritis remain unclear. The DNA-binding highmobility group box-1 protein (HMGB1) initiates and propagates inflammation when released by activated macrophages, and functions as an ‘alarm cytokine’ signaling tissue damage. In this study, we showed elevated HMGB1 expression in renal granulomas in rats with crystal-induced granulomatous nephritis caused by feeding an adenine-rich diet. HMGB1 levels were also raised in urine and serum, as well as in monocyte chemoattractant protein-1 (MCP-1), a mediator of granulomatous inflammation. Injection of HMGB1 worsened renal function and upregulated MCP-1 in rats with crystalinduced granulomatous nephritis. HMGB1 also induced MCP-1 secretion through mitogen-activated protein kinase (MAPK) and phosphoinositide-3-kinase (PI3K) pathways in rat renal tubular epithelial cells in vitro. Hmgb1+/− mice with crystal-induced nephritis displayed reduced MCP-1 expression in the kidneys and in urine and the number of macrophages in the kidneys was significantly decreased. We conclude that HMGB1 is a new mediator involved in crystalinduced nephritis that amplifies granulomatous inflammation in a cycle where MCP-1 attracts activated macrophages, resulting in excessive and sustained HMGB1 release. HMGB1 could be a novel target for inhibiting chronic granulomatous diseases. © 2010 USCAP, Inc. All rights reserved.

    DOI: 10.1038/labinvest.2010.64

    Scopus

    PubMed

  • Taniguchi S, Hashiguchi T, Ono T, Takenouchi K, Nakayama K, Kawano T, Kato K, Matsushita R, Nagatomo M, Nakamura S, Nakashima T, Maruyama I .  Association between reduced ADAMTS13 and diabetic nephropathy. .  Thrombosis research125 ( 6 ) e310 - 6   2010.6

     More details

    Language:English   Publisher:Thrombosis Research  

    Introduction: Deficiency of Von Willebrand factor (VWF)-cleaving protease (ADAMTS13) causes platelet thrombosis in the microcirculation. Intrarenal coagulation is thought to be associated with the development and progression of diabetic nephropathy. Our aim was to clarify the association between plasma ADAMTS13 antigen (ADAMTS13Ag) levels and diabetic nephropathy. Material and Methods: We measured the plasma levels of VWF antigen (VWFAg) and ADAMTS13Ag, and calculated the VWF/ADAMTS13 ratio in 86 type 2 diabetic patients and 26 healthy volunteers, to investigate the relationship between these levels and renal function. With regard to diabetic macroangiopathy, the relationship between these levels and carotid intima-media thickness (IMT) was also investigated. Results and Conclusions: A significant positive and negative correlation was noted between ADAMTS13Ag and the estimated glomerular filtration rate (eGFR), vWF/ADAMTS13 ratio and eGFR, respectively. The diabetic patients were divided into normoalbuminuria (n = 50), microalbuminuria (n = 8) and overt nephropathy (n = 28) groups. Compared among these three groups and the 26 healthy volunteers, ADAMTS13Ag was significantly lower only in the overt nephropathy group. The mean carotid IMT was measured in 69 patients and was significantly negatively correlated with ADAMTS13Ag and positively correlated with VWF/ADAMTS13 ratio. When these 69 patients were divided into four groups according to eGFR and ADAMTS13 levels (ADAMTS13/eGFR; low/low: n = 12; high/low: n = 7; low/high: n = 25; high/high: n = 25), the mean carotid IMT was increased in patients with a low ADAMTS13Ag in the same eGFR group. The present study suggests that reduced ADAMTS13 might be associated with diabetic nephropathy. © 2010 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.thromres.2010.02.013

    Scopus

    PubMed

  • Shrestha B, Hashiguchi T, Ito T, Miura N, Takenouchi K, Oyama Y, Kawahara K, Tancharoen S, Ki-I Y, Arimura N, Yoshinaga N, Noma S, Shrestha C, Nitanda T, Kitajima S, Arimura K, Sato M, Sakamoto T, Maruyama I .  B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. .  Journal of immunology (Baltimore, Md. : 1950)184 ( 9 ) 4819 - 26   2010.5

     More details

    Language:English   Publisher:Journal of Immunology  

    Vascular endothelial growth factor A (VEGF-A) is a prominent growth factor for both angiogenesis and lymphangiogenesis. Recent studies have shown the importance of VEGF-A in enhancing the growth of lymphatic endothelial cells in lymph nodes (LNs) and the migration of dendritic cells into LNs. VEGF-A is produced in inflamed tissues and/or in draining LNs, where B cells are a possible source of this growth factor. To study the effect of B cell-derived VEGF-A, we created transgenic mice (CD19Cre/hVEGF-Afl) that express human VEGF-A specifically in B cells. We found that the human VEGF-A produced by B cells not only induced lymphangiogenesis in LNs, but also induced the expansion of LNs and the development of high endothelial venules. Contrary to our expectation, we observed a significant decrease in the Ag-specific Ab production postimmunization with OVA and in the proinflammatory cytokine production postinoculation with LPS in these mice. Our findings suggest immunomodulatory effects of VEGF-A: B cell-derived VEGF-A promotes both lymphangiogenesis and angiogenesis within LNs, but then suppresses certain aspects of the ensuing immune responses. Copyright © 2010 by The American Association of Immunologists, Inc.

    DOI: 10.4049/jimmunol.0903063

    Scopus

    PubMed

  • 大野 佳子, 榎原 るり子, 浜崎 眞美, 庵木 清子, 日谷 希和, 今村 佳代子, 橋口 照人, 丸山 征郎 .  介護福祉学生に対する職務継続のための健康教育の評価 .  日本予防医学会雑誌5 ( 1 ) 17 - 22   2010.5介護福祉学生に対する職務継続のための健康教育の評価

     More details

    Language:Japanese   Publisher:(一社)日本予防医学会  

    介護福祉士の中途退職の要因は腰痛等の健康障害による割合が最多であり、職務継続のためには健康管理が重要であるにも関わらず、基礎教育における1次予防教育または教育評価の報告例はまだない。本研究では、介護福祉学生に対して健康管理状況と介護福祉士になる自信、健康を維持していける自信・不安等の自己効力感について実態を把握し、自己の健康管理能力を高める目的で健康教育を実施し、評価した。評価指標は健康管理への自己効力感と健康不安度の変化等で、教育方法は介入群43名と対照群22名に対してベースラインの評価をした後、対照群には通常の講義演習による基礎教育を行い、介入群には基礎教育に加え集団健康教育ならびに個別健康教育を実施し、評価した。統計解析はStudentのt検定等を用い、統計解析ソフトSPSS12.0Jを用いた。その結果、介入群は対照群と比較して腰痛への不安が軽減(t=3.78、p<0.0001)する他、健康管理に対する自信度が高くなる(t=3.12、p=0.003)、コミュニケーションへの不安が軽減する(p=0.001)等の効果があった。基礎教育において腰痛への不安軽減や健康管理への自己効力感が高まることにより、卒後に介護福祉士としての職務継続の阻害因子となり得る健康不安に対して、予防的に対処できることが示唆された。(著者抄録)

  • Kikuchi K., Kawahara K.I., Tsuji C., Tajima Y., Kuramoto T., Shihara M., Koga Y., Shiomi N., Uchikado H., Morimoto Y., Miura N., Mera K., Ohno Y., Miyagi N., Hashiguchi T., Maruyama I., Hayabuchi N., Nakayama K., Shigemori M. .  Post mortem contrast-enhanced computed tomography in a case of sudden death from acute pulmonary thromboembolism .  Experimental and Therapeutic Medicine1 ( 3 ) 503 - 505   2010.5

     More details

    Language:Japanese   Publisher:Experimental and Therapeutic Medicine  

    A 77-year-old woman suffered a cardiopulmonary arrest the day after transvenous embolization of dural ateriovenous fistulae. The patient died despite receiving prompt cardiopulmonary resuscitation. Post mortem computed tomography (CT) was performed to determine the cause of death. No lesion was detected on a whole-body plain CT. However, a post mortem contrast-enhanced CT (CECT) performed after the administration of intravenous contrast and cardiac compressions detected pulmonary thromboembolism. Thus, post mortem CECT was useful in determining the cause of sudden death in this case.

    DOI: 10.3892/etm_00000079

    Scopus

  • Ohno Y., Hashiguchi T., Maenosono R., Yamashita H., Taira Y., Minowa K., Yamashita Y., Kato Y., Kawahara K.I., Maruyama I. .  The diagnostic value of endothelial function as a potential sensor of fatigue in health .  Vascular Health and Risk Management6 ( 1 ) 135 - 144   2010.4

     More details

    Language:Japanese   Publisher:Vascular Health and Risk Management  

    Purpose: Many epidemiological research studies have shown that vital exhaustion and psychosocial factors are associated with the occurrence of cerebrocardiovascular disease (CCVD). Fatigue is thought to induce endothelial dysfunction and may be linked to the occurrence of CCVD; however, no studies have investigated this potential link. We studied to determine the effect of fatigue on endothelial function in healthy subjects with no traditional CCVD risk factors or potential confounding factors to be controlled. Subjects and methods: Peripheral arterial tonometry (PAT) was used to evaluate endothelial function. The influence of the following parameters on endothelial function was analyzed in 74 office workers without traditional CCVD risk factors at health check-ups: endothelial function before and after work, subjective fatigue, lifestyle factors such as sleeping time, and psychosocial factors such as depression and social support. Results: Twenty-five subjects (33.8%) had low endothelial function; reactive hyperemia (RH)-PAT index <1.67, even though no abnormalities were reported in the health check-ups. There was no significant difference in endothelial function before versus after labor. Of note, endothelial function was associated with the individual's level of subjective fatigue (t = 2.98, P = 0.008) and showed a daily fluctuation, sometimes to a pathological degree (<1.67). Conclusion: We showed that, even in healthy people, endothelial function fluctuates diurnally, with an interaction between the individual's cognitive fatigue and the environment, sometimes to a pathological degree. Based on these findings, we suggest that endothelial function is an objective assessment tool of fatigue in healthy individuals. © 2010 Ohno et al, publisher and licensee Dove Medical Press Ltd.

    Scopus

  • Kozono S, Matsuyama T, Biwasa KK, Kawahara K, Nakajima Y, Yoshimoto T, Yonamine Y, Kadomatsu H, Tancharoen S, Hashiguchi T, Noguchi K, Maruyama I .  Involvement of the endocannabinoid system in periodontal healing. .  Biochemical and biophysical research communications394 ( 4 ) 928 - 33   2010.4

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    Endocannabinoids including anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are important lipid mediators for immunosuppressive effects and for appropriate homeostasis via their G-protein-coupled cannabinoid (CB) receptors in mammalian organs and tissues, and may be involved in wound healing in some organs. The physiological roles of endocannabinoids in periodontal healing remain unknown. We observed upregulation of the expression of CB1/CB2 receptors localized on fibroblasts and macrophage-like cells in granulation tissue during wound healing in a wound-healing model in rats, as well as an increase in AEA levels in gingival crevicular fluid after periodontal surgery in human patients with periodontitis. In-vitro, the proliferation of human gingival fibroblasts (HGFs) by AEA was significantly attenuated by AM251 and AM630, which are selective antagonists of CB1 and CB2, respectively. CP55940 (CB1/CB2 agonist) induced phosphorylation of the extracellular-regulated kinases (ERK) 1/2, p38 mitogen-activated protein kinase (p38MAPK), and Akt in HGFs. Wound closure by CP55940 in an in-vitro scratch assay was significantly suppressed by inhibitors of MAP kinase kinase (MEK), p38MAPK, and phosphoinositol 3-kinase (PI3-K). These findings suggest that endocannabinoid system may have an important role in periodontal healing. © 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2010.03.080

    Scopus

    PubMed

  • Ohno Y, Hashiguchi T, Maenosono R, Yamashita H, Taira Y, Minowa K, Yamashita Y, Kato Y, Kawahara K, Maruyama I .  The diagnostic value of endothelial function as a potential sensor of fatigue in health. .  Vascular health and risk management6   135 - 44   2010.3The diagnostic value of endothelial function as a potential sensor of fatigue in health.

     More details

    Language:English  

    DOI: 10.2147/vhrm.s8950

    PubMed

  • Meng X, Tancharoen S, Kawahara KI, Nawa Y, Taniguchi S, Hashiguchi T, Maruyama I .  1,5-Anhydroglucitol attenuates cytokine release and protects mice with type 2 diabetes from inflammatory reactions. .  International journal of immunopathology and pharmacology23 ( 1 ) 105 - 19   2010.1

     More details

    Language:English   Publisher:International Journal of Immunopathology and Pharmacology  

    1,5-anhydrogIucitol (1,5-AG) decreases in diabetic patients and is used as a marker of glycemic control. Type 2 diabetic patients are susceptibile to lipopolysaccharides (LPS), which stimulate macrophages to release large quantities of tumor necrosis factor (TNF)-α and interleukin (IL)-6. This study examines the effects of 1,5-AG on lung inflammation induced by LPS and consequent systemic inflammation to determine whether the decrease of 1,5-AG concentration induces susceptibility to LPS. Before the challenge with LPS (1 mg/kg in vivo and 500 ng/ml in vitro), we pretreated db/db mice and RAW264.7 cells with 1,5-AG at 38.5 mg/kg and 500 μg/mI, respectively. The levels of IL-6, TNF-α, macrophage chemoattractant protein (MCP)-1 and IL-1β in the serum and in the cell supernatants were measured. We also measured macrophage recruitment and the expression of inducible nitric oxide synthase (iNOS) in pulmonary tissues. We found that 1,5-AG attenuated serum cytokine release and protected db/db mice from LPS-induced pulmonary inflammation. In addition, 1,5-AG suppressed cytokine release and iNOS expression by suppressing Akt/NF-κB activity in RAW264.7 cells. These results suggest that 1,5-AG may be a mediator in, as well as marker for diabetes, and 1,5-AG intake may confer tolerance to LPS in patients with type 2 diabetes. © by Biolife, s.a.s.

    DOI: 10.1177/039463201002300110

    Scopus

    PubMed

  • Kikuchi K., Kawahara K.i., Biswas K.K., Ito T., Tancharoen S., Shiomi N., Koda Y., Matsuda F., Morimoto Y., Oyama Y., Takenouchi K., Miura N., Arimura N., Nawa Y., Arimura S., Jie M.X., Shrestha B., Iwata M., Mera K., Sameshima H., Ohno Y., Maenosono R., Tajima Y., Uchikado H., Kuramoto T., Nakayama K., Shigemori M., Yoshida Y., Hashiguchi T., Maruyama I. .  HMGB1: A new marker for estimation of the postmortem interval .  Experimental and Therapeutic Medicine1 ( 1 ) 109 - 111   2010.1

     More details

    Language:Japanese   Publisher:Experimental and Therapeutic Medicine  

    Estimation of the postmortem interval (PMIPMIPMI) is one of the most important tasks in forensic medicine. Numerous methods have been proposed for the determination of the time since death by chemical means. High mobility group box-1 (HMHMGB1), a nonhistone DNADNADNA-binding protein is released by eukaryotic cells upon necrosis. Postmortem serum levels of HMGB1 of 90 male Wistar rats stored at 4, 14 and 24 °C since death were measured by enzyme-linked immunosorbent assay. The serum HMHMGB1 level showed a time-dependent increase up to seven days at 4 °C. At 14 °C, the HMGB1 level peaked at day 3, decreased at day 4, and then plateaued. At 24 °C, the HMHMGB1 level peaked at day 2, decreased at day 3, and then plateaued. Our findings suggest that HMGB1 is related to the PMIPMIPMI in rats.

    DOI: 10.3892/etm_00000019

    Scopus

  • Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, Eguchi T, Maruyama I, Kawano Y .  Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. .  British journal of haematology148 ( 2 ) 285 - 92   2010.1

     More details

    Language:English   Publisher:British Journal of Haematology  

    Kawasaki syndrome (KS) is an acute febrile vasculitis of childhood. Coronary artery abnormalities (CAA) are a significant problem in KS patients. High dose intravenous immunoglobulin (IVIG) is effective for reducing the occurrence of CAA. Clinical and histopathological findings suggest that vascular endothelial growth factor (VEGF) is involved in CAA. In circulating blood, newly activated platelets are the major source of VEGF, which is released in large amounts in vascular inflammation. The present study analysed 80 KS patients (69 IVIG responders and 11 IVIG non-responders) and evaluated the role of platelet VEGF in KS vasculitis. Serum VEGF and platelet VEGF levels were significantly higher in KS patients than controls (P < 0·001). Platelet VEGF reflected the reactivity of IVIG treatment and was decreased in responders (P < 0·001), but remained increased in non-responders (P = 0·01). Platelet VEGF levels, but not serum VEGF levels, before IVIG were significantly correlated with the maximum CAA z-score (r = 0·524, P = 0·02). Our findings demonstrate that platelet VEGF may reflect the severity of vasculitis related to the pathological development of CAA in KS. Platelet VEGF may be an important feature of KS pathophysiology. © 2009 Blackwell Publishing Ltd.

    DOI: 10.1111/j.1365-2141.2009.07922.x

    Scopus

    PubMed

  • Kikuchi K, Tancharoen S, Matsuda F, Biswas KK, Ito T, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I, Kawahara K .  Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4. .  Biochemical and biophysical research communications390 ( 4 ) 1121 - 5   2009.12

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    Aquaporin-4 (AQP4) plays a role in the generation of post-ischemic edema. Pharmacological modulation of AQP4 function may thus provide a novel therapeutic strategy for the treatment of stroke, tumor-associated edema, epilepsy, traumatic brain injury, and other disorders of the central nervous system (CNS) associated with altered brain water balance. Edaravone, a free radical scavenger, is used for the treatment of acute ischemic stroke (AIS) in Japan. In this study, edaravone significantly reduced the infarct area and improved the neurological deficit scores at 24 h after reperfusion in a rat transient focal ischemia model. Furthermore, edaravone markedly reduced AQP4 immunoreactivity and protein levels in the cerebral infarct area. In light of observations that edaravone specifically inhibited AQP4 in a rat transient focal ischemia model, we propose that edaravone might reduce cerebral edema through the inhibition of AQP4 expression following cerebral infarction. © 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2009.09.015

    Scopus

    PubMed

  • Morimoto Y, Kikuchi K, Ito T, Tokuda M, Matsuyama T, Noma S, Hashiguchi T, Torii M, Maruyama I, Kawahara K .  MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced pro-inflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. .  Biochemical and biophysical research communications389 ( 1 ) 90 - 4   2009.11

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    The Japanese apricot, known as Ume in Japanese, has been a traditional Japanese medicine for centuries, and is a familiar and commonly consumed food. The health benefits of Ume are now being widely recognized and have been strengthened by recent studies showing that MK615, an extract of compounds from Ume, has strong anticancer and anti-inflammatory effects. However, the potential role of MK615 in the periodontal field remains unknown. Here, we found that MK615 significantly reduced the production of pro-inflammatory mediators (tumor necrosis factor-alpha and interleukin-6) induced by Porphyromonas gingivalis lipopolysaccharide (LPS), a major etiological agent in localized chronic periodontitis, in murine macrophage-like RAW264.7 cells. MK615 markedly inhibited the phosphorylation of ERK1/2, p38MAPK, and JNK, which is associated with pro-inflammatory mediator release pathways. Moreover, MK615 completely blocked LPS-triggered NF-κB activation. The present results suggest that MK615 has potential as a therapeutic agent for treating inflammatory diseases such as periodontitis. © 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2009.08.103

    Scopus

    PubMed

  • Hashiguchi T, Tanaka K, Lee LJ, Sasaki K, Natsugoe S, Kawahara K, Arimura K, Maruyama I .  Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis. .  Medical hypotheses73 ( 5 ) 760 - 3   2009.11

     More details

    Language:English   Publisher:Medical Hypotheses  

    Human serum contains thousands of proteolytically derived low-molecular-weight peptide fragments (serum peptidome). The concept of utilizing the serum peptidome for cancer diagnosis has been developed. A pathological serum peptidome appears when the homeostatic balance between proteases and protease inhibitors is disrupted. We hypothesize if analyses of the serum peptidome are of diagnostic value as information on which molecules are disrupted, and the pathological course it will take in unknown pathological conditions and disseminated intravascular coagulation (DIC). We analyzed the serum peptidome in 3 stages (early stage, pre-DIC and DIC stages) in one patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes) syndrome, an intractable disease with unknown pathology, using a 1-dimensional gel electrophoresis/matrix-assisted laser desorption/ionization-mass spectrometry (1-DE/MS)-based rapid quantitative approach. A very large number of peptide fragments appeared in the DIC stage, compared to pre-DIC. In addition, we identified fragments of transthyretin (ALGISPFHEHAEVVFTANDSGPR, m/z 2451.18) and α1-antitrypsin (EDPQGDAAQKTDTSHHDQDHPTFN, m/z 2691.02) that significantly increased in the DIC stage, compared to those in the pre-DIC stage. Rapid analyses of the serum peptidome may lead to a diagnostic method that can predict on-going protease activated pathological conditions and help to decide on multilateral strategies including nutritional support and drug therapy. © 2009 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.mehy.2009.04.026

    Scopus

    PubMed

  • Meng X, Kawahara K, Matsushita K, Nawa Y, Shrestha B, Kikuchi K, Sameshima H, Hashiguchi T, Maruyama I .  Attenuation of LPS-induced iNOS expression by 1,5-anhydro-d-fructose. .  Biochemical and biophysical research communications387 ( 1 ) 42 - 6   2009.9

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    1,5-anhydro-d-fructose (1,5-AF), a monosaccharide formed from starch and glycogen, exhibits antioxidant and antibacterial activity, and inhibits cytokine release by attenuating NF-κB activation in LPS-stimulated mice. The present study examined whether 1,5-AF inhibits lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) in vitro and in vivo. We found that 1,5-AF significantly blocked the production of NO, and protein and mRNA expression of iNOS, and up-regulated IL-10 production in vitro. We also investigated the effects of 1,5-AF on acute lung inflammation in C57BL/6J mice. We found that protein and mRNA expression of iNOS in lung tissues were inhibited by 1,5-AF pretreatment. In addition, the serum level of IL-10 was upregulated by 1,5-AF. Collectively, the iNOS transcriptional and translational inhibitory effects of 1,5-AF seem to be prolonged and enhanced by the production of IL-10. These results suggest that 1,5-AF could be a useful adjunct in the treatment of acute lung inflammation. © 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2009.06.108

    Scopus

    PubMed

  • Nawa Y, Kawahara K, Tancharoen S, Meng X, Sameshima H, Ito T, Masuda Y, Imaizumi H, Hashiguchi T, Maruyama I .  Nucleophosmin may act as an alarmin: implications for severe sepsis. .  Journal of leukocyte biology86 ( 3 ) 645 - 53   2009.9

     More details

    Language:English   Publisher:Journal of Leukocyte Biology  

    NPM is a major nucleolar multifunctional protein involved in ribosome biogenesis, centrosome duplication, cell-cycle progression, apoptosis, cell differentiation, and sensing cellular stress. Alarmins are endogenous molecules released from activated cells and/or dying cells, which activate the immune system and cause severe damage to cells and tissue organs. In the present work, stimulation of cells with the alarmin-inducible molecule endotoxin, for 16 h, resulted in NPM release into the culture supernatants of RAW264.7 cells, a murine macrophage cell line. Extracellular NPM was detected in the ascites of the CLP model. NPM was translocated into the cytoplasm from the nucleus in LPS -stimulated RAW264.7 cells; furthermore, NPM was detected in the cytosols of infiltrated macrophages in the CLP model. rNPM induced release of proinflammatory cytokines, TNF-α, IL-6, and MCP-1, from RAW264.7 cells and increased the expression level of ICAM-1 in HUVECs. NPM induced the phosphorylation of MAPKs in RAW264.7 cells. Our data indicate that NPM may have potent biological activities that contribute to systemic inflammation. Further investigations of the role of NPM may lead to new therapies for patients with septic shock or other inflammatory diseases. © Society for Leukocyte Biology.

    DOI: 10.1189/jlb.1008644

    Scopus

    PubMed

  • 橋口 照人 .  生体蛋白質の non-homeostatic degradation 解析による病態予知診断 : 次世代検査医学への応用を目指して .  臨床化学38   49   2009.7

     More details

    Language:Japanese  

  • Kikuchi K, Kawahara K, Biswas KK, Ito T, Tancharoen S, Morimoto Y, Matsuda F, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Yoshida Y, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Hashiguchi T, Maruyama I .  Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. .  Biochemical and biophysical research communications385 ( 2 ) 132 - 6   2009.7

     More details

    Language:English   Publisher:Biochemical and Biophysical Research Communications  

    High mobility group box-1 (HMGB1), a non-histone DNA-binding protein, is massively released into the extracellular space from neuronal cells after ischemic insult and exacerbates brain tissue damage in rats. Minocycline is a semisynthetic second-generation tetracycline antibiotic which has recently been shown to be a promising neuroprotective agent. In this study, we found that minocycline inhibited HMGB1 release in oxygen-glucose deprivation (OGD)-treated PC12 cells and triggered the activation of p38mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinases (ERK1/2). The ERK kinase (MEK)1/2 inhibitor U-0126 and p38MAPK inhibitor SB203580 blocked HMGB1 release in response to OGD. Furthermore, HMGB1 triggered cell death in a dose-dependent fashion. Minocycline significantly rescued HMGB1-induced cell death in a dose-dependent manner. In light of recent observations as well as the good safety profile of minocycline in humans, we propose that minocycline might play a potent neuroprotective role through the inhibition of HMGB1-induced neuronal cell death in cerebral infarction. © 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2009.04.041

    Scopus

    PubMed

  • Kikuchi K, Kawahara K, Tancharoen S, Matsuda F, Morimoto Y, Ito T, Biswas KK, Takenouchi K, Miura N, Oyama Y, Nawa Y, Arimura N, Iwata M, Tajima Y, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I .  The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. .  The Journal of pharmacology and experimental therapeutics329 ( 3 ) 865 - 74   2009.6

     More details

    Language:English   Publisher:Journal of Pharmacology and Experimental Therapeutics  

    Edaravone, a potent free radical scavenger, is clinically used for the treatment of cerebral infarction in Japan. Here, we examined the effects of edaravone on the dynamics of high-mobility group box-1 (HMGB1), which is a key mediator of ischemic-induced brain damage, during a 48-h postischemia/ reperfusion period in rats and in oxygen-glucose-deprived (OGD) PC12 cells. HMGB1 immunoreactivity was observed in both the cytoplasm and the periphery of cells in the cerebral infarction area 2 h after reperfusion. Intravenous administration of 3 and 6 mg/kg edaravone significantly inhibited nuclear translocation and HMGB1 release in the penumbra area and caused a 26.5 ± 10.4 and 43.8 ± 0.5% reduction, respectively, of the total infarct area at 24 h after reperfusion. Moreover, edaravone also decreased plasma HMGB1 levels. In vitro, edaravone dose-dependently (1-10 μM) suppressed OGD- and H2O2-induced HMGB1 release in PC12 cells. Furthermore, edaravone (3-30 μM) blocked HMGB1-triggered apoptosis in PC12 cells. Our findings suggest a novel neuroprotective mechanism for edaravone that abrogates the release of HMGB1. Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics.

    DOI: 10.1124/jpet.108.149484

    Scopus

    PubMed

  • Nagata M., Ijichi S., Hashiguchi T., Morioka H., Arimura K. .  Metabolic syndrome-related markers in obese university students in Kagoshima, Japan: Implications of uric acid and plasminogen activator inhibitor type-1 .  Diabetes and Metabolic Syndrome: Clinical Research and Reviews3 ( 2 ) 96 - 102   2009.6

     More details

    Language:Japanese   Publisher:Diabetes and Metabolic Syndrome: Clinical Research and Reviews  

    Aim: Although lifestyle changes in university students are highly influential in causing their later obese-related diseases, there is still limited knowledge about obese university students. Metabolic syndrome-related markers and conditions were investigated among obese students in Kagoshima University, Japan. Methods: We evaluated 46 obese students (31 males and 15 females), with high body mass index (BMI) (≥30), aged between 18 and 24 years, and who were recruited at university annual health check-ups in 2006 and 2007. All subjects underwent measurement of waist circumference, laboratory evaluations for the diagnostic criteria (Japan Metabolic Syndrome Criteria Study Group) and levels of uric acid and plasminogen activator inhibitor type-1 (PAI-1), and behavioral assessments using a questionnaire about personal and lifestyle factors. Results: 39.1% of the obese university students fulfilled the criteria for metabolic syndrome. In the metabolic syndrome constituents, higher prevalence was obtained in hypertension and hypertriglyceridemia. Levels of uric acid and PAI-1 were high with statistical significance in metabolic syndrome. A broader expansion of positive correlations between PAI-1 and the metabolic syndrome components as compared with those of uric acid suggested the important roles of PAI-1 in the pathological processes or outcomes of metabolic syndrome. Conclusion: Our findings suggested that strategies to prevent hypertension and/or dyslipidemia are important for the prophylaxis of metabolic syndrome in university students, and that dietary fat lowering has a prophylactic importance in the control of hyperuricemia. Furthermore, a causal relationship between the regularly missed breakfasts and metabolic syndrome was suggested. © 2009 Diabetes India.

    DOI: 10.1016/j.dsx.2009.02.009

    Scopus

  • Kawahara K, Hashiguchi T, Masuda K, Saniabadi AR, Kikuchi K, Tancharoen S, Ito T, Miura N, Morimoto Y, Biswas KK, Nawa Y, Meng X, Oyama Y, Takenouchi K, Shrestha B, Sameshima H, Shimizu T, Adachi T, Adachi M, Maruyama I .  Mechanism of HMGB1 release inhibition from RAW264.7 cells by oleanolic acid in Prunus mume Sieb. et Zucc. .  International journal of molecular medicine23 ( 5 ) 615 - 20   2009.5

     More details

    Language:English   Publisher:International Journal of Molecular Medicine  

    High mobility group box-1 protein (HMGB1), primarily from the nucleus, is released into the extracellular milieu either passively from necrotic cells or actively through secretion by monocytes/macrophages. Extracellular HMGB1 acts as a potent inflammatory agent by promoting the release of cytokines such as tumor necrosis factor (TNF)-α, has procoagulant activity, and is involved in death due to sepsis. Accordingly, HMGB1 is an appropriate therapeutic target. In this study, we found that an extract of Prunus mume Sieb. et Zucc. (Ume) fruit (Ume extract), an abundant source of triterpenoids, strongly inhibited HMGB1 release from lipopolysaccharide (LPS)-stimulated macrophage-like RAW264.7 cells. The inhibitory effect on HMGB1 release was enhanced by authentic oleanolic acid (OA), a naturally occurring triterpenoid. Similarly, the HMGB1 release inhibitor in Ume extract was found to be OA. Regarding the mechanisms of the inhibition of HMGB1 release, the OA or Ume extract was found to activate the transcription factor Nrf2, which binds to the antioxidative responsive element, and subsequently the heme oxygenase (HO)-1 protein was induced, indicating that the inhibition of HMGB1 release from LPS-stimulated RAW264.7 cells was mediated via the Nrf2/HO-1 system; an essentially antioxidant effect. These results suggested that natural sources of triterpenoids warrant further evaluation as 'rescue' therapeutics for sepsis and other potentially fatal systemic inflammatory disorders.

    DOI: 10.3892/ijmm_00000172

    Scopus

    PubMed

  • Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T .  Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy. .  Ophthalmology116 ( 5 ) 921 - 6   2009.5Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.

     More details

    Language:English  

    DOI: 10.1016/j.ophtha.2008.12.024

    PubMed

  • Eguchi T, Nomura Y, Hashiguchi T, Masuda K, Arata M, Hazeki D, Ueno K, Nishi J, Kawano Y, Maruyama I .  An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome. .  The Pediatric infectious disease journal28 ( 4 ) 339 - 41   2009.4

     More details

    Language:English   Publisher:Pediatric Infectious Disease Journal  

    We examined the serum values of high mobility group box 1 (HMGB1) in 36 patients with Kawasaki syndrome (KS) (29 responders and 7 poor-responders to initial intravenous immunoglobulin treatment). A mean value of HMGB1 of poor-responders was significantly elevated compared with those of responders (P ≤ 0.0042). Among the 6 factors showing significant differences between responders and poor-responders including HMGB1 (admission illness day, white blood cell counts, C-reactive protein, aspartate aminotransferase, lactate dehydrogenase), values of HMGB1 showed the widest area under the receiver operating characteristic curve. In conclusion, an elevated HMGB1 value could be a potential marker for poor-responders. Copyright © 2009 by Lippincott Williams & Wilkins.

    DOI: 10.1097/INF.0b013e31818ffe60

    Scopus

    PubMed

  • Arimura N, Ki-i Y, Hashiguchi T, Kawahara K, Biswas KK, Nakamura M, Sonoda Y, Yamakiri K, Okubo A, Sakamoto T, Maruyama I .  Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. .  Laboratory investigation; a journal of technical methods and pathology89 ( 3 ) 278 - 89   2009.3

     More details

    Language:English   Publisher:Laboratory Investigation  

    High-mobility group box 1 (HMGB1) protein is a multifunctional protein, which is mainly present in the nucleus and is released extracellularly by dying cells and/or activated immune cells. Although extracellular HMGB1 is thought to be a typical danger signal of tissue damage and is implicated in diverse diseases, its relevance to ocular diseases is mostly unknown. To determine whether HMGB1 contributes to the pathogenesis of retinal detachment (RD), which involves photoreceptor degeneration, we investigated the expression and release of HMGB1 both in a retinal cell death induced by excessive oxidative stress in vitro and in a rat model of RD-induced photoreceptor degeneration in vivo. In addition, we assessed the vitreous concentrations of HMGB1 and monocyte chemoattractant protein 1 (MCP-1) in human eyes with RD. We also explored the chemotactic activity of recombinant HMGB1 in a human retinal pigment epithelial (RPE) cell line. The results show that the nuclear HMGB1 in the retinal cell is augmented by death stress and upregulation appears to be required for cell survival, whereas extracellular release of HMGB1 is evident not only in retinal cell death in vitro but also in the rat model of RD in vivo. Furthermore, the vitreous level of HMGB1 is significantly increased and is correlated with that of MCP-1 in human eyes with RD. Recombinant HMGB1 induced RPE cell migration through an extracellular signal-regulated kinase-dependent mechanism in vitro. Our findings suggest that HMGB1 is a crucial nuclear protein and is released as a danger signal of retinal tissue damage. Extracellular HMGB1 might be an important mediator in RD, potentially acting as a chemotactic factor for RPE cell migration that would lead to an ocular pathological wound-healing response. © 2009 USCAP, Inc All rights reserved.

    DOI: 10.1038/labinvest.2008.165

    Scopus

    PubMed

  • Deguchi T, Hashiguchi T, Horinouchi S, Uto T, Oku H, Kimura K, Makisumi K, Arimura K .  Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. .  Diabetic medicine : a journal of the British Diabetic Association26 ( 3 ) 247 - 52   2009.3

     More details

    Language:English   Publisher:Diabetic Medicine  

    Aim: To identify the relationship between vascular endothelial growth factor (VEGF) and diabetic polyneuropathy (DPN). Methods: Two hundred and twenty diabetic patients participated, 113 with DPN and 107 without DPN. All patients were also classified according to the four stages of DPN (no neuropathy: stage 0; asymptomatic neuropathy: stage 1; symptomatic neuropathy: stage 2; disabling neuropathy: stage 3). Serum VEGF concentration was measured using an enzyme-linked immunosorbent assay (ELISA) and levels between the patients with and without DPN and also between the different stages of DPN, were compared. Results: The mean serum VEGF level in all patients was 264.6 ± 218.8 pg/ml. The mean serum VEGF level was higher in patients with DPN (310.1 ± 224.3 pg/ml) than in the patients without DPN (216.5 ± 204.0 pg/ml, P = 0.0014). Serum VEGF was higher in the 'symptomatic' stage (stage 2, 364.8 ± 225.9 pg/ml) in comparison with the 'asymptomatic' (stage 1, 256.7 ± 224.4 pg/ml, P = 0.015) and 'disabling' (stage 3, 180.3 ± 109.4 pg/ml, P = 0.042) stages. The mean serum VEGF level in patients with diabetic retinopathy (261.1 ± 210.6 pg/ml) and in patients with diabetic nephropathy (241.5 ± 185.7 pg/ml) was not increased. Conclusions: The serum VEGF level is increased in patients with DPN, particularly in patients in the neurologically active 'symptomatic' stage. © 2009 Diabetes UK.

    DOI: 10.1111/j.1464-5491.2009.02680.x

    Scopus

    PubMed

  • Nakahara T., Tsuruta R., Kaneko T., Yamashita S., Fujita M., Kasaoka S., Hashiguchi T., Suzuki M., Maruyama I., Maekawa T. .  High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage .  Neurocritical Care11 ( 3 ) 362 - 368   2009.1

     More details

    Language:Japanese   Publisher:Neurocritical Care  

    Background: High-mobility group box 1 protein (HMGB1) is a nuclear factor that is a potent proinflammatory mediator, and may trigger increases in other inflammatory cytokines. The inflammatory cytokines in the cerebrospinal fluid (CSF) of patients with subarachnoid hemorrhage (SAH) have been reported previously, but HMGB1 has not. In this study, we measured HMGB1 and the inflammatory cytokines in the CSF of patients with SAH. Methods: CSF samples were collected on days 3, 7, and 14 from the drainage tubes of the postaneurysm clips of 39 patients with SAH. HMGB1, interleukin-6 (IL-6), IL-8, and tumor necrosis factor alpha (TNF-α) were measured in the CSF, and compared between the patients with favorable (good recovery and moderate disability) and unfavorable outcomes (severe disability, vegetative state, and death) at 3 months. Results: In the unfavorable outcome group, HMGB1 (P = 0.017), IL-6 (P = 0.003), IL-8 (P = 0.041), and TNF-α (P = 0.002) were significantly increased. HMGB1 correlated significantly with IL-6, IL-8, and TNF-α (R = 0.672, 0.421, and 0.697, respectively). Conclusions: HMGB1 was increased in the CSF of SAH patients with an unfavorable outcome, as were the other cytokines. These results suggest that HMGB1 and cytokines are related to the brain damage observed after SAH. HMGB1 might play a key role in the inflammatory response in the CNS of SAH patients. © 2009 Humana Press Inc.

    DOI: 10.1007/s12028-009-9276-y

    Scopus

  • ITO Takashi, KAWAHARA Ko-ichi, HASHIGUCHI Teruto, MARUYAMA Ikuro .  Thrombomodulin maintains the systemic circulation in good condition .  Japanese Journal of Thrombosis and Hemostasis20 ( 4 ) 418 - 421   2009

     More details

    Language:Japanese   Publisher:The Japanese Society on Thrombosis and Hemostasis  

    DOI: 10.2491/jjsth.20.418

  • Iwata M, Kawahara KI, Kawabata H, Ito T, Mera K, Biswas KK, Tancharoen S, Higashi Y, Kikuchi K, Hashiguchi T, Kanekura T, Maruyama I .  Thrombomodulin exerts cytoprotective effect on low-dose UVB-irradiated HaCaT cells. .  Biochemical and biophysical research communications377 ( 2 ) 642 - 647   2008.12Thrombomodulin exerts cytoprotective effect on low-dose UVB-irradiated HaCaT cells.

     More details

    Language:English  

    DOI: 10.1016/j.bbrc.2008.10.049

    PubMed

  • Kawahara K.I., Hashiguchi T., Kikuchi K., Tancharoen S., Miura N., Ito T., Oyama Y., Nawa Y., Biswas K.K., Meng X., Morimoto Y., Shrestha B., Sameshima H., Maruyama I. .  Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells .  International Journal of Molecular Medicine22 ( 5 ) 639 - 644   2008.12

     More details

    Language:Japanese   Publisher:International Journal of Molecular Medicine  

    High mobility group box 1 (HMGB1) is a nonhistone nuclear protein which is released from the nucleus of activated macrophages into the extracellular space in response to stimuli such as endotoxin or necrosis. The HMGB1 functions as a potent proinflammatory cytokine in the extracellular spaces. Recently, HMGB1 has been implicated in the progression of atherosclerosis. However, the association between HMGB1 and the development of atherosclerosis is poorly understood. Therefore, we examined whether serotonin (5-HT), a key factor involved in the development of atherosclerosis, induced HMGB1 release in human umbilical vein endothelial cells (HUVECs). We found that 5-HT induced the release of HMGB1 but not of ERK1/2 and JNK from HUVECs via the 5-HT receptor (5-HT1B)/p38 mitogen-activated protein kinase (MAPK) signaling pathway. The p38MAPK inhibitor SB203580 and the 5-HT1B antagonist GR55526 markedly inhibited HMGB1 release from 5-HT-stimulated HUVECs. The vascular endothelial growth factor (VEGF) derived from activated macrophages in atherosclerotic lesions also plays an important role in the progression of atherosclerosis. We found that HMGB1 induced VEGF production in macrophage-like RAW264.7 cells. HMGB1 induced the activation of p38MAPK, ERK1/2 and Akt. The PI3-kinase inhibitor LY294002 significantly inhibited VEGF production in HMGB1-stimulated macrophages, while other kinase inhibitors did not. These results suggest that HMGB1 release may contribute as a risk factor in the development and progression of atherosclerosis.

    DOI: 10.3892/ijmm_00000066

    Scopus

  • Kawahara K, Hashiguchi T, Kikuchi K, Tancharoen S, Miura N, Ito T, Oyama Y, Nawa Y, Biswas KK, Meng X, Morimoto Y, Shrestha B, Sameshima H, Maruyama I .  Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells. .  International journal of molecular medicine22 ( 5 ) 639 - 44   2008.11Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells.

     More details

    Language:English  

    PubMed

  • Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H, Nawa Y, Meng X, Shrestha B, Hashiguchi T, Maruyama I .  Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. .  Arteriosclerosis, thrombosis, and vascular biology28 ( 10 ) 1825 - 30   2008.10

     More details

    Language:English   Publisher:Arteriosclerosis, Thrombosis, and Vascular Biology  

    Objective - High mobility group box 1 protein (HMGB1) was identified as a mediator of endotoxin lethality. We previously reported that thrombomodulin (TM), an endothelial thrombin-binding protein, bound to HMGB1, thereby protecting mice from lethal endotoxemia. However, the fate of HMGB1 bound to TM remains to be elucidated. Methods and Results - TM enhanced thrombin-mediated cleavage of HMGB1. N-terminal amino acid sequence analysis of the HMGB1 degradation product demonstrated that thrombin cleaved HMGB1 at the Arg10-Gly11 bond. Concomitant with the cleavage of the N-terminal domain of HMGB1, proinflammatory activity of HMGB1 was significantly decreased (P<0.01). HMGB1 degradation products were detected in the serum of endotoxemic mice and in the plasma of septic patients with disseminated intravascular coagulation (DIC), indicating that HMGB1 could be degraded under conditions in which proteases were activated in the systemic circulation. Conclusions - TM not only binds to HMGB1 but also aids the proteolytic cleavage of HMGB1 by thrombin. These findings highlight the novel antiinflammatory role of TM, in which thrombin-TM complexes degrade HMGB1 to a less proinflammatory form. © 2008 American Heart Association, Inc.

    DOI: 10.1161/ATVBAHA.107.150631

    Scopus

    PubMed

  • 堀内 正久, 橋口 照人, 後藤 正道, 吉家 清貴, 山岡 章浩, 梅北 善久, 郡山 千早, 今中 啓之, 宇宿 功市郎, 小田 紘 .  低学年でのPBLテュートリアルが学習意識に及ぼした影響 .  医学教育39 ( 4 ) 267 - 271   2008.8低学年でのPBLテュートリアルが学習意識に及ぼした影響

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    1)低学年(2年生後期)で受講するPBLテュートリアルの前後で、受動的な学習法(講義を聴く)や能動的な学習法(自分で調べる、発表する、討論する、教える)に対する意識の変化を検討した。2)17年度と18年度の2回、調査を行った。両年度とも、統計的に有意に、能動的な学習法を肯定する意識の変化が観察された。「講義を聴く」については、年度により異なる結果を示した。3)今回のPBLテュートリアルは、学習法に対する意識の変化をもたらした可能性がある。(著者抄録)

  • Arimura N, Ki-I Y, Hashiguchi T, Sakamoto T, Maruyama I .  High-mobility group box 1 protein in endophthalmitis. .  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie246 ( 7 ) 1053 - 8   2008.7

     More details

    Language:English   Publisher:Graefe's Archive for Clinical and Experimental Ophthalmology  

    Background: High-mobility group box 1 protein (HMGB1) is recently described as a late mediator of lethal endotoxemia with proinflammatory cytokine-like properties. The purpose of this study was to determine whether HMGB1 is involved in endophthalmitis. Methods: In this retrospective case-control study, vitreous levels of HMGB1 were measured by an enzyme-linked immunosorbent assay in ten eyes with endophthalmitis, and in 12 eyes with idiopathic macular holes which served as controls. Formalin-fixed and paraffin-embedded tissue sections of an enucleated eye with endophthalmitis, and a control eye with recurrent conjunctival malignant melanoma, were analyzed by immunohistochemistry with an anti-HMGB1 antibody. Results: The vitreous HMGB1 level of the patients with endophthalmitis was 13.96±17.17 ng/ml (mean±SD), which was significantly higher than that of the controls (0.236±0.128 ng/ml; P=.0006, Mann-Whitney U test). There were significant correlations between HMGB1 level and disease duration, presenting visual acuity, and final visual acuity. In the eye with endophthalmitis, HMGB1 expression was diffusely observed, particularly in the extranuclear region of the retina and the choroid with infiltrating inflammatory cells. Conclusion: HMGB1 can be released in the vitreous of eyes with endophthalmitis depending on inflammation and tissue damage. Our results suggest that HMGB1 may be a late mediator of endophthalmitis, and related to the progression of endophthalmitis. © Springer-Verlag 2008.

    DOI: 10.1007/s00417-008-0827-2

    Scopus

    PubMed

  • Arimura K., Hashiguchi T., Watanabe O. .  Crow-Fukase syndrome and VEGF .  Brain and Nerve60 ( 6 ) 611 - 619   2008.6

     More details

    Language:Japanese   Publisher:Brain and Nerve  

    Crow-Fukase syndrome is diagnosed based on the presence of chronic sensori-motor polyneuropathy along with other characteristic generalized symptoms denoted by the acronym of POEMS which stands for polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes. In this syndrome, the serum levels of the vascular endothelial growth factor (VEGF) are abnormally elevated, and this is a predictive factor for its diagnosis. Although the causes of CFS/POEMS remain unknown, VEGF is evidently correlated with its pathogenesis. Human glioblastoma cells are known to express VEGF. In models of CFS/POEMS, mice that are peritoneally transplanted with human glioblastomas exhibit high serum levels of VEGF, prominent edema with increased circulation volume, and pathological findings in the liver, spleen, and kidney. VEGF that is highly concentrated in platelets may be released in massive amounts due to coagulation in the peripheral tissue and may thus exert its maximal physiological effects and produce the abovementioned diffuse pathological findings. The correlation between polyneuropathy and elevated VEGF remains unclear. However, VEGF may affect the blood-nerve barrier by increased microvascular hyperpermeability, upregulated cytokines such as matrix metalloproteases may induce blood-nerve barrier breakdown and demyelination of the peripheral nerve. Furthermore, microangiopathy due to proliferative endothelial cells and hypercoagulated occlusion also affect axonal damage. Novel strategies that have recently been proposed for the management of this disease include high-dose chemotherapy combined with autologous peripheral blood stem cell transplantation (PBSCT) and molecular-targeted therapy against plasma cells and VEGF. Notably, PBSCT exerts a dramatic effect on polyneuropathy; such an effect has rarely been achieved by the previously described modalities of low-dose melphallan and steroid therapy. PBSCT is observed to induce a rapid and persistent decrease in the serum VEGF levels. In conclusion, VEGF is not only the primary molecule involved in the pathogenesis of CSF, but also an important marker for both the diagnosis and treatment of this disease.

    Scopus

  • Kawahara K, Biswas KK, Unoshima M, Ito T, Kikuchi K, Morimoto Y, Iwata M, Tancharoen S, Oyama Y, Takenouchi K, Nawa Y, Arimura N, Jie MX, Shrestha B, Miura N, Shimizu T, Mera K, Arimura S, Taniguchi N, Iwasaka H, Takao S, Hashiguchi T, Maruyama I .  C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. .  Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology17 ( 3 ) 129 - 38   2008.5

     More details

    Language:English   Publisher:Cardiovascular Pathology  

    Background: C-reactive protein (CRP) is widely used as a sensitive biomarker for inflammation. Increasing evidence suggests that CRP plays a role in inflammation. High-mobility group box-1 (HMGB1), a primarily nuclear protein, is passively released into the extracellular milieu by necrotic or damaged cells and is actively secreted by monocytes/macrophages. Extracellular HMGB1 as a potent inflammatory mediator has stimulated immense curiosity in the field of inflammation research. However, the molecular dialogue implicated between CRP and HMGB1 in delayed inflammatory processes remains to be explored. Methods and results: The levels of HMGB1 in culture supernatants were determined by Western blot analysis and enzyme-linked immunosorbent assay in macrophage RAW264.7 cells. Purified CRP induced the release of HMGB1 in a dose- and time-dependent fashion. Immunofluorescence analysis revealed nuclear translocation of HMGB1 in response to CRP. The binding of CRP to the Fcγ receptor in RAW264.7 cells was confirmed by fluorescence-activated cell sorter analysis. Pretreatment of cells with IgG-Fc fragment, but not IgG-Fab fragment, efficiently blocked this binding. CRP triggered the activation of p38MAPK and ERK1/2, but not Jun N-terminal kinase. Moreover, both p38MAPK inhibitor SB203580 and small interfering RNA significantly suppressed the release of HMGB1, but not the MEK1/2 inhibitor U-0126. Conclusion: We demonstrated for the first time that CRP, a prominent risk marker for inflammation including atherosclerosis, could induce the active release of HMGB1 by RAW264.7 cells through Fcγ receptor/p38MAPK signaling pathways, thus implying that CRP plays a crucial role in the induction, amplification, and prolongation of inflammatory processes, including atherosclerotic lesions. © 2008 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.carpath.2007.08.006

    Scopus

    PubMed

  • Morimoto Y, Kawahara KI, Tancharoen S, Kikuchi K, Matsuyama T, Hashiguchi T, Izumi Y, Maruyama I .  Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. .  Journal of periodontal research43 ( 1 ) 76 - 83   2008.2Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1.

     More details

    Language:English  

    DOI: 10.1111/j.1600-0765.2007.00996.x

    PubMed

  • HORIUCHI Masahisa, HASHIGUCHI Teruto, GOTO Masamichi, YOSHIIE Kiyotaka, YAMAOKA Hiroaki, UMEKITA Yoshihisa, KORIYAMA Chihaya, IMANAKA Hiroyuki, USUKU Koichiro, ODA Hiroshi .  Effect of early problem-based learning tutorial education on medical students' views about learning .  Igaku Kyoiku / Medical Education (Japan)39 ( 4 ) 267 - 271   2008

     More details

    Language:Japanese   Publisher:Japan Society for Medical Education  

    1) In problem-based learning (PBL) tutorials during the2nd year, general symptoms (fatigue, weight change, bleeding, fever, pain, and edema) were chosen as subjects.Changes in the students'way of thinking about how to learn were evaluated before and after PBL tutorials.<BR>2) After tutorials students were significantly more likely to believe that their participation in tutorials was a more effective way of learning. The students'views after tutorials on listening to lectures differed between2006and2007.<BR>3) We conclude that PBL tutorials affect medical students'views about learning.

    DOI: 10.11307/mededjapan1970.39.267

  • Ki-I Y, Arimura N, Noda Y, Yamakiri K, Doi N, Hashiguchi T, Maruyama I, Shimura M, Sakamoto T .  Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion. .  Current eye research32 ( 12 ) 1065 - 72   2007.12

     More details

    Language:English   Publisher:Current Eye Research  

    Purpose: To identify the roles of stromal-derived factor (SDF-1) and inflammatory cytokines in retinal vein occlusion (RVO). Methods: Samples were collected by vitrectomy and the levels of SDF-1, vascular endothelial growth factor, and inflammatory cytokines (interleukins [IL-1β, IL-6, IL-8, IL-10, IL-12p70]; tumor necrosis factor-α) were measured in 20 eyes with RVO, and 9 eyes with epiretinal membrane served as negative controls. Four eyes with inflammatory diseases were also investigated. Results: SDF-1 levels in active RVO (A-RVO; 4 eyes with iris neovascularization) were significantly higher than those in quiescent RVO (Q-RVO; 16 eyes without iris neovascularization) and the negative controls (p <.01), whereas there were no significant difference between the Q-RVO and the negative controls. There were no significant correlations between the concentrations of SDF-1 and other cytokines. Conclusions: Elevation of intravitreous SDF-1 levels in A-RVO but not Q-RVO suggested a pivotal role of SDF-1 in angiogenic changes during RVO. Copyright © Informa Healthcare USA, Inc.

    DOI: 10.1080/02713680701758727

    Scopus

    PubMed

  • Maruyama I., Ito T., Hashiguchi T. .  Newly identified message for rescue and repair from necrotic cell: Biology and clinical relevance of "endokine, HMGB1" .  Hirosaki Medical Journal59 ( SUPPL. )   2007.12

     More details

    Language:Japanese   Publisher:Hirosaki Medical Journal  

    Responses to stimuli in cellar level are diverse and such hierarchical as secretion of stored factors, synthesis of lipid mediators and protein synthesis through genomic transcription. However, how can the cells respond in the case of necrosis? Recently a characteristic intranuclear protein, high-mobility group box 1 protein (HMGB) is released from necrotic cells. The protein is an abundant nuclear protein with a dual function both inside and outside the cells. In physiological state, HMGB1 is present in the nucleus, and binds to DNA, playing a variety of crucial functions, including transcription and keeping the characteristic DNA architecture. However, the protein is released to extracellular space from most of necrotic cells, activated macrophages and dendritic cells. Out of the cells, HMGB1 acts as a signal of tissue damage and can promote inflammation, immune responses, and results tissue regeneration. During sepsis and/or disseminated intravascular coagulation (DIC), however, massive accumulation of HMGB1 in the systemic circulation will cause multiple organ failure (MOF) and subsequent lethal outcome. Thus HMGB1 in the systemic circulation has been considered as a lethal mediator of sepsis, and a promising therapeutic target for sepsis. Recently we identified that thrombomodulin (TM), a natural anticoagulant glycoprotein expressed on the surface of endothelial cells, plays an important role in sequestering HMGB1. TM may prevent HMGB1 from reaching remote organs, thereby restricting the spectrum of HMGB1 action in the site of injury. Here we review recent progress made in defining the physiological and pathological roles of HMGB1 and therapeutic strategies aimed at blocking circulatory HMGB1.

    Scopus

  • Kawahara K, Setoyama K, Kikuchi K, Biswas KK, Kamimura R, Iwata M, Ito T, Morimoto Y, Hashiguchi T, Takao S, Maruyama I .  HMGB1 release in co-cultures of porcine endothelial and human T cells. .  Xenotransplantation14 ( 6 ) 636 - 41   2007.11

     More details

    Language:English   Publisher:Xenotransplantation  

    High mobility group box-1 (HMGB1) protein, primarily from the nucleus, is released into the extracellular milieu either passively by necrotic or damaged cells, or actively by secretion from monocytes/macrophages. Extracellular HMGB1 acts as a potent inflammatory stimulator by promoting cytokine (for example, tumor necrosis factor-α) production, and also has pro-coagulant activity. The signaling pathway initiated by receptor for advanced glycation end-product (RAGE), which is the HMGB1 receptor, also induces complement activation. Recent studies have implicated HMGB1 in acute cardiac allograft rejection, and have identified infiltrating T cells and other damaged cells as its main sources. HMGB1 blockade using the anti-HMGB1 antibody HMGB1 box-A (amino-terminal region) and soluble RAGE rescues mice from acute rejection. We therefore studied the release of HMGB1 in co-cultures of porcine aortic endothelial cells (PAEC) and human leukocytes. Human T cells, but not B cells, monocytes or neutrophils, stimulated significant HMGB1 release in culture with PAEC; this activity required cell-cell contact and was dose-dependent, as determined by Western blotting. The released HMGB1 originated from both cell types, as immunofluorescent microscopy showed that it was present in the cytosol of PAEC in contact with T cells, and had disappeared from the T-cell nuclei. These results demonstrate that direct interactions between PAEC and T cells might be a key factor in triggering HMGB1 release, which suggests that HMGB1 is associated with graft rejection in the early phase. © 2007 Blackwell Munksgaard.

    DOI: 10.1111/j.1399-3089.2007.00434.x

    Scopus

    PubMed

  • Kimura K, Hashiguchi T, Deguchi T, Horinouchi S, Uto T, Oku H, Setoyama S, Maruyama I, Osame M, Arimura K .  Serum VEGF--as a prognostic factor of atherosclerosis. .  Atherosclerosis194 ( 1 ) 182 - 8   2007.9

     More details

    Language:English   Publisher:Atherosclerosis  

    Vascular endothelial growth factor (VEGF) has been noted in the pathogenesis of atherosclerosis. To examine the usefulness of the serum concentration of VEGF as an index of atherosclerosis, we analyzed the serum VEGF concentrations in 443 adults who underwent a medical checkup. The mean serum VEGF concentration of men (229 ± 147 pg/ml) was significantly higher than that of women (182 ± 112 pg/ml). The platelet count showed a slight correlation with the serum VEGF concentration in both genders (men R = 0.287, women R = 0.296), corresponding with the results of experiments that platelets are the major source of VEGF in circulating peripheral blood. In men, the serum VEGF concentrations correlated with platelet counts, body fat percentages, leukocyte counts, and HDL-cholesterol concentrations (negative correlation). In the multiple regression analysis performed for men's serum VEGF concentrations, the decision coefficient (R2) was maximized (R2 = 0.173) when the leukocyte count, the body fat percentage, and the HDL-cholesterol concentration were taken into account besides the platelet count. Male smokers' serum VEGF concentrations were higher than non-smokers'. Smoking in men significantly affected the sex difference in the serum VEGF concentration, leukocyte count, and HDL-cholesterol concentration. We concluded that the serum VEGF concentration might be closely related to atherosclerosis accelerating factor, especially in men. © 2006 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.atherosclerosis.2006.07.025

    Scopus

    PubMed

  • Arimura S, Kawahara K, Biswas KK, Abeyama K, Tabata M, Shimoda T, Ogomi D, Matsusaki M, Kato S, Ito T, Sugihara K, Akashi M, Hashiguchi T, Maruyama I .  Hydroxyapatite formed on/in agarose gel induces activation of blood coagulation and platelets aggregation. .  Journal of biomedical materials research. Part B, Applied biomaterials81 ( 2 ) 456 - 61   2007.5

     More details

    Language:English   Publisher:Journal of Biomedical Materials Research - Part B Applied Biomaterials  

    We reported earlier that hydroxyapatite (HA) formed on/in agarose gels (HA/agarose) produced by alternate soaking process is a bone-filling material possessing osteoconductive and hemostatic effects. This process could allow us to make bone-like apatite that was formed on/in organic polymer hydrogel matrices. Here, we investigated the mechanism of hemostasis induced by HA/agarose and found that HA/agarose, but not agarose or HA powder, significantly shortened activated partial thromboplastin time (APTT). While HA/agarose did not show significant platelet aggregation, it markedly enhanced adenosine diphosphate (ADP)-induced platelet aggregation. Moreover, Western blot analysis revealed selective adsorption of vitronectin onto HA/agarose. We also observed marked differences between HA powder and HA/agarose in their XRD patterns. The crystallinity of HA powder was much higher compared to that of HA/agarose. Furthermore, 50-100 nm of tube-form aggregations was observed in HA powder on the other hand 100-200 nm of particles was observed in HA/agarose by SEM observation. Thus 100-200 nm of low crystallized particles on the surface structure of HA/agarose may play an important role in hemostasis. Our results demonstrated a crucial role of HA/agarose in the mechanism of hemostasis and suggested a potential role for HA/agarose as a bone-grafting material. © 2006 Wiley Periodicals, Inc.

    DOI: 10.1002/jbm.b.30684

    Scopus

    PubMed

  • Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I .  High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. .  Journal of thrombosis and haemostasis : JTH5 ( 1 ) 109 - 16   2007.1

     More details

    Language:English   Publisher:Journal of Thrombosis and Haemostasis  

    Background: Sepsis is a life-threatening disorder resulting from systemic inflammatory and coagulatory responses to infection. High-mobility group box 1 protein (HMGB1), an abundant intranuclear protein, was recently identified as a potent lethal mediator of sepsis. However, the precise mechanisms by which HMGB1 exerts its lethal effects in sepsis have yet to be confirmed. We recently reported that plasma HMGB1 levels correlated with disseminated intravascular coagulation (DIC) score, indicating that HMGB1 might play an important role in the pathogenesis of DIC. Objectives: To investigate the mechanisms responsible for the lethal effects of HMGB1, and more specifically, to explore the effects of HMGB1 on the coagulation system. Methods: Rats were exposed to thrombin with or without HMGB1, and a survival analysis, pathologic analyses and blood tests were conducted. The effects of HMGB1 on the coagulation cascade, anticoagulant pathways and surface expression of procoagulant or anticoagulant molecules were examined in vitro. Results: Compared to thrombin alone, combined administration of thrombin and HMGB1 resulted in excessive fibrin deposition in glomeruli, prolonged plasma clotting times, and increased mortality. In vitro, HMGB1 did not affect clotting times, but inhibited the anticoagulant protein C pathway mediated by the thrombin-thrombomodulin complex, and stimulated tissue factor expression on monocytes. Conclusions: These findings demonstrate the procoagulant role of HMGB1 in vivo and in vitro. During sepsis, massive accumulation of HMGB1 in the systemic circulation would promote the development of DIC. © 2007 International Society on Thrombosis and Haemostasis.

    DOI: 10.1111/j.1538-7836.2006.02255.x

    Scopus

    PubMed

  • 山本 英彦, 武友 麻衣, 田中 宏暁, 吉田 るみ子, 萱嶋 誠, 小野 敦子, 名取 省一, 橋口 照人, 丸山 征郎 .  生活習慣病の予防・改善のための運動療法 ベンチステップ運動を用いた無作為化比較試験 .  人間ドック21 ( 4 ) 854 - 859   2006.12生活習慣病の予防・改善のための運動療法 ベンチステップ運動を用いた無作為化比較試験

     More details

    Language:Japanese   Publisher:(公社)日本人間ドック学会  

    目的:従業員の定期健康診断で生活習慣の改善を指示された人を対象に、ステップ台を用いた8週間の運動プログラムを実施し、その前後での運動能力や体重、腹囲、総コレステロール値、血圧などを測定することでベンチステップ運動の有効性を検討する。方法:対象者33名を無作為に2群に振り分け、運動群には運動負荷試験により決定した乳酸閾値に相当する台高と昇降頻度でのベンチステップ運動(踏み台昇降)を行った。運動は10分連続を1単位として1日3単位、週21単位の運動を指示し、試験期間中の食事指導や食事制限は行わなかった。結果:運動群では8週間の試験終了後に運動能力の有意な向上のほか、腹囲や総コレステロール値に有意な改善が認められた。予定されたプログラム(週21単位)の完全実施率は11.8%のみであり、週14単位以上実施した人を合わせても42.2%の実施率であった。しかし週14単位以上実施した人では有意な体重減少が認められ、高血圧の人も全例に血圧の低下が認められた。結論:乳酸閾値でのステップ運動を8週間継続することで腹囲や高コレステロール血症者の総コレステロール値の有意な低下が示された。またこの運動を週14単位以上行うことで体重減少や血圧低下も認められ、生活習慣病を予防・改善するための運動量としては乳酸閾値でのステップ運動を1日2単位、週14単位以上行うことが推奨される。(著者抄録)

  • 伊藤 隆史, 川原 幸一, 橋口 照人, 丸山 征郎 .  致死性因子HMGB1はDICのポテンシエーターとして働く .  日本血栓止血学会誌 = The Journal of Japanese Society on Thrombosis and Hemostasis17 ( 5 ) 538   2006.10

     More details

    Language:Japanese  

  • Biswas KK, Tancharoen S, Sarker KP, Kawahara K, Hashiguchi T, Maruyama I .  Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. .  FEBS letters580 ( 2 ) 703 - 10   2006.1

     More details

    Language:English   Publisher:FEBS Letters  

    Cepharanthine (CEP), a biscoclaurine alkaloid, has been reported to induce cell death, however, the molecular mechanism of this phenomenon remains unclear. We herein report that CEP induced apoptosis in HuH-7 cells through nuclear fragmentation, DNA ladder formation, cytochrome c release, caspase-3 activation and poly-(ADP-ribose)-polymerase cleavage. CEP triggered the generation of reactive oxygen intermediates, the activation of mitogen activated protein kinase (MAPK) p38, JNK1/2 and p44/42, and the downregulation of protein kinase B/Akt. Antioxidants and SP600125, an inhibitor of JNK1/2, but not inhibitors of p38 MAPK and MEK1/2, significantly prevented cell death, thus implying that reactive oxygen species and JNK1/2 play crucial roles in the CEP-induced apoptosis of HuH-7 cells. © 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.febslet.2005.12.048

    Scopus

    PubMed

  • Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, Yamaji K, Uchimura T, Izumi Y, Maruyama I .  Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. .  FEBS letters580 ( 2 ) 613 - 9   2006.1

     More details

    Language:English   Publisher:FEBS Letters  

    Anandamide (AEA) exhibits anti-inflammatory effects. However, its role in the periodontal field remains unknown. Here, we found that gingival crevicular fluid contained a detectable level of AEA. The cannabinoid receptors CB1 and CB2 were expressed by human gingival fibroblasts (HGFs), and markedly upregulated under pathological conditions. AEA significantly reduced the production of pro-inflammatory mediators (IL-6, IL-8 and MCP-1) induced by Porphyromonas gingivalis LPS in HGFs, and this effect was attenuated by AM251 and SR144528, selective antagonists of CB1 and CB2, respectively. Moreover, AEA completely blocked LPS-triggered NF-κB activation, implying that AEA may regulate hyperinflammatory reactions in periodontitis. © 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.febslet.2005.12.079

    Scopus

    PubMed

  • Yamamoto Hidehiko, Taketomo Mai, Tanaka Hiroaki, Yoshida Rumiko, Kayashima Makoto, Ono Atsuko, Natori Shoichi, Hashiguchi Teruto, Maruyama Ikuro .  An Exercise Program for Prevention and/or Improvement of Lifestyle Related Disease: A Randomized Controlled Trial Using a Bench Step Exercise .  Official Journal of Japan Society of Ningen Dock21 ( 4 ) 854 - 859   2006

     More details

    Language:Japanese   Publisher:Japan Society of Ningen Dock  

    For the prevention or improvement of lifestyle related disease an 8-week exercise program involving a bench step exercise was arranged. Methods: Thirty-three employees who had been recommended to change their lifestyle following a routine health check were enrolled. Before and after the program, their physical performance was evaluated, and their waistline, total cholesterol value and blood pressure was recorded and compared. There were no dietary restrictions. The 33 subjects were randomly divided into two groups: an exercise group and a control group. The exercise group was instructed to execute a bench-stepping exercise over ten consecutive minutes three times a day (i. e. twenty-one times a week) at a bench height and stepping rate that varied depending on each individual's lactate threshold as determined by an exercise stress test. Results: Only 11.8% of the participants completed the step exercise program as planned (21 times/week), but 42.2% executed it 14 or more times a week. These participants showed not only an improved physical performance, but experienced a significant reduction in weight, waistline size and total cholesterol value. Furthermore, the blood pressure of those participants suffering from hypertension was lowered. Conclusion: The step exercise over 8weeks at the lactate intensity threshold leads to a significant reduction in waistline, total cholesterol value and blood pressure. We recommend executing the step exercise at the lactate intensity threshold more than twice a day (i. e.14 or more times/week).

    DOI: 10.11320/ningendock2005.21.854

  • Miao T., Hashiguchi T., Maruyama I. .  Nonlinear analysis of heart rate variability and plethysmogram in subjects with normal and abnormal cardiovascular function .  Conference Proceedings - IEEE International Conference on Systems, Man and Cybernetics4   2885 - 2890   2006

     More details

    Language:Japanese   Publisher:Conference Proceedings - IEEE International Conference on Systems, Man and Cybernetics  

    We used nonlinear methods of Detrended Fluctuation Analysis (DFA) and Recurrence Quantification Analysis (RQA) to analysis of plethysmograms and their peak intervals in subjects with normal and pathological cardiovascular functions. Our results on HRV using DFA showed that scaling exponent indicated quantitatively differentiations among normal and pathologies. The measures of RQA were found to provide an unambiguous and quantitatively characterization of the plethysmogram time series in different cases. Accordingly, the integrations of these two analyses had the ability to identify and quantify normal and pathological cases, implying a possible clinical application. © 2006 IEEE.

    DOI: 10.1109/ICSMC.2006.385312

    Scopus

  • 川原 幸一, ビスワズ カマル・K, 伊藤 隆史, 橋口 照人, 丸山 征郎 .  CRPはp38MAPKを介してHMGB1を放出する .  Shock : 日本Shock学会雑誌20 ( 1 ) 32   2005.4

     More details

    Language:Japanese  

  • ビスワズ カマル・K, 川原 幸一, パダ シャーカ・K, 鵜島 雅子, 阿邊山 和浩, 橋口 照人, 丸山 征郎 .  内因性カンナビノイドがHMGB1の遊離を誘導する .  Shock : 日本Shock学会雑誌20 ( 1 ) 31   2005.4

     More details

    Language:Japanese  

  • Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T, Krishna Biswas K, Iwamoto H, Maruyama I .  Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. .  Thrombosis research115 ( 4 ) 319 - 25   2005

     More details

    Language:English   Publisher:Thrombosis Research  

    Activated protein C (APC) is an important natural anticoagulant that is proteolytically generated from protein C (PC) by the modulation of thrombin activity in the presence of thrombomodulin on an endothelial surface. Recent studies have demonstrated that, beyond its anticoagulant acitivities, APC had anti-inflammatory and cytoprotective properties. The mechanisms underlying APC's anti-inflammatory effects remain unknown. Our goal was to elucidate and confirm these mechanisms. We first examined the effect of APC on reactive oxygen species (ROS) and inflammatory cytokine production in murine macrophage-like RAW264.7 cells. We further examined the effect of APC on chemically induced lipid peroxidation and advanced glycation end-products (AGE) formation. APC in the range of 10-50 μg/mL could reduce lipopolysaccharide (LPS)-induced ROS generation, nuclear factor κB (NF-κB) activation and resultant proinflammatory cytokine production. Additional cell-free experiments revealed that APC (10-50 μg/mL) had inhibitory effects on lipid peroxidation and AGE formation. These findings suggest that APC, via its intrinsic anti-oxidant properties, may, in settings of oxidant stress, exert important cytoprotective and anti-inflammatory effects that are distinct from its anticoagulant activity as an antioxidant protein. If that is true, APC may contribute to ROS-related chronic disorders including atherosclerosis and diabetes as well as acute shock conditions. © 2004 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.thromres.2004.09.011

    Scopus

    PubMed

  • Sarker KP, Biswas KK, Yamaji K, Yamakuchi M, Hashiguchi T, Lee KY, Maruyama I .  Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban. .  Pathophysiology of haemostasis and thrombosis34 ( 1 ) 41 - 7   2005

     More details

    Language:English   Publisher:Pathophysiology of Haemostasis and Thrombosis  

    Thrombin, a serine protease that plays a pivotal role in blood coagulation, wound healing, and angiogenesis, has also been implicated in the mitogenesis of various cell types. Previously, we showed that thrombin and the thrombin receptor agonist peptide (TRAP-14; SFLLRNPNDKYEPF) for protease-activated receptor 1 (PAR1) induce vascular endothelial growth factor (VEGF) secretion in PC-12 cells. In this study, we show that thrombin and TRAP-14 also stimulate VEGF secretion in the human NB-1 neuroblastoma cells. In these cells, we further show that thrombin-induced VEGF secretion was blocked by cycloheximide and actinomycin D, indicating that de novo protein synthesis is essential for this process. Reduced thrombin-induced VEGF secretion upon treatment with LY294002, calphostin C, or BAPTA, further suggests that the process is dependent on phosphatidyl-inositol-3-kinase, protein kinase C, and calcium. However, the complete loss of thrombin-induced VEGF production upon treatment with argatroban, a derivative of arginine and a potent anticoagulant/antithrombin agent, supports the notion that argatroban serves as a useful therapeutic tool for thrombin-associated pathologic conditions. Here, it appears that argatroban may be effective in controlling disorders linked to thrombin-induced VEGF production in neuronal cells. Copyright © 2005 S. Karger AG.

    DOI: 10.1159/000088547

    Scopus

    PubMed

  • Iino S, Abeyama K, Kawahara K, Yamakuchi M, Hashiguchi T, Matsukita S, Yonezawa S, Taniguchi S, Nakata M, Takao S, Aikou T, Maruyama I .  The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value. .  Clinical cancer research : an official journal of the American Association for Cancer Research10 ( 18 Pt 1 ) 6179 - 88   2004.9

     More details

    Language:English   Publisher:Clinical Cancer Research  

    Islet cell tumors, endocrine neoplasm arising from pancreatic islets of Langerhans, are histologically difficult to diagnose as benign or malignant. Molecular markers are associated with the clinical characteristics that most of insulinoma are usually benign tumors, whereas other islet cell tumors are malignant but have not been identified. In this context, we newly found that an endothelial anticoagulant thrombomodulin was expressed in the normal islet β cells and insulinoma, but not of other islet components or non-insulinoma islet cell tumors. Clinically, all of the subjects (n = 15) of the insulinoma group showed no metastasis together with thrombomodulin expression in the lesions, whereas the other islet cell tumor groups showed a high incidence of metastasis (82%) and a low expression rate of thrombomodulin (6%). To examine the functional role of thrombomodulin, especially regarding the clinical characteristics of islet cell tumors, we tested the effect of exogenous thrombomodulin overexpression on cell adhesiveness and proliferation using MIN6 insulinoma cell line. In cell-based experiments, thrombomodulin overexpression reduced cell proliferation and enhanced Ca2+-independent cell aggregation, possibly through direct interaction with neural cell adhesion molecule. Taken together, these results are suggesting that thrombomodulin may act as antimetastatic molecule of insulinomas. In addition, thrombomodulin is a clinically useful molecular marker not only for identifying β-cell-origin islet cell tumors (i.e., insulinomas) but also for predicting disease prognosis of islet cell tumors.

    DOI: 10.1158/1078-0432.CCR-03-0750

    Scopus

    PubMed

  • Kasai T, Abeyama K, Hashiguchi T, Fukunaga H, Osame M, Maruyama I .  Decreased total nitric oxide production in patients with duchenne muscular dystrophy. .  Journal of biomedical science11 ( 4 ) 534 - 7   2004.7Decreased total nitric oxide production in patients with duchenne muscular dystrophy.

     More details

  • Kasai T., Abeyama K., Hashiguchi T., Fukunaga H., Osame M., Maruyama I. .  Decreased total nitric oxide production in patients with duchenne muscular dystrophy .  Journal of Biomedical Science11 ( 4 ) 534 - 537   2004.6

     More details

    Language:Japanese   Publisher:Journal of Biomedical Science  

    Plasma nitric oxide (NO) levels in Duchenne muscular dystrophy (DMD) patients were significantly lower than those observed in both healthy controls and in patients with other neuromuscular disorders. The correlation between NO level and ejection fraction was significant (r = -0.384, p = 0.0391) in the DMD group. Disruption of NO systems may contribute to the development of muscular dystrophy and have implications for therapeutic strategies. Copyright © 2004 National Science Council, ROC and S. Karger AG, Basel.

    DOI: 10.1159/000077905

    Scopus

  • Motobe T, Hashiguchi T, Uchimura T, Yamakuchi M, Taniguchi N, Komiya S, Maruyama I .  Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. .  Shock (Augusta, Ga.)21 ( 1 ) 8 - 12   2004.1

     More details

    Language:English   Publisher:Shock (Augusta, Ga.)  

    Acute hypotension, hypoxemia, cardiac arrhythmias, cardiac arrest, (or a combination of these), and sudden death are well-recognized complications of the cemented hip arthroplasty procedure. Collectively, these are known as the bone cement implantation syndrome (BCIS). The endogenous cannabinoids, anandamide (ANA) and 2-arachidonylglycerol (2-AG), are reported to be strong vasodilators and play a role in the hypotension associated with hemorrhagic and septic shock. In the present study, a potential role for the endogenous cannabinoids in influencing hemodynamic variables in BCIS was investigated. Thirty-five patients (35 hips) entered a prospective, randomized clinical trial. The patients were divided into two groups. Group 1 comprised 16 patients who had the component inserted using a conventional cementing technique, whereas group 2 consisted of 19 patients who had the femoral component inserted without cement. Blood samples were taken at six consecutive time points: before anesthesia, after reaming the femur, 2 min after insertion of stems with or without cement into the femur, and 10 min, 20, and 30 min after stem insertion. In group 1 (with cement), the mean levels of ANA and 2-AG significantly increased after stem insertion. In a comparison of each group after stem insertion, mean ANA and 2-AG levels in group 1 also significantly differed from those in group 2. By contrast, in group 2 (without cement) neither ANA nor 2-AG levels exhibited a significant increase or change at any point in time. In conclusion, we have shown for the first time that endogenous cannabinoids are candidates for lipid mediators of BCIS.

    DOI: 10.1097/01.SHK.0000094766.36694.49

    Scopus

    PubMed

  • Kanekura T, Hashiguchi T, Mera Y, Katahira A, Nakamura I, Maruyama I, Kanzaki T .  Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. .  Dermatology (Basel, Switzerland)208 ( 1 ) 79 - 80   2004Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis.

     More details

  • Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee KY, Maruyama I .  Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. .  Journal of neurochemistry87 ( 6 ) 1345 - 53   2003.12

     More details

    Language:English   Publisher:Journal of Neurochemistry  

    Ebselen, a selenium-containing heterocyclic compound, prevents ischemia-induced cell death. However, the molecular mechanism through which ebselen exerts its cytoprotective effect remains to be elucidated. Using sodium nitroprusside (SNP) as a nitric oxide (NO) donor, we show here that ebselen potently inhibits NO-induced apoptosis of differentiated PC12 cells. This was associated with inhibition of NO-induced phosphatidyl Serine exposure, cytochrome c release, and caspase-3 activation by ebselen. Analysis of key apoptotic regulators during NO-induced apoptosis of differentiated PC12 cells showed that ebselen blocks the activation of the apoptosis signaling-regulating kinase 1 (ASK1), and inhibits phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal protein kinase (JNK). Moreover, ebselen inhibits NO-induced p53 phosphorylation at Ser15 and c-Jun phosphorylation at Ser63 and Ser73. It appears that inhibition of p38 MAPK and p53 phosphorylation by ebselen occurs via a thiol-redox-dependent mechanism. Interestingly, ebselen also activates p44/42 MAPK, and inhibits the downregulation of the antiapoptotic protein Bcl-2 in SNP-treated PC12 cells. Together, these findings suggest that ebselen protects neuronal cells from NO cytotoxicity by reciprocally regulating the apoptotic and antiapoptotic signaling cascades.

    DOI: 10.1046/j.1471-4159.2003.02096.x

    Scopus

    PubMed

  • Arisato T, Hashiguchi T, Sarker KP, Arimura K, Asano M, Matsuo K, Osame M, Maruyama I .  Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. .  Journal of thrombosis and haemostasis : JTH1 ( 12 ) 2589 - 93   2003.12

     More details

    Language:English   Publisher:Journal of Thrombosis and Haemostasis  

    Background: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific potent mitogen that induces angiogenesis and microvascular hyperpermeability. Recently, it has been reported that megakaryocytes and platelets contain VEGF in their cytoplasm. Objectives: To elucidate and confirm the bioactivity and role of VEGF in platelets (platelet VEGF), which may be closely related to vascular thrombosis and atherosclerosis. Methods: The VEGF localization in mega-karyocytes on bone marrow smears was analyzed by immuno-fluorescence and confocal laser scanning microscopic analysis. The intracellular VEGF expressed in platelets was determined by flow cytometric analysis. Platelet-rich plasma and washed platelets were used to analyze the secretion of VEGF during platelet aggregation by thrombin or gelatinase A (matrix me-talloproteinase-2) stimulation. Immunohistochemical studies for VEGF in the thrombotic region were performed. Results and conclusions: Megakaryocytes and platelets are a very rich source of circulating VEGF. Gelatinase A, which is closely associated with vascular remodeling, enhances the VEGF levels released from platelets. VEGF was clearly detected in the fibrin nets of a thrombus. Taken together, platelet VEGF is bioactive as a direct angiogenic growth factor, and may play a very important role in wound healing and atherosclerosis in con-junction with other platelet cytokines such as platelet-derived growth factor, platelet-derived endothelial cell growth factor, transforming growth factor (TGF)-α, and TGF-β. © 2003 International Society on Thrombosis and Haemostasis.

    DOI: 10.1046/j.1538-7836.2003.00475.x

    Scopus

    PubMed

  • TOKASHIKI Takashi, HASHIGUCHI Teruto, ARIMURA Kimiyoshi, EIRAKU Nobutaka, MARUYAMA Ikuro, OSAME Mitsuhiro .  Predictive Value of Serial Platelet Count and VEGF Determination for the Management of DIC in the Crow-Fukase (POEMS) Syndrome .  Internal Medicine42 ( 12 ) 1240 - 3   2003.12

     More details

    Language:English   Publisher:The Japanese Society of Internal Medicine  

    We report a case of a 62-year-old man diagnosed as Crow-Fukase syndrome (POEMS syndrome), in which the serial platelet count and vascular endothelial growth factor (VEGF) concentration were determined before and during the state of disseminated intravascular coagulation (DIC). The serum VEGF concentration was noted to be gradually decreased prior to DIC, after which it abruptly decreased with a corresponding drop in platelet count upon the onset of DIC. The physiological effects of VEGF are viewed as one of the causative factors in DIC and its abrupt and excessive release may have caused the exacerbation of the patient's clinical symptoms.<br>(Internal Medicine 42: 1240-1243, 2003)

    DOI: 10.2169/internalmedicine.42.1240

    Scopus

    PubMed

  • 加藤 英二, 茨 聡, 丸山 有子, 丸山 英樹, 下野 隆一, 前出 喜信, 徳久 琢也, 熊澤 一真, 楠元 雅寛, 松井 貴子, 加藤 博美, 石山 昭彦, 簗詰 伸太郎, 松村 眞紀, 池ノ上 克, 丸山 征郎, 橋口 照人 .  PMX-DHP療法を施行した新生児,乳児における血中anandamide,2-arachidonylglycerol濃度の変化の検討 .  エンドトキシン血症救命治療研究会誌7 ( 1 ) 106 - 112   2003.12PMX-DHP療法を施行した新生児,乳児における血中anandamide,2-arachidonylglycerol濃度の変化の検討

     More details

    Language:Japanese   Publisher:(株)自然科学社  

  • Biswas KK, Sarker KP, Abeyama K, Kawahara K, Iino S, Otsubo Y, Saigo K, Izumi H, Hashiguchi T, Yamakuchi M, Yamaji K, Endo R, Suzuki K, Imaizumi H, Maruyama I .  Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. .  Hepatology (Baltimore, Md.)38 ( 5 ) 1167 - 77   2003.11

     More details

    Language:English   Publisher:Hepatology  

    The endogenous cannabinoid anandamide, a lipid mediator, induces various physiologic events such as vascular relaxation, inhibition of gap-junctions formation, tumor proliferation, neurologic analgesia, and apoptosis. Although increased concentration of anandamide in plasma has been implicated in pathophysiologic states including endotoxin-induced hypotension, the effects of anandamide on hepatocytes still remain unclear. In this study, we present evidence that plasma anandamide concentration is highly increased in severe hepatitis and cirrhosis patients. In addition, concentrations of anandamide within the pathophysiologic range potently induced apoptosis of hepatoma cell line (Hep G2) and primary hepatocytes, suggesting a possible link between increased anandamide level and hepatocyte damage. Anandamide-induced cell death was preceded by G0/G1 cell-cycle arrest, activation of proapoptotic signaling (i.e., p38 MAPK and JNK), and inhibition of antiapoptotic signaling (i.e., PKB/Akt) pathways. Moreover, anandamide increased susceptibility to oxidative stress-induced hepatocyte damage. In this context, methyl-β-cyclodextrin (MCD), a membrane cholesterol depletor, or mevastatin, an HMG-CoA reductase inhibitor, or N-acetyl cysteine, an antioxidant, potently inhibited the anandamide-induced proapoptotic events and cell death, whereas putative cannabinoid receptor antagonists did not exhibit an inhibitory effect on anandamide-induced cell death. Furthermore, binding assay using polymyxin beads revealed that anandamide could interact with cholesterol. In conclusion, our data suggest that cholesterol present in the cell membrane determines the fate of hepatocytes exposed to anandamide, possibly functioning as an anandamide receptor.

    DOI: 10.1053/jhep.2003.50459

    Scopus

    PubMed

  • Crow-Fukase syndrome and VEGF .    47 ( 4 ) 545 - 554   2003.8

     More details

  • Niiyama T, Higuchi I, Hashiguchi T, Suehara M, Uchida Y, Horikiri T, Shiraishi T, Saitou A, Hu J, Nakagawa M, Arimura K, Osame M .  Capillary changes in skeletal muscle of patients with Ullrich's disease with collagen VI deficiency. .  Acta neuropathologica106 ( 2 ) 137 - 42   2003.8

     More details

    Language:English   Publisher:Acta Neuropathologica  

    We examined the capillaries in muscle biopsy specimens from two patients with Ullrich's disease with collagen VI deficiency by light and electron microscopy. Collagen VI plays an important role in platelet aggregation for binding von Willebrand factor. Using immunohistochemistry, collagen VI was shown to be absent on capillaries from patients with Ullrich's disease, while von Willebrand factor, collagen IV, and vascular endothelial growth factor were normally expressed. Electron microscopy revealed narrow lumens, large nuclei in endothelial cells, and fenestration of a capillary. The number of pinocytotic vesicles per unit endothelial cytoplasm was increased. The cytoplasm of endothelial cells was strongly stained with uranyl acetate and lead citrate. Replication of the capillary basement membrane was observed. On the other hand, easy bleeding and coagulation were not observed in the two patients. These findings suggested that the collagen VI deficiency might have caused the electron microscopic changes of capillaries, while the function of the capillaries is apparently retained.

    DOI: 10.1007/s00401-003-0714-1

    Scopus

    PubMed

  • Arisato T, Sarker KP, Kawahara K, Nakata M, Hashiguchi T, Osame M, Kitajima I, Maruyama I .  The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells. .  Cellular and molecular life sciences : CMLS60 ( 8 ) 1716 - 24   2003.8

     More details

    Language:English   Publisher:Cellular and Molecular Life Sciences  

    Thrombin, a serine protease generated by the activation of the blood coagulation cascade following vessel injury, induces vascular endothelial growth factor (VEGF) release. However, the molecular mechanism of thrombin-induced VEGF release is largely unknown. An agonist of protease-activated receptor-1 (PAR1), SFLL-RNPNDKYEPF, mimicked thrombin-induced VEGF release in human vascular smooth muscle (HVSM) cells, as determined by enzyme-linked immunosorbent assay, reverse transcriptase-polymerase chain reaction, and Northern blotting. In contrast, the agonist of PAR3, TFRGAP, did not affect VEGF release or expression. SFLL-RNPNDKYEPF, but not TFRGAP, up-regulated [Ca2+]i. Moreover, the calcium ionophone A23187 was found to trigger VEGF release in HVSM cells. Thrombin-induced VEGF release was blocked by anti-thrombin, heparin, a synthetic thrombin receptor inhibitor E5510, the calcium chelator BAPTA, the protein kinase C inhibitor calphostin C, and the MEK 1/2 inhibitor U0126. Thus, our data show that thrombin caused VEGF release via PAR1 activation in a manner dependent on [Ca2+]i and p44/42 downstream from the receptor activation.

    DOI: 10.1007/s00018-003-3140-6

    Scopus

    PubMed

  • Yamaji K., Sarker K.P., Kawahara K., Iino S., Yamakuchi M., Abeyama K., Hashiguchi T., Maruyama I. .  Anandamide induces apoptosis in human endothelial cells: Its regulation system and clinical implications .  Thrombosis and Haemostasis89 ( 5 ) 875 - 884   2003.5

     More details

    Language:Japanese   Publisher:Thrombosis and Haemostasis  

    Anandamide (AEA), an endogenous cannabinoid, is generated by macrophages during shock conditions, and is thought to be a causative mediator of septic shock. Thus, we hypothesized that AEA plays a crucial role in endothelial cell (EC) injury. Here, we demonstrate that AEA induces apoptosis in a time- and dose-dependent manner in human umbilical vein endothelial cells (HUVECs). AEA triggered phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen activated protein kinase. AEA also showed a marked increase of interleukin Iβ-converting enzyme (ICE)CED-3 family protease (caspase-3) activity. AEA-induced EC death was inhibited by a selective vanilloid receptor I (VRI) antagonist, capsazepine, and was enhanced by a VRI agonist, capsaicin, indicating that AEA induces apoptosis in ECs via VRI. In conclusion, we propose that AEA may play a crucial role in EC injury under conditions of shock, and that the use of inhibitors of the AEA regulation system may have a therapeutic effect under these conditions.

    DOI: 10.1055/s-0037-1613475

    Scopus

  • Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I .  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. .  Arthritis and rheumatism48 ( 4 ) 971 - 81   2003.4

     More details

    Language:English   Publisher:Arthritis and Rheumatism  

    Objective. High mobility group box chromosomal protein 1 (HMGB-1), a nuclear DNA binding protein, was recently rediscovered as a new proinflammatory cytokine. The purpose of this study was to demonstrate HMGB-1 expression in vivo and to identify the role of HMGB-1 in the pathogenesis of rheumatoid arthritis (RA). Methods. HMGB-1 concentrations in synovial fluid (SF) and serum from RA and osteoarthritis (OA) patients were measured by immunoblot analysis. The protein's specific receptor, receptor for advanced glycation end products (RAGE), was examined in SF macrophages (SFMs). We measured levels of proinflammatory cytokines released by SFMs treated with HMGB-1 via enzyme-linked immunosorbent assay and used soluble RAGE (sRAGE) to block the release of tumor necrosis factor α (TNFα). Immunohistochemical analysis and immunofluorescence assay were employed to examine localization of HMGB-1 in RA synovium and its translocation in SFMs after TNFα stimulation. Results. HMGB-1 concentrations were significantly higher in SF of RA patients than in that of OA patients. SFMs expressed RAGE and released TNFα, interleukin-1β (IL-1β), and IL-6 upon stimulation with HMGB-1. HMGB-1 was found in CD68-positive cells of RA synovium, and TNFα stimulation translocated HMGB-1 from the nucleus to the cytosol in SFMs. Blockade by sRAGE inhibited the release of TNFα from SFMs. Conclusion. HMGB-1 was more strongly expressed in SF of RA patients than in that of OA patients, inducing the release of proinflammatory cytokines from SFMs. HMGB-1 plays a pivotal role in the pathogenesis of RA and may be an original target of therapy as a novel cytokine.

    DOI: 10.1002/art.10859

    Scopus

    PubMed

  • Yotsumoto S, Shimomai K, Hashiguchi T, Uchimiya H, Usuki K, Nishi M, Kanekura T, Kanzaki T .  Estrogen dermatitis: a dendritic-cell-mediated allergic condition. .  Dermatology (Basel, Switzerland)207 ( 3 ) 265 - 8   2003Estrogen dermatitis: a dendritic-cell-mediated allergic condition.

     More details

    Language:English  

    DOI: 10.1159/000073088

    PubMed

  • Niiyama T, Higuchi I, Suehara M, Hashiguchi T, Shiraishi T, Nakagawa M, Arimura K, Maruyama I, Osame M .  Electron microscopic abnormalities of skeletal muscle in patients with collagen VI deficiency in Ullrich's disease. .  Acta neuropathologica104 ( 1 ) 67 - 71   2002.7

     More details

    Language:English   Publisher:Acta Neuropathologica  

    By electron microscopy, we examined the skeletal muscle from two patients with Ullrich's disease. One patient had a deletion in the collagen VI alpha 2 gene. The muscle biopsy specimens showed no collagen VI immunoreaction, while the expression of collagen IV was increased. Collagen VI is a microfibrillar protein in the extracellular matrix with cell adhesive properties, and collagen IV is a principal component of the basal lamina. Electron microscopy revealed unevenness, extension, and folding of the muscle plasma membrane, and showed thickening and overproduction of the basal lamina. The data show that type VI collagen is certainly one of the important extracellular matrix components maintaining the structural integrity of skeletal muscle, and a defect of the collagen VI protein causes abnormalities of the muscle plasma membrane, dystrophic muscle changes, and upregulation of collagen IV.

    DOI: 10.1007/s00401-002-0522-z

    Scopus

    PubMed

  • Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine .  Nephron90 ( 4 ) 401 - 7   2002.4

     More details

    Language:English  

    DOI: 10.1159/000054727

    Scopus

    PubMed

  • HASHIGUCHI Teruto, TARA Mitsutoshi, NIINA Kiyoshige, HIGUCHI Itsuro, ARIMURA Kimiyoshi, OSAME Mitsuhiro, MARUYAMA Ikuro .  Adult T-cell Leukemia (ATL) Cells which Express Neural Cell Adhesion Molecule (NCAM) and Infiltrate into the Central Nervous System. .  Internal Medicine41 ( 1 ) 34 - 8   2002.1

     More details

    Language:English   Publisher:The Japanese Society of Internal Medicine  

    We encountered a patient with adult T-cell leukemia/lymphoma (ATL) which expressed neural cell adhesion molecule (NCAM). The tumor cells markedly infiltrated the central nervous system (CNS) during the course of the ATL. The patient died 20 months after disease onset, which was considered to be early in the course. During the invasion of the CNS, the surface phenotype of the peripheral blood ATL cells by flow cytometric analysis was CD2+, CD3+, CD4+, CD7-, CD8-, CD16-, NCAM (CD56)+, HLA-DR-. We speculate that the infiltration of ATL cells into the CNS was closely related to the expression of the NCAM in this patient.<br>(Internal Medicine 41: 34-38, 2002)

    DOI: 10.2169/internalmedicine.41.34

    PubMed

  • Hashiguchi Teruto, Tara Mitsutoshi, Niina Kiyoshige, Higuchi Itsuro, Arimura Kimiyoshi, Osame Mitsuhiro, Maruyama Ikuro .  神経細胞粘着分子(NCAM)を発現し中枢神経系に浸潤した成人T細胞白血病(ATL)の1例(Adult T-cell Leukemia (ATL) Cells which Express Neural Cell Adhesion Molecule (NCAM) and Infiltrate into the Central Nervous System) .  Internal Medicine41 ( 1 ) 34 - 38   2002.1神経細胞粘着分子(NCAM)を発現し中枢神経系に浸潤した成人T細胞白血病(ATL)の1例(Adult T-cell Leukemia (ATL) Cells which Express Neural Cell Adhesion Molecule (NCAM) and Infiltrate into the Central Nervous System)

     More details

    Language:English   Publisher:(一社)日本内科学会  

    49歳男.鹿児島県生まれの日本人で健康診断で白血球増多症を指摘され,血清中のヒトT細胞白血病ウイルス抗体が陽性であった.MRIで脳の白質および灰白質にATL細胞のび漫性浸潤を認めた.末梢血中ATL細胞の表現型はCD2+,CD3+,CD4+,CD7-,CD8-,CD16-,NCAM(CD56)+,HLA-DR-であった.発症20ヵ月後に死亡した

  • Arimura K, Osame M, Hashiguchi T .  [Vascular endothelial growth factor and Crow-Fukase syndrome]. .  Rinsho shinkeigaku = Clinical neurology41 ( 12 ) 1144 - 6   2001.12[Vascular endothelial growth factor and Crow-Fukase syndrome].

     More details

    Language:Japanese  

    PubMed

  • UMEHARA Fujio, MICHIZONO Kumiko, HASHIGUCHI Teruto, ARIMURA Kimiyoshi, FUJIMOTO Noboru, OKADA Yasunori, OSAME Mitsuhiro .  Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome .    50   57   2001.10Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome

     More details

    Language:English  

  • Higuchi I, Shiraishi T, Hashiguchi T, Suehara M, Niiyama T, Nakagawa M, Arimura K, Maruyama I, Osame M .  Frameshift mutation in the collagen VI gene causes Ullrich's disease. .  Annals of neurology50 ( 2 ) 261 - 5   2001.8

     More details

    Language:English   Publisher:Annals of Neurology  

    Patients with Ullrich's disease have generalized muscle weakness, multiple contractures of the proximal joints, and hyperextensibility of the distal joints. Recently, we found a deficiency of collagen VI protein in two patients with Ullrich's disease. In this study, we detected a homozygous 26 bp deletion in exon 14 of the collagen VI alpha 2 gene (COL6A2) in one patient. This mutation causes a frameshift and a premature termination codon, and results in a truncated collagen VI alpha 2 chain. Our data suggest that at least some cases of Ullrich's disease result from recessive mutations in COL6A2.

    DOI: 10.1002/ana.1120

    Scopus

    PubMed

  • Y Wang, Y Liu, Y Ito, T Hashiguchi, Kitajima, I, M Yamakuchi, H Shimizu, S Matsuo, H Imaizumi, Maruyama, I .  Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock .  ANALYTICAL BIOCHEMISTRY294 ( 1 ) 73 - 82   2001.7

     More details

    Language:English   Publisher:ACADEMIC PRESS INC  

    Anandamide (ANA) and 2-arachidonoylglycerol (2-AG), two endogenous cannabinoids, can be generated by activated macrophages and platelets, respectively, in the context of endotoxic shock, and are proposed to play a crucial role in the induction of the shock-related hypotension. Taking advantage of our recently discovered function of polymyxin B (PMB) binding to ANA and 2-AG, we developed a new method for measuring ANA and 2-AG by applying PMB-immobilized beads to selectively adsorb them in biological fluids, instead of organic solvent extraction. The eluate from beads can be directly fractionated by reverse-phase high-performance liquid chromatography (HPLC), and the fractionations corresponding to authentic ANA and 2-AG are collected and derivatized with fluorogenic reagent and subsequently quantified by HPLC with fluorometric detection. The calibration graphs of ANA and 2-AG; were linear over a range of 1 to 500 pmol/ml. The limits of detection for ANA and 2-AG were 20 and 50 fmol, respectively. Intraassay precision was 2.24-4.25 and 3.47-5.44%, and interassay was 4.05-6.14 and 4.92-7.28% for ANA and 2-AG, respectively. Using this method, we first determined a 4-fold and 3-fold higher level of ANA and 2-AG, respectively, in the sera of patients with endotoxic shock than in normal serum. This finding should help in elucidating the role of the endogenous cannabinoids in the hypotension of human endotoxic shock. This method is rapid, sensitive, and reliable for simultaneously quantifying ANA and 2-AG in biological fluids, and has potential for clinical usage. (C) 2001 Academic Press.

    DOI: 10.1006/abio.2001.5015

    Web of Science

    Scopus

    PubMed

  • Uchimura T, Nakano K, Hashiguchi T, Iwamoto H, Miura K, Yoshimura Y, Hanyu N, Hirata K, Imakuma M, Motomiya Y, Maruyama I .  Elevation of N-(carboxymethyl)valine residue in hemoglobin of diabetic patients. Its role in the development of diabetic nephropathy. .  Diabetes care24 ( 5 ) 891 - 6   2001.5Elevation of N-(carboxymethyl)valine residue in hemoglobin of diabetic patients. Its role in the development of diabetic nephropathy.

     More details

    Language:English  

    DOI: 10.2337/diacare.24.5.891

    PubMed

  • Michizono K, Umehara F, Hashiguchi T, Arimura K, Matsuura E, Watanabe O, Fujimoto N, Okada Y, Osame M .  Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. .  Neurology56 ( 6 ) 807 - 10   2001.3

     More details

    Language:English   Publisher:Neurology  

    The authors quantitatively measured levels of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinases (TIMP), and vascular endothelial growth factor (VEGF) in blood samples of POEMS syndrome. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 were more increased in patients with POEMS syndrome than in patients with other neurologic disorders or in healthy controls. Serum levels of VEGF and TIMP-1 were strongly correlated with each other. Increased circulating levels of MMP-1, -2, -3, -9, and TIMP-1 may lead to a better understanding the pathogenesis of POEMS syndrome.

    DOI: 10.1212/wnl.56.6.807

    Scopus

    PubMed

  • 橋口 照人, 丸山 征郎 .  今月の主題 血管新生 各論 VEGFと疾患とのかかわり .  臨床検査44 ( 13 ) 1617 - 1621   2000.12今月の主題 血管新生 各論 VEGFと疾患とのかかわり

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1542904637

  • Niimi H, Arimura K, Jonosono M, Hashiguchi T, Kawabata M, Osame M, Kitajima I .  VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. .  Internal medicine (Tokyo, Japan)39 ( 12 ) 1101 - 4   2000.12VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.

     More details

    Language:English  

    DOI: 10.2169/internalmedicine.39.1101

    PubMed

  • Hashiguchi T, Arimura K, Matsumuro K, Otsuka R, Watanabe O, Jonosono M, Maruyama Y, Maruyama I, Osame M .  Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. .  Muscle & nerve23 ( 7 ) 1051 - 6   2000.7

     More details

    Language:English   Publisher:Muscle and Nerve  

    We report a marked difference in concentration of vascular endothelial growth factor (VEGF) between serum and plasma in patients with Crow-Fukase syndrome (CFS). The serum/plasma VEGF levels in 4 CFS patients were 8,634/152, 5,203/176, 3,724/127, and 868/13 pg/ml, respectively. We also showed that platelets were a major source of this VEGF and that VEGF was released during platelet aggregation by physiological stimulation. It is suggested that in CFS, local VEGF concentration is markedly elevated by aggregation of platelets containing excessive physiological activities of VEGF. Our findings provide important information for developing more effective therapeutic trials. (C) 2000 John Wiley and Sons, Inc.

    DOI: 10.1002/1097-4598(200007)23:7<1051::aid-mus7>3.0.co;2-v

    Scopus

    PubMed

  • Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis .  Journal of the Neurological Sciences173 ( 1 ) 45 - 52   2000.2

     More details

  • Hashiguchi T, Arimura K, Osame M .  [Crow-Fukase (POEMS) syndrome]. .  Ryoikibetsu shokogun shirizu ( 32 ) 595 - 8   2000[Crow-Fukase (POEMS) syndrome].

     More details

    Language:Japanese  

    PubMed

  • Hashiguchi T., Arimura K., Osame M. .  Crow-Fukase (POEMS) syndrome .  Ryōikibetsu shōkōgun shirīzu ( 32 ) 595 - 598   2000

     More details

    Language:Japanese   Publisher:Ryōikibetsu shōkōgun shirīzu  

    Scopus

  • NIIMI Hideki, ARIMURA Kimiyoshi, JONOSONO Manabu, HASHIGUCHI Teruto, KAWABATA Masaharu, OSAME Mitsuhiro, KITAJIMA Isao .  VEGF Is Causative for Pulmonary Hypertension in a Patient with Crow-Fukase (POEMS) Syndrome. .  Internal Medicine39 ( 12 ) 1101 - 1104   2000

     More details

    Language:English   Publisher:The Japanese Society of Internal Medicine  

    We report a case of Crow-Fukase (POEMS) syndrome associated with pulmonary hypertension (PH). In this case, the concentration of vascular endothelial growth factor (VEGF) was extremely high in the serum, and the levels of IL-1β, IL-6, TNF-α, and thiamine, which were thought in past reports to be mediators of PH in Crow-Fukase syndrome, were normal. After prednisolone therapy, PH disappeared with a dramatic decrease in serum VEGF. Our results suggest that VEGF is closely correlated with PH in Crow-Fukase syndrome.<br>(Internal Medicine 39: 1101-1104, 2000)

    DOI: 10.2169/internalmedicine.39.1101

    PubMed

  • KAETSU Hiroshi, HASHIGUCHI Teruto, FOSTER Don, ICHINOSE Akitada .  Expression and Release of the a and b Subunits for Human Coagulation Factor XIII in Baby Hamster Kidney (BHK) Cells .  The Journal of Biochemistry119 ( 5 ) 961 - 969   1996.5

     More details

    Language:English   Publisher:The Japanese Biochemical Society  

    The <i>a</i> subunit of coagulation factor XIII lacks a hydrophobic signal sequence for secretion from cells, while the <i>b</i> subunit has a typical signal sequence. To determine whether the <i>a</i> subunit can be synthesized and released, expression vectors containing the cDNA for either subunit were transfected into baby hamster kidney (BHK) cells. Western blotting analysis and gel filtration chromatography demonstrated that the recombinant <i>a</i> and <i>b</i> subunits (rXIII<i>a</i> and rXIII<i>b</i>) had the same molecular weights and subunit structures (<i>a</i><sup>2</sup>, <i>b</i><sup>2</sup>, and <i>a</i><sup>2</sup><i>b</i><sup>2</sup>) as the native molecules. rXIII<i>a</i> was enzymatically active when activated by thrombin. Most rXIII<i>b</i> was secreted as measured by ELISA, while most rXIII<i>a</i> was detected in the cytosol by subcellular fractionation. Co-expression with rXIII<i>b</i> in the same cells did not promote the release of rXIII<i>a</i>. Treatment of the cells with brefeldin A, a potent inhibitor of protein transportation, blocked the secretion of rXIII<i>b</i>, although it had no effect on the release of rXIII<i>a</i>. Several drugs and heat stress induced the release of rXIII<i>a</i>, which correlated directly with that of cytoplasmic lactate dehydrogenase. These results suggest that the <i>a</i> subunit is released from cells as a consequence of cell injury, which is independent of the classical secretory pathway.

  • Kaetsu Hiroshi, Hashiguchi Teruto, Foster Don .  ベイビーハムスター腎(BHK)細胞中でのヒト凝固因子VIIIのaおよびbサブユニットの発現と放出 .  The Journal of Biochemistry119 ( 5 ) 961 - 969   1996.5ベイビーハムスター腎(BHK)細胞中でのヒト凝固因子VIIIのaおよびbサブユニットの発現と放出

     More details

    Language:English   Publisher:(公社)日本生化学会  

    凝固因子VIIIaサブユニットは分泌の為の疎水性シグナル配列を欠き,bサブユニットは特有の配列を持つ.aサブユニットが合成・放出されるかを決める為,一方のサブユニットのcDNAを含む表現ベクターをBHK中に移植し,ウェスタンブロット分析とゲル濾過クロマトグラフィーから組換えa・bサブユニット(rVIIIaとrVIIIb)は同じ分子量とサブユニット構造を持つとわかった.rVIIIaはトロンビンで活性化され酵素活性をもつ.rVIIIbはELISAで測定すると分泌され,rVIIIaはsubcellular分割法により細胞ゾル中にみられる.rVIIIbとの共表現ではrVIIIaの放出は促進されず,蛋白輸送阻害剤brefeldin Aで細胞処理するとrVIIIb分泌は抑制されrVIIIaにはこうかがない.幾つかの薬と熱ストレスがrVIIIa放出を誘発し,細胞質のlactase dehydrogenaseの放出と直接関連がある.これよりaサブユニットは細胞傷害の結果放出され古典的分泌経路とは無関係であるといえる

  • Kaetsu H., Hashiguchi T., Foster D., Ichinose A. .  Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells .  Journal of Biochemistry119 ( 5 ) 961 - 969   1996.5

     More details

    Language:Japanese   Publisher:Journal of Biochemistry  

    The a subunit of coagulation factor XIII lacks a Hydrophobic signal sequence for secretion from cells, while the b subunit has a typical signal sequence. To determine whether the α subunit can be synthesized and released, expression vectors containing the cDNA for either subunit were transfected into baby hamster kidney (BHK) cells. Western blotting analysis and gel filtration chromatography demonstrated that the recombinant a and b subunits (rXIIIa and rXIIIb) had the same molecular weights and subunit structures (a2, b2, and a2b2) as the native molecules. rXIIIa was enzymatically active when activated by thrombin. Most rXIIIb was secreted as measured by ELISA, while most rXIIIa was detected in the cytosol by subcellular fractionation. Co-expression with rXIIIb in the same cells did not promote the release of rXIIIa. Treatment of the cells with brefeldin A, a potent inhibitor of protein transportation, blocked the secretion of rXIIIb, although it had no effect on the release of rXIIIa. Several drugs and heat stress induced the release of rXIIIa, which correlated directly with that of cytoplasmic lactate dehydrogenase. These results suggest that the a subunit is released from cells as a consequence of cell injury, which is independent of the classical secretory pathway.

    DOI: 10.1093/oxfordjournals.jbchem.a021336

    Scopus

  • Kaetsu Hiroshi, Hashiguchi Teruto, Foster Don, Ichinose Akitada .  Expression and Release of the a and b Subunits for Human Coagulation Factor XIII in Baby Hamster Kidney (BHK) Cells. .  J Biochem (Tokyo)119 ( 5 ) 961 - 969   1996

     More details

    Language:English   Publisher:The Japanese Biochemical Society  

    The <i>a</i> subunit of coagulation factor XIII lacks a hydrophobic signal sequence for secretion from cells, while the <i>b</i> subunit has a typical signal sequence. To determine whether the <i>a</i> subunit can be synthesized and released, expression vectors containing the cDNA for either subunit were transfected into baby hamster kidney (BHK) cells. Western blotting analysis and gel filtration chromatography demonstrated that the recombinant <i>a</i> and <i>b</i> subunits (rXIII<i>a</i> and rXIII<i>b</i>) had the same molecular weights and subunit structures (<i>a</i><sup>2</sup>, <i>b</i><sup>2</sup>, and <i>a</i><sup>2</sup><i>b</i><sup>2</sup>) as the native molecules. rXIII<i>a</i> was enzymatically active when activated by thrombin. Most rXIII<i>b</i> was secreted as measured by ELISA, while most rXIII<i>a</i> was detected in the cytosol by subcellular fractionation. Co-expression with rXIII<i>b</i> in the same cells did not promote the release of rXIII<i>a</i>. Treatment of the cells with brefeldin A, a potent inhibitor of protein transportation, blocked the secretion of rXIII<i>b</i>, although it had no effect on the release of rXIII<i>a</i>. Several drugs and heat stress induced the release of rXIII<i>a</i>, which correlated directly with that of cytoplasmic lactate dehydrogenase. These results suggest that the <i>a</i> subunit is released from cells as a consequence of cell injury, which is independent of the classical secretory pathway.

  • Ichinose A, Izumi T, Hashiguchi T .  The normal and abnormal genes of the a and b subunits in coagulation factor XIII. .  Seminars in thrombosis and hemostasis22 ( 5 ) 385 - 91   1996

     More details

    Language:English   Publisher:Seminars in Thrombosis and Hemostasis  

    Factor XIII consists of two catalytic and two noncatalytic b subunits. The gene for the a subunit is located on chromosome 6, the gene for the b subunit on chromosome 1. Both genes have been characterized. There are several different allelic forms of the a subunit in the normal population and some microheterogeneity for the b subunit. Most patients with congenital factor XIII deficiency lack the a subunit in plasma; few patients appear to have a complete lack of the b subunit. The genes from patients with factor XIII deficiencies were obtained and examined. Based on these analyses a new genetic classification for factor XIII deficiency is proposed: a deficiency of the a subunit (formerly termed type II), a deficiency of the b subunit (formerly known as type I), and a possible combined deficiency of both a and b subunits.

    DOI: 10.1055/s-2007-999036

    Scopus

    PubMed

  • Hashiguchi T, Ichinose A .  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain. .  The Journal of clinical investigation95 ( 3 ) 1002 - 8   1995.3

     More details

    Language:English   Publisher:Journal of Clinical Investigation  

    We studied the defect responsible for deficiency of the b subunit for factor XIII in the first known case of this condition. The patient is a compound heterozygote of two genetic defects: deletion of A-4161 at the acceptor splice junction of intron A, resulting in a loss of the obligatory AG splicing sequence; and, replacement of G-11499 by T in exon VIII, resulting in an amino acid substitution of Cys430 by Phe. To determine how the latter mutation impaired b subunit synthesis, recombinant b subunit bearing the mutation was expressed in BHK cells. The mutant as well as wild- type b subunit was synthesized by the cells. However, the apparent molecular weight of the mutant was slightly higher than those of the wild-type and plasma b subunits under nonreducing conditions, probably because of destruction of a disulfide bond. The mutant b subunit was secreted from the cells much less effectively than the wild type and remained susceptible to endoglycosidase H, indicating that it was not transported from the endoplasmic reticulum to the Golgi apparatus where the processing of oligosaccharides occurs. Immunofluorescence study suggested that the mutant protein was retained in the endoplasmic reticulum. These studies demonstrate that a Cys430-Phe mutation does not prevent the de novo synthesis of the b subunit, but alters the conformation of the mutant protein sufficiently to impair its intracellular transport, resulting in its deficiency in this patient.

    DOI: 10.1172/JCI117744

    Scopus

    PubMed

  • 橋口 照人, 一瀬 白帝 .  凝固第13因子bサブユニット欠損症:その遺伝子異常の解析 .  血液・腫瘍科29 ( 6 ) 455 - 462   1994.12凝固第13因子bサブユニット欠損症:その遺伝子異常の解析

     More details

    Language:Japanese   Publisher:(有)科学評論社  

  • 橋口 照人, 高橋 兼久, 岡留 格 .  Famotidine投与中に白血球減少をきたした3症例 .  基礎と臨床26 ( 8 ) 3693 - 3697   1992.7Famotidine投与中に白血球減少をきたした3症例

     More details

    Publisher:ライフサイエンス出版(株)  

  • HASHIGUCHI Teruto, MARUYAMA Ikuro, SONODA Ken, NAKASHIMA Hiroaki, NAKAMURA Naoto, SONODA Yoshito, OSAME Mitsuhiro .  Ehlers-Danlos Syndrome combined with von Recklinghausen Neurofibromatosis. .  Internal Medicine31 ( 5 ) 671 - 673   1992

     More details

    Language:English   Publisher:The Japanese Society of Internal Medicine  

    We recently had the opportunity to study a 25-year-old male with both Ehlers-Danlos syndrome (EDS) and von Recklinghausen neurofibromatosis (VRNF). We describe the clinical manifestations of the case and discuss the probable pathomechanism of the combination of the two syndromes, with a review of the literature. As recent literature suggests that both syndromes are linked to chromosome 17, we conclude that their combination is not coincidental, but genetically linked.<br>(Internal Medicine 31 : 671-673, 1992)

    DOI: 10.2169/internalmedicine.31.671

    Scopus

    PubMed

  • 橋口 照人, 有村 敏明, 幸山 正 .  有機燐中毒における急性膵炎併発に関する検討 症例報告を含めて .  ICUとCCU15 ( 3 ) 291 - 296   1991.3有機燐中毒における急性膵炎併発に関する検討 症例報告を含めて

     More details

    Language:Japanese   Publisher:医学図書出版(株)  

  • 橋口 照人, 納 光弘 .  さまざまな自律神経障害 中枢神経系変性疾患と自律神経 .  Clinical Neuroscience7 ( 7 ) 744 - 746   1989.7さまざまな自律神経障害 中枢神経系変性疾患と自律神経

     More details

    Language:Japanese   Publisher:(株)中外医学社  

  • Ikeda K, Abe M, Masamoto I, Ishii C, Arimura E, Ushikai M, Oketani K, Hashiguchi T, Horiuchi M .  Comparison of dipstick and quantitative tests for proteinuria and hematuria in middle-aged, male Japanese employees: A single-center study. .  Health science reports4 ( 2 ) e267   2021.6Comparison of dipstick and quantitative tests for proteinuria and hematuria in middle-aged, male Japanese employees: A single-center study.

     More details

  • Furukawa Yoshitaka, Hamada Heiichiro, Kamikawaji Kazuto, Unoki Taiji, Inoue Hiromasa, Tashiro Yukie, Okamoto Mika, Baba Masanori, Hashiguchi Teruto .  Mycobacterium avium菌血症、HIV RNA高値、HBV感染症、カポジ肉腫、サイトメガロウイルス網膜炎が遷延化していたAIDS患者での治療成功(Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis) .  Journal of Infection and Chemotherapy26 ( 2 ) 279 - 281   2020.2Mycobacterium avium菌血症、HIV RNA高値、HBV感染症、カポジ肉腫、サイトメガロウイルス網膜炎が遷延化していたAIDS患者での治療成功(Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis)

     More details

    Publisher:エルゼビア・ジャパン(株)  

    症例は40歳代前半の男性で、HIVに感染しており、高熱、貧血、ALP高値、肺の嚢胞性病変、上胃部痛が持続していたため当院へ紹介され入院となった。当院の検査でMycobacterium avium菌血症、血漿中のHIV-1 RNAコピー数の高値、CD4陽性T細胞数の低値、血清中のB型肝炎ウイルス(HBV)のDNAおよびHBsAg陽性が示された。紹介元の医療施設で行われていた胃の腫瘍に対する生検の所見からはカポジ肉腫が示唆されていた。M.avium菌血症に対し抗抗酸菌治療を開始し、後には抗レトロウイルス療法(ART)を開始するも高熱は収まらなかった。ALP高値から胆管炎を疑いスルバクタム/セフォペラゾン配合剤を投与するも効果はみられなかった。その後も重症の炎症エピソードを繰り返し発症したが、投薬内容を特別に変えなくともそうした炎症エピソードは毎回自然消退していた。M.avium菌血症は当院初診から79日目まで間欠的に検出されており、治療を持続する必要性が示唆された。ART開始から5ヵ月後の時点ではHIV-1のRNAコピー数は依然として高値であったが11ヵ月後には著明に減少し、CD4陽性T細胞数にも回復が認められた。

  • 谷口 尚大郎, 橋口 照人, 下池 弘美, 谷口 亜貴, 黒木 美代, 岩崎 恵子, 天野 一志, 中村 周治, 米澤 真理子, 江夏 基夫, 鎗水 民生, 湯田 敏行, 楠元 志都生 .  リアルワールドに潜在する40歳未満の食後高血糖者の検討 .  宮崎県医師会医学会誌42 ( 1 ) 82 - 86   2018.3リアルワールドに潜在する40歳未満の食後高血糖者の検討

     More details

    Publisher:(公社)宮崎県医師会  

    血糖測定会に参加した40歳未満の397名を対象として、若年者に潜在する食後高血糖者の割合、背景および関連因子について検討を行った。140mg/dl以上の食後高血糖者は397名中21名(5.3%)で、そのうち19名は過去に尿糖あるいは血糖値異常を指摘されたことがなかった。食後血糖正常群と比較して、食後高血糖群では、男性の割合、食後2時間未満での血糖測定割合が有意に高く、糖尿病の家族歴を持つ割合も高い傾向にあった。多変量解析では、食後2時間未満での血糖測定のみが食後高血糖と独立した関連を有していた。食後高血糖者のほとんどは過去に耐糖能異常を指摘されたことがなかったことから、若年男性の食後2時間未満の血糖測定は、食後高血糖のスクリーニングに寄与する可能性がある。(著者抄録)

  • 前之園 隆一, 水上 尚子, 桶谷 直也, 入來 泰久, 湯之上 真吾, 小林 沙織, 中村 幸美, 大園 七瀬, 高崎 州亜, 湯浅 敏典, 木佐貫 彰, 大石 充, 橋口 照人 .  Complex fractionated atrial electrogramアブレーション前後の全心房伝導時間PA-TDI durationと心房細動再発との関連 .  超音波検査技術42 ( 4 ) 399 - 409   2017.8Complex fractionated atrial electrogramアブレーション前後の全心房伝導時間PA-TDI durationと心房細動再発との関連

     More details

    Publisher:(一社)日本超音波検査学会  

    目的:発作性心房細動のアブレーション治療では、肺静脈隔離術(PVI)が一般的であり、PVI後の再発予測因子として、組織ドプラ法を用いた全心房伝導時間(PA-TDI duration)が左房容積係数(LAVI)より有用であることが報告されている。我々の施設では、発作性心房細動の治療としてComplex fractionated atrial electrogramを指標としたアブレーション(CFAE ablation)を主に施行しているが、本法についての再発予測因子について検討された研究はない。今回我々は、CFAE ablation後の再発予測因子について検討を行った。対象と方法:対象は発作性心房細動で初回アブレーションを施行した160名中、PA-TDI durationの計測が可能であった107名を非再発群と再発群に分けて比較検討した。比例ハザード分析による多変量解析の検討を行い、予測因子となる可能性が示唆された因子については、Receiver Operating Characteristic curve(ROC曲線)による解析を行った。また、PA-TDI duration及びLAVIについては、CFAE ablation単独群とCFAE ablation+PVI群に分別して経過観察を行い心房細動再発との関連について検討した。結果:アブレーション前の心房細動再発予測因子に関して、再発群は非再発群と比較して左房径(LAD)(41.1±5.4mm vs.38.1±5.1mm、p<0.01)が有意に拡大を認めた。比例ハザード分析による多変量解析を行い、左房容量(LAV)、LADが心房細動再発の予測因子となる可能性が示唆されたが、ROC曲線による解析では、ROC曲線下の面積(AUC)が、LAVは0.609、LADは0.651と予測能としては低いという結果であった。また、CFAE ablation単独およびCFAE ablation+PVI両群ともアブレーション前のPA-TDI duration、LAVIは非再発群と再発群に有意差は認めなかったが、6ヵ月後のPA-TDI durationでは、両群とも再発群では、アブレーション前よりも有意に延長を認めた(CFAE ablation単独:142.9±18.5msec vs.155.4±17.6msec、p<0.01。CFAE ablation+PVI:135.6±20.3msec vs.155.1±21.8msec、p<0.01)。非再発群では、CFAE ablation単独例において、アブレーション前より有意に短縮を認めた(141.8±23.3msec vs.131.1±23.9msec、p=0.011)。LAVIでは、CFAE ablation単独及びCFAE ablation+PVI両群とも有意差を認めなかった。結語:アブレーション前の心房細動再発予測因子は、発作性心房細動に対するCFAE ablation後の再発予測因子とはなりえなかった。しかしながら、アブレーション前と比較して6ヵ月後のPA-TDI durationが延長すると、心房細動を再発しやすいことが示唆された。(著者抄録)

  • Takeoka K, Hidaka Y, Hishinuma A, Ikeda K, Okubo S, Tsuchiya T, Hashiguchi T, Furuta K, Hotta T, Matsushita K, Matsumoto H, Murakami M, Maekawa M .  [Harmonization of TSH Measurements.] .  Rinsho byori. The Japanese journal of clinical pathology64 ( 4 ) 375 - 379   2016.5[Harmonization of TSH Measurements.]

     More details

  • Hatanaka M, Higashi Y, Fukushige T, Baba N, Kawai K, Hashiguchi T, Su J, Zeng W, Chen X, Kanekura T .  Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts. .  Anticancer research34 ( 12 ) 7091 - 6   2014.12Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.

     More details

  • Kanai S, Matsumoto G, Sano K, Ueda K, Fujisawa S, Obayashi K, Hashiguchi T, Yanagihara K, Moriyoshi M, Kitagawa K, Wada H, Morinobu A, Wada T, Honda T .  [Recognition of the importance of reversed CPC in CPC]. .  Rinsho byori. The Japanese journal of clinical pathology60 ( 5 ) 449 - 57   2012.5[Recognition of the importance of reversed CPC in CPC].

     More details

  • Matsushita S, Tada KI, Kawahara KI, Kawai K, Hashiguchi T, Maruyama I, Kanekura T .  Advanced malignant melanoma responds to Prunus mume Sieb. Et Zucc (Ume) extract: Case report and in vitro study. .  Experimental and therapeutic medicine1 ( 4 ) 569 - 574   2010.7Advanced malignant melanoma responds to Prunus mume Sieb. Et Zucc (Ume) extract: Case report and in vitro study.

     More details

  • Meng X, Kawahara K, Nawa Y, Miura N, Shrestha B, Tancharoen S, Sameshima H, Hashiguchi T, Maruyama I .  1,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-kappaB p65 phosphorylation. .  Biochemical and biophysical research communications380 ( 2 ) 343 - 8   2009.31,5-Anhydro-D-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-kappaB p65 phosphorylation.

  • Arimura K, Hashiguchi T, Watanabe O .  [Crow-Fukase syndrome and VEGF]. .  Brain and nerve = Shinkei kenkyu no shinpo60 ( 6 ) 611 - 9   2008.6[Crow-Fukase syndrome and VEGF].

     More details

  • Tokashiki Takashi, Hashiguchi Teruto, Arimura Kimiyoshi, Eiraku Nobutaka, Maruyama Ikuro, Osame Mitsuhiro .  Crow-Fukase (POEMS)症候群におけるDICの治療で血小板数及びVEGFの経時的測定が予後予測に有用であった1例(Predictive Value of Serial Platelet Count and VEGF Determination for the Management of DIC in the Crow-Fukase (POEMS) Syndrome) .  Internal Medicine42 ( 12 ) 1240 - 1243   2003.12Crow-Fukase (POEMS)症候群におけるDICの治療で血小板数及びVEGFの経時的測定が予後予測に有用であった1例(Predictive Value of Serial Platelet Count and VEGF Determination for the Management of DIC in the Crow-Fukase (POEMS) Syndrome)

     More details

    Publisher:(一社)日本内科学会  

    62歳男子.Crow-Fukase症候群があり,血管内凝固症候群(DIC)発症前から血小板数と血清中VEGF(血管内皮増殖因子)濃度を経時的に測定した.VEGF濃度はDIC発症に先行して徐々に減少し,発症後は血小板減少とともに急激に低下した

  • Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T, Maruyama I .  Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. .  Thrombosis and haemostasis89 ( 5 ) 875 - 84   2003.5Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications.

     More details

  • Nimi Hideki, Arimura Kimiyoshi, Jonosono Manabu, Hashiguchi Teruto, Kawabata Masaharu, Osame Mitsuhiro, Kitajima Isao .  Crow-Fukase(POEMS)症候群の1例における肺高血圧の原因はVEGFである(VEGF Is Causative for Pulmonary Hypertension in a Patient with Crow-Fukase(POEMS) Syndrome) .  Internal Medicine39 ( 12 ) 1101 - 1104   2000.12Crow-Fukase(POEMS)症候群の1例における肺高血圧の原因はVEGFである(VEGF Is Causative for Pulmonary Hypertension in a Patient with Crow-Fukase(POEMS) Syndrome)

     More details

    Publisher:(一社)日本内科学会  

    肺動脈収縮期血圧が62mmHgの肺高血圧を伴った49歳のCrow-Fukase症候群の1例で,血清VEGFが著しく高値であった.プレドニゾロン療法により肺動脈収縮期血圧は31mmHgに低下,血清VEGFも632pg/mlから320pg/mlに低下した

▼display all

Books

  • 薬学生のための病態検査学

    三浦 雅一, 竹橋 正則, 丹羽 和紀, 高寺 恒雄, 松永 俊之, 小迫 知弘 , 添田 秦司 , 木村 聡 , 佐藤 圭創, 橋口 照人, 古川 勝敏

    南江堂  2014  ( ISBN:9784524403110

     More details

    Language:Japanese

    CiNii Books

MISC

  • Adult T-cell leukemia/lymphoma presenting with ulceration of the digits

    Fujii K., Kirishima M., Yoshimitsu M., Hashiguchi T., Tanimoto A., Kanekura T.

    Journal of Dermatology   50 ( 5 )   e168 - e170   2023.5

     More details

    Language:Japanese   Publisher:Journal of Dermatology  

    DOI: 10.1111/1346-8138.16698

    Scopus

  • 炎症・免疫機序による血栓止血のトピックス 自己免疫性後天性凝固因子欠乏症

    橋口 照人

    炎症と免疫   30 ( 1 )   100 - 105   2021.12

     More details

    Language:Japanese   Publisher:(株)先端医学社  

    凝固因子欠乏症は先天性と後天性にわけられ先天性にくらべて後天性の頻度が高いことは留意すべきである(図1)。後天性にはインヒビターの出現により止血反応が阻害されるAiCFDとインヒビターの出現のないnAiCFDがある。AiCFDとnAiCFDの比較において圧倒的にnAiCFDが多いこともまた留意すべきである。出血傾向の症例をみた際、CMTはインヒビターを含む凝固反応阻害因子の有無のスクリーニングに有用であり、その鑑別の第一選択となる。しかしながら、凝固第XIII因子欠乏症、一部のフィブリノゲン欠乏症、VWF、さらに線溶系の異常であるα2-PI、PAI-1、TAFI欠乏症においてはPT、APTTの異常に反映されない。CMTの曲線は明らかに下に凸の場合は凝固反応阻害因子の存在しない欠乏パターン(先天性あるいは消費による凝固因子欠乏症など)とみなされるが、欠乏パターンであっても凝固因子活性を阻害することなく凝固因子に結合してそのクリアランスを亢進させる抗体の場合は下に凸の曲線を描くことになる。重要なことは原因不明の出血傾向の症例を診察する際にAiCFDの可能性をつねに念頭におくことである。一方、AiCFDの診断の際は活性/抗原量比、インヒビターの証明に努めるとともに、慎重にnAiCFDの可能性を除外すべきである。肝機能低下、大動脈瘤による慢性的な凝固線溶系の亢進による凝固因子の消費、ALアミロイドーシスによる凝固第X因子の低下、体外循環によるVWFの消費(後天性VWD)はその例である。インヒビターの簡易検出法の開発はこれからの重要課題である。(著者抄録)

  • 若手が考える臨床検査医像とは?(第1部)

    五十嵐 岳, 橋口 照人, 高原 彩佳, 松本 剛

    日本臨床検査医学会誌   69 ( 12 )   928 - 931   2021.12

     More details

    Language:Japanese   Publisher:(一社)日本臨床検査医学会  

  • 血栓止血検査標準化における2020年の提言:アンチトロンビン(AT)活性測定試薬の標準化と健常成人におけるAT活性基準値設定の試み

    家子 正裕, 森下 英理子, 朝倉 英策, 内藤 澄悦, 小嶋 哲人, 鈴木 敦夫, 橋口 照人, 石黒 精, 辻 明宏, 安本 篤史, 篠澤 圭子, 村上 正巳, 荻原 義人, 池尻 誠, 叶内 和範, 津田 博子, 堀田 多恵子, 大村 一将, 井上 まどか, 遠見 真理, 田中 秀明, 鈴木 健史, 太田 徳仁, 川村 雅英, 菊地 茂

    日本検査血液学会雑誌   22 ( 1 )   129 - 135   2021.2

     More details

    Language:Japanese   Publisher:(一社)日本検査血液学会  

    アンチトロンビン(AT)を含む凝固制御因子の先天的欠乏症による血栓症は指定難病(327)に指定されており、その診断には健常成人の基準値下限未満であることが条件となる。現在、我が国では7種類のAT活性測定試薬が流通している。これらの試薬の測定原理にはトロンビン阻害法と凝固第Xa因子阻害法があるが、標準化されておらず基準値も異なる。そこで、日本検査血液学会標準化委員会は日本血栓止血学会標準化委員会と合同でAT標準化ワーキンググループ(AT-WG)を組織し、AT試薬の標準化とAT活性の普遍的基準値の決定を行った。参加11施設でAT活性測定試薬7試薬を用いてサーベイランスをおこなった。その結果、NIBSCとの相関より試薬毎の換算式が得られ、AT試薬のハーモナイゼーションが可能となった。健常成人214名および遺伝子診断されたAT欠乏症78名のサンプルを用いてAT活性を測定し、試薬毎の換算式より得られた値を基にAT基準値を設定した。健常成人のAT活性の平均値±2SD(学問的基準値)の下限値は85.2%であったが、AT欠乏症患者の換算AT値を考慮し、基準値を平均±3SDとした臨床検査上基準値では下限は75.1%となった。我々はこの臨床検査上基準値を診断的下限値として用いることを提唱した。(著者抄録)

  • 臨床検査医学、研究と臨床のニューホライズン 生体内ペプチド断片の多様性とゆらぎ 検査医学の新たな視点として

    橋口 照人

    臨床病理   67 ( 9 )   959 - 962   2019.9

     More details

    Language:Japanese   Publisher:(一社)日本臨床検査医学会  

  • miRNAによる自然免疫制御機構

    山口 宗一, 郡山 豊泰, 清水 利昭, 竹之内 和則, 大山 陽子, 政元 いずみ, 橋口 照人

    臨床病理   67 ( 8 )   803 - 814   2019.8

     More details

    Language:Japanese   Publisher:(一社)日本臨床検査医学会  

    マイクロRNA(miRNA)は細胞機能調節分子としての役割がクローズアップされ、さまざまな生理的、病的状態において重要な働きを持つことが証明されている。18〜22塩基の低分子非翻訳一本鎖RNA(small non-coding RNA)は、その役割や組織分布などからカテゴリー化されるようになり、がん関連miRNAはOnco-miRと呼ばれ、多くの腫瘍細胞の増殖能、転移能を増強していることが明らかになった。本稿では、細菌感染症、自然免疫を制御するmiRNAについて、以下の項目で最新の話題を紹介した。1)細菌感染による活性化マクロファージとmiRNA,2)細胞内寄生細菌感染による活性化マクロファージとmiRNA,3)レジオネラ菌感染とmiRNA,4)miR-218のレジオネラ菌感染における意味付け、5)Rictorとマクロファージ、6)細胞外分泌小胞のmiRNA。

  • 臨床検査と標準化 各検査領域における標準化の現状と課題 凝固系検査の標準化

    橋口 照人

    臨床病理   65 ( 12 )   1278 - 1284   2017.12

     More details

    Language:Japanese   Publisher:(一社)日本臨床検査医学会  

  • 抗凝固療法の新たな一歩

    橋口 照人

    臨床化学   46 ( 3 )   246 - 246   2017.7

     More details

    Language:Japanese   Publisher:(一社)日本臨床化学会  

  • 鹿児島感染制御サーベイランスシステムの活用

    折田 美千代, 川村 英樹, 古城 剛, 郡山 豊泰, 茂見 茜里, 稲森 彩, 児玉 祐一, 大山 陽子, 橋口 照人, 西 順一郎

    日本医療情報学会看護学術大会論文集   18回   71 - 72   2017.6

     More details

    Language:Japanese   Publisher:日本医療情報学会看護部会  

  • 自己免疫性出血病FXIII/13診療ガイド

    一瀬 白帝, 和田 英夫, 惣宇利 正善, 橋口 照人, 矢冨 裕, 小川 孔幸, 北島 勲, 朝倉 英策, 岡本 好司, 家子 正裕, 山本 晃士, 江口 豊, 保田 晋助, 松本 功, 自己免疫性出血病FXIII/13日本血栓止血学会診療ガイド作成委員会, 日本血栓止血学会学術標準化委員会

    日本血栓止血学会誌   28 ( 3 )   393 - 420   2017.6

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

  • 【DOACの臨床とモニタリング】抗凝固療法の更なる進化を願う

    橋口 照人

    Thrombosis Medicine   6 ( 4 )   286 - 290   2016.12

     More details

    Language:Japanese   Publisher:(株)先端医学社  

    DOACの副作用としての出血性イベントが少なからず存在する以上、ましてその中には生命を脅かす出血性イベントが含まれるのであるから患者に対する倫理の観点からもDOACを処方する際は、その効能のみならず、出血性イベントを発症した際の対応についてしっかり説明されるべきであろう。予後の改善を目的とした理想的な抗凝固療法の発展のためには、モニタリング法の確立と過度の抗凝固状態あるいは出血性イベント時における中和薬の存在が次世代の課題となるであろう。(著者抄録)

  • 【凝固検査の標準化】外因系凝固反応とプロトロンビン時間の多様性

    橋口 照人

    日本血栓止血学会誌   27 ( 6 )   631 - 635   2016.12

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

    プロトロンビン時間(PT)の原型は1935年のQuickらの発表に遡る.PT反応に関わる凝固第VII因子(FVII),凝固第X因子(FX),プロトロンビンはCa2+を介してリン脂質膜上のphosphatidylserineに各々の分子のGla残基を介して結合して酵素複合体を形成するが,PTの標準化を困難にする要因の一つとして細胞膜リン脂質成分の組成比の多様性が挙げられる.細胞膜リン脂質成分を反応の場とした組織因子(TF)/FVIIa複合体によるFXの活性化反応,あるいはプロトロンビナーゼ複合体によるトロンビンの生成反応には完全型から不完全型の多様性が存在して,PTはそれらの総和としての結果である.また,Ca2+濃度は至適濃度より高くても低くても酵素複合体の構成を妨げる結果となり凝固時間は延長する.トロンビンは構造上,酵素複合体から遊離できる分子であり反応液中のアンチトロンビンによる不活化の効率もPT反応に影響する.(著者抄録)

  • 【腎臓病と貧血】エリスロポエチンと鉄代謝、骨髄異形成症候群への臨床応用

    橋口 照人

    臨床化学   45 ( 2 )   117 - 119   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本臨床化学会  

  • 自己免疫性出血病FXIII/13診断ガイド

    一瀬 白帝, 和田 英夫, 惣宇利 正善, 橋口 照人, 矢冨 裕, 小川 孔幸, 北島 勲, 朝倉 英策, 岡本 好司, 家子 正裕, 山本 晃士, 江口 豊, 自己免疫性出血病FXIII/13日本血栓止血学会診断基準作成委員会

    日本血栓止血学会誌   26 ( 6 )   658 - 668   2015.12

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

  • 血管医学検査 基礎から臨床へ 総論 血管(機能)を診ることの意義

    橋口 照人

    血管医学   16 ( 2 )   177 - 180   2015.7

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    血管(機能)を診ることの意義は、最も直接的に血栓症の発症を予測し、予防することにあると一般的には考えられている。しかしながら、血管の機能破綻は動脈硬化へのプロセスの機序以外にも、"過労死"に代表されるように日常的に存在することを理解すべきである。血管機能の破綻は血栓症の発症に代表されるが、発症の過程には側副血行路をはじめとした進化の賜物とも言える代償機構が働く。しかしながら、過労死に代表されるようなストレスによる血管機能低下に対する代償機構は脆弱であると考えられる。(著者抄録)

  • 血管医学検査 基礎から臨床へ RH-PAT(Reactive hyperemia peripheral arterial tonometory)

    橋口 照人, 前之園 隆一

    血管医学   16 ( 2 )   181 - 185   2015.7

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    Flow mediated dilatation(FMD)のコンセプトを基礎としてreactive hyperemia peripheral arterial tonometory(RH-PAT)が開発された。操作が簡便かつ高感度であり、非駆血側を内部コントロールとして標準化できることから、血管機能に対するいくつかの概念を確認することができた。それは、(1)血管内皮機能は健常人において多様性のあること、(2)血管内皮機能は日内変動を有すること、(3)日常における疲労感は血管内皮機能に影響すること、(4)血管内皮は疲労を感知するセンサーであること、であるRH-PATの開発により血管内皮機能の低下の機序は動脈硬化に至るプロセス以外にも存在することを可視化できたと言える。(著者抄録)

  • 臨床化学の方向性と学会誌が果たすべき役割

    和田 隆志, 橋口 照人, 前川 真人, 吉田 博, 荒川 秀俊, 斉藤 邦明, 仁井見 英樹, 原 章規, 酒瀬川 信一, 目黒 周, 城野 博史, 後藤 正男, 中嶋 克行

    臨床化学   44 ( 3 )   222 - 236   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本臨床化学会  

  • 【血小板の誕生から死までの"ライフストーリー"】核の無い血小板の"死"Anucleated Platelet Death

    橋口 照人, Panta Sushil

    Thrombosis Medicine   5 ( 2 )   149 - 152   2015.6

     More details

    Language:Japanese   Publisher:(株)先端医学社  

    核のない細胞におけるアポトーシスの概念が血小板において報告され、そのプロセスはmolecular clockとして報告され血小板の寿命を規定する(default signaling system)。また、赤血球におけるアポトーシスはeryptosisとして報告されている。さらに、血小板は活性化とともに壊死のプロセスをとることが報告され、necrotic plateletsのsubpopulationは高いprocoagulant活性を示す。これらの観察は血栓の質の研究に新たな展開を期待させる。(著者抄録)

  • 凝固と血管新生因子VEGF-A

    橋口 照人, 竹之内 和則, 清水 利昭, 山口 宗一

    バイオメディカル   24   31 - 34   2014.12

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    血管内皮細胞増殖因子(VEGF-A)は血管新生作用・血管透過性作用を有するangiogenesis、vasculogenesisの鍵分子である。血中のVEGF-Aはそのほとんどが血小板に含まれており止血反応に続く創傷治癒の過程に重要な役割を果たすと考えられる。血小板は骨髄巨核球から産生されることから血小板のVEGF-Aの含量は骨髄機能を反映している可能性を考えている。これまでに血小板VEGF-Aが川崎病の病態と関連していること(Ueno K、et al.Br J Haematol、2010)、また再生不良性貧血において骨髄予備能を反映していること(Kodama、Y、et al.Int J hematol、2012)を報告してきた。血小板の含む増殖因子量の評価は骨髄機能を反映した病態を示す可能性があり、血小板機能における一次止血機能の評価とは別の側面であると考える。(著者抄録)

  • 異常値をひもとく(第21回) 高アミラーゼ血症を伴う多発性骨髄腫

    古城 剛, 田淵 智久, 松下 昌風, 橋口 照人

    臨床検査   58 ( 13 )   1663 - 1668   2014.12

     More details

    Language:Japanese   Publisher:(株)医学書院  

  • 【血小板研究の最近の進歩】血小板と炎症

    橋口 照人

    医学のあゆみ   251 ( 2 )   165 - 168   2014.10

     More details

    Language:Japanese   Publisher:医歯薬出版(株)  

    血小板は止血機構における一次凝集反応に加えて免疫系にも深くかかわっている。その関与は循環血中のPAMPs・DAMPsを最前線で感知して自然免疫を活性化するものであり、血小板膜上にはToll様受容体が機能的に発現している。そして血小板と白血球との相互作用における炎症反応の増幅の観察は血小板の研究における大きな進歩であった。一方、核を有さない血小板にもアポトーシス、ネクローシスといったプログラム死のプロセスが存在して組織修復と炎症のバランスを巧みに調節している。これらの観察は血栓症の成因を解明するうえで重要であり、血栓症の治療開発における新しい分子標的を探す手がかりになると考える。(著者抄録)

  • 【microRNAの検査医学への展望】広がる血管microRNAの役割

    山口 宗一, 橋口 照人

    臨床化学   43 ( 2 )   112 - 120   2014.4

     More details

    Language:Japanese   Publisher:(一社)日本臨床化学会  

  • Iron Regulatory Protein 1/HIF2α軸 鉄代謝調節メカニズムの新展開

    橋口 照人, Shrestha Binita, 伊藤 隆史, 山口 宗一

    臨床化学   43 ( 1 )   69 - 69   2014.1

     More details

    Publisher:(一社)日本臨床化学会  

  • 【臨床検査の新時代】神経疾患のバイオマーカーの新展開

    荒田 仁, 大窪 隆一, 渡邊 修, 高嶋 博, 橋口 照人

    日本内科学会雑誌   102 ( 12 )   3174 - 3182   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本内科学会  

  • 研究手法入門 生化学的・免疫学的実験法 ELISA、マルチプレックス

    大山 陽子, 橋口 照人

    呼吸   32 ( 10 )   929 - 934   2013.10

     More details

    Language:Japanese   Publisher:(一社)呼吸研究  

    我々生体内では、DNAやRNA、タンパクなど多くの分子が互いに結合や解離といった特異的な反応を絶えず行うことによって、生命が営まれている。これら生体分子同士の特異的な反応を利用し、特定の分子を検出・同定する実験方法が多く考えられてきた。DNA同士の結合を利用することでDNAを検出するサザンハイブリダイゼーションやDNA-RNAの結合を利用することでRNAを検出するノーザンハイブリダイゼーション、なかでもタンパクの検出においては、優れた特異性と多様性双方をあわせもつ点から免疫反応(抗原抗体反応)を用いた手法が多く開発されている。そのなかの代表的な方法の1つがELISAおよびマルチプレックスである。本稿では、これらの実験法について概説する。(著者抄録)

  • 【血液症候群(第2版)-その他の血液疾患を含めて-】血栓形成性疾患 後天性血栓形成性疾患 高フィブリノゲン血症

    大山 陽子, 橋口 照人

    日本臨床   別冊 ( 血液症候群第2版III )   59 - 63   2013.5

     More details

    Language:Japanese   Publisher:(株)日本臨床社  

  • 【血栓症に対する臨床検査】血栓症を血液検査で診断する 血栓症発症へのプロセスと血管系

    橋口 照人, 大山 陽子

    血栓と循環   21 ( 1 )   27 - 32   2013.4

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    <論文のポイント>[1]凝固・線溶系は健常人においても低次元のレベルで作動している。[2]血管は必ず老化する。[3]ずり応力により血管内皮細胞よりNO(一酸化窒素)が産生され血管は拡張する。[4]血管内皮細胞は疲労感を感知するセンサーと考えることができる。(著者抄録)

  • 【検査値の異常に気づく、対応する】抗リン脂質抗体症候群

    橋口 照人, 竹之内 和則

    月刊レジデント   5 ( 12 )   43 - 47   2012.12

     More details

    Language:Japanese   Publisher:(株)医学出版  

  • 【新規経口抗凝固薬の光と影】新旧経口抗凝固薬の薬理学的特徴に基づいた使用上の注意 APTTと内因系凝固機能

    橋口 照人, 一瀬 白帝

    Medicina   49 ( 6 )   1008 - 1011   2012.6

     More details

    Language:Japanese   Publisher:(株)医学書院  

    <ポイント>★トロンボプラスチンの概念は1800年代に遡る.★内因系凝固反応を構成する因子は欠損症・異常症の解析により発見されてきた.★APTTはダビガトラン,エドキサバンの治療域における薬効モニタリングにはならない.★APTTは出血傾向の診断法の1つであり,血栓傾向を予知するものではない.(著者抄録)

  • 新しい抗凝固薬・抗血小板薬

    橋口 照人, 清水 利昭, 竹之内 和則

    医薬ジャーナル   48 ( 3 )   867 - 873   2012.3

     More details

    Language:Japanese   Publisher:(株)医薬ジャーナル社  

    高齢化社会が加速するに伴い、QOL(quality of life)を著しく損なう血栓・塞栓症への予防対策は、年を追うごとに重要になってきている。特に心房細動患者の塞栓症発症のリスクは高く、日常の臨床において患者にとって容易かつ安全域の広い経口薬の開発が進められている。数々の国際的大規模臨床試験が着々と進行し、これらの薬剤がワルファリンに替わり血栓・塞栓症予防の主流になってくると思われる。(著者抄録)

  • 虚血条件下での神経様細胞におけるエダラボンのHMGB1に対する効果

    菊池 清志, 川原 幸一, 松田 史代, 伊藤 隆史, 森元 陽子, Tancharoen Salunya, 三浦 直樹, 竹重 暢之, 折戸 公彦, 山下 伸, 内門 久明, 宮城 尚久, 塩見 直人, 倉本 晃一, 徳富 孝志, 重森 稔, 坂本 六大, 菊池 千恵美, 飯田 成美, 吉田 義弘, 橋口 照人, 丸山 征郎, 森岡 基浩, 田中 永一郎

    神経外傷   34 ( 2 )   225 - 227   2011.12

     More details

    Language:Japanese   Publisher:(一社)日本脳神経外傷学会  

  • 【DIC-診断・治療の最前線】DICの病態生理 最近のトピックス NETosisとDIC

    橋口 照人

    医学のあゆみ   238 ( 1 )   10 - 12   2011.7

     More details

    Language:Japanese   Publisher:医歯薬出版(株)  

    この数年、臨床における血液凝固系の学問領域に炎症とのかかわりにおいて、いくつかの新しい概念が導入されてきた。炎症の環境のなかで、核をもたない血小板が凝固系のイニシエーターである組織因子を翻訳発現できるとする報告や、血小板が単球と複合体を形成することにより単球の炎症活性を増幅する機構が報告されている。そして活性化された好中球によるNETs(neutrophil extracellular traps)の放出は、病原体に対する新しい生体反応と、好中球の壊死でもアポトーシスでもない新しい細胞死の概念(NETosis)をもたらした。(著者抄録)

  • 【血栓症と血管医学の再検証】血管機能とアイドリング

    橋口 照人

    日本血栓止血学会誌   22 ( 1 )   11 - 17   2011.2

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

  • ミノサイクリンは、虚血条件下のPC12細胞において、無酸素無糖培養が誘導するHMGB1放出とHMGB1が誘導するアポトーシスを減弱する

    菊池 清志, 川原 幸一, 内門 久明, 宮城 尚久, 倉本 晃一, 宮城 知也, 森元 陽子, 伊藤 隆史, Tancharoen Salunya, 三浦 直樹, 宮田 圭, 菊池 千恵美, 坂本 六大, 塩見 直人, 橋口 照人, 丸山 征郎, 徳富 孝志, 重森 稔

    神経外傷   33 ( 2 )   241 - 243   2010.12

     More details

    Language:Japanese   Publisher:(一社)日本脳神経外傷学会  

  • トロンボモジュリンによる致死性因子HMGB1の制御機構

    伊藤 隆史, 川原 幸一, 橋口 照人, 丸山 征郎

    日本血栓止血学会誌   20 ( 4 )   418 - 421   2009.8

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

    急性炎症とは,生体にとっての非常事態体制である.感染を察知した免疫細胞や,損傷に伴って壊死した細胞は,High mobility group box 1 protein(HMGB1)を放出することによって周囲に非常事態宣言をする.これを受けた周囲の細胞は,炎症,免疫,組織修復のプログラムを立ち上げ,非常事態に対応しようとする.このように,HMGB1は生体防御的役割を担っているが,その一方で,大量に産生されて全身を循環するHMGB1は,全身性炎症反応症候群(SIRS)や播種性血管内凝固症候群(DIC)を引き起こし,致死的に働く.このHMGB1の全身化を防ぐ役割を担っていると考えられるのが,抗凝固タンパク質として知られるトロンボモジュリン(TM)である.TMはトロンビンと結合するとともにHMGB1とも結合し,トロンビン-TM複合体がHMGB1を分解して不活化する.TMは凝固反応や炎症反応を多面的に制御していると考えられる.(著者抄録)

  • 【血小板機能とatherothrombosis】血小板と白血球の相互作用による機能変化

    橋口 照人, 丸山 征郎

    血管医学   10 ( 2 )   157 - 160   2009.5

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    血小板は、止血のみならず炎症との関わりにおいて注目されている。炎症の環境の中で、核を持たない血小板が凝固系のイニシエーターである組織因子(TF)を翻訳発現できるとする報告や、遊走能を持たない血小板が好中球や単球と複合体を形成することにより遊走を可能とし、更には好中球や単球の炎症活性を増幅する機構が報告されている。そして血小板により活性化された好中球によるNETs(neutrophil extracellular traps)の放出と自壊は、好中球の壊死でもアポトーシスでもない新しい細胞死の概念である。(著者抄録)

  • 血小板系 血小板と単球・好中球のクロストーク

    橋口 照人, 丸山 征郎

    Annual Review血液   2009   189 - 192   2009.1

     More details

    Language:Japanese   Publisher:(株)中外医学社  

    近年,血小板は止血のみならず,炎症との関わりにおいて注目されている.炎症の環境の中で,核をもたない血小板が凝固系のイニシエーターである組織因子を翻訳発現できるとする報告や,遊走能をもたない血小板が好中球や単球と複合体を形成することにより遊走を可能とし,さらには好中球や単球の炎症活性を増幅する機構が報告されている.そして血小板により活性化された好中球によるNETs(neutrophil extracellular traps)の放出と自壊は好中球の壊死でもアポトーシスでもない新しい細胞死の概念である.(著者抄録)

  • 【凝固線溶反応と炎症反応のクロストーク】活性化血小板による好中球、単球の制御

    橋口 照人

    医薬の門   48 ( 5 )   454 - 456   2008.10

     More details

    Language:Japanese   Publisher:鳥居薬品(株)  

    近年、血小板は止血のみならず、炎症との関わりにおいて注目されている。炎症の環境の中で、核をもたない血小板が凝固系のイニシエーターである組織因子を翻訳発現できるとする報告や、遊走能をもたない血小板が好中球や単球と複合体を形成することにより遊走を可能とし、さらには好中球や単球の炎症活性を増幅する機構が報告されている。そして血小板により活性化された好中球によるNETs(neutrophil extracellular traps)の放出は好中球の壊死でもアポトーシスでもない新しい細胞死の概念である。(著者抄録)

  • 【Crow-深瀬症候群(POEMS症候群)】Crow-深瀬症候群とVEGF

    有村 公良, 橋口 照人, 渡邊 修

    BRAIN and NERVE: 神経研究の進歩   60 ( 6 )   611 - 619   2008.6

     More details

    Language:Japanese   Publisher:(株)医学書院  

  • 壊死細胞の救済と修復のための新たに同定されたメッセージ "エンドカイン、HMGB1"の生物学及び臨床的関連(NEWLY IDENTIFIED MESSAGE FOR RESCUE AND REPAIR FROM NECROTIC CELL: BIOLOGY AND CLINICAL RELEVANCE OF "ENDOKINE, HMGB1")

    Maruyama Ikuro, Ito Takashi, Hashiguchi Teruto

    弘前医学   59 ( Suppl. )   S1 - S11   2007.11

     More details

    Language:English   Publisher:弘前大学大学院医学研究科・弘前医学会  

  • High mobility group box 1 and refeeding-resistance in anorexia nervosa [1]

    Yasuhara D., Hashiguchi T., Kawahara K., Nakahara T., Harada T., Taguchi H., Yamada S., Maruyama I., Inui A.

    Molecular Psychiatry   12 ( 11 )   976 - 977   2007.11

     More details

    Language:Japanese   Publisher:Molecular Psychiatry  

    DOI: 10.1038/sj.mp.4002050

    Scopus

  • 【DIC】基礎編 凝固学最近のトピックス

    橋口 照人

    クリニカ   34 ( 4 )   204 - 206   2007.7

     More details

    Language:Japanese   Publisher:(株)トプコ出版部  

  • Inhibition of HMGB1 by deep ocean water attenuates endotoxin-induced sepsis

    Kawahara K.i., Hashiguchi T., Ito T., Kikuchi K., Morimoto Y., Shimizu T., Oyama Y., Takenouchi K., Arimura S.i., Taniguchi N., Maruyama I., Iwata M., Tancharoen S., Unoshima M., Iwasaka H.

    Medical Hypotheses   68 ( 6 )   1429 - 1430   2007.4

     More details

    Language:Japanese   Publisher:Medical Hypotheses  

    DOI: 10.1016/j.mehy.2006.10.025

    Scopus

  • 【浮腫を診る】むくみとVEGF

    橋口 照人

    綜合臨床   55 ( 11 )   2611 - 2614   2006.11

     More details

    Language:Japanese   Publisher:(株)永井書店  

  • Erratum: Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-κB pathway inhibition (FEBS Letters (2006) 580 (613-619) DOI: 10.1016/j.febslet.2005.12.079)

    Nakajima Y., Furuichi Y., Biswas K.K., Hashiguchi T., Kawahara K.I., Yamaji K., Uchimura T., Izumi Y., Maruyama I.

    FEBS Letters   580 ( 7 )   2006.3

     More details

    Language:Japanese   Publisher:FEBS Letters  

    DOI: 10.1016/j.febslet.2006.02.046

    Scopus

  • Erratum: Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt (FEBS Letters (2006) 580 (703-710) DOI: 10.1016/j.febslet.2005.12.048)

    Biswas K., Tancharoen S., Sarker K., Kawahara K., Hashiguchi T., Maruyama I.

    FEBS Letters   580 ( 6 )   2006.3

     More details

    Language:Japanese   Publisher:FEBS Letters  

    DOI: 10.1016/j.febslet.2006.01.067

    Scopus

  • 【血管内皮細胞の構造と機能】血管内皮細胞機能検査法

    橋口 照人, 丸山 征郎

    血液フロンティア   15 ( 12 )   2009 - 2014   2005.11

     More details

    Language:Japanese   Publisher:(株)医薬ジャーナル社  

    近年,血管内皮細胞機能検査として,血管の駆血開放後におこる拡張反応flow mediated dilatation(FMD)の測定が知られるようになった.本検査はアセチルコリンによる冠動脈の拡張反応と同じく一酸化窒素(NO)を介する機序とされるが,血管拡張の機序を考察する上で,血管内皮細胞依存/非依存,NO依存/非依存の区別を意識することが大切と思われる.また,FMD測定は内皮細胞依存性かつNO依存性の高い検査法であるが,交感神経活動の影響を含めたデータの再現性に問題が残されている.最近,これらの問題点を考慮したPeripheral Arterial Tonometry(PAT)が注目されつつあるのであわせて紹介する(著者抄録)

  • Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis [1]

    Kanekura T., Hashiguchi T., Mera Y., Katahira A., Nakamura I., Maruyama I., Kanzaki T.

    Dermatology   208 ( 1 )   79 - 80   2004.2

     More details

    Language:Japanese   Publisher:Dermatology  

    DOI: 10.1159/000075053

    Scopus

  • 【Peripheral neuropathy 診療と研究の最近の進歩】Crow-Fukase症候群とVEGF

    有村 公良, 橋口 照人, 梅原 藤雄

    神経研究の進歩   47 ( 4 )   545 - 554   2003.8

     More details

    Language:Japanese   Publisher:(株)医学書院  

    血管内皮増殖因子(VEGF)の持つ生理活性の研究や高VEGF血症を引き起こすヌード・マウスの病理学的検討から,Crow-Fukase症候群における異常に高値のVEGFは,本症候群の種々の特徴的な病態と関連することが次第に明らかになってきた.一方,Crow-Fukase症候群は特徴的な臨床症状がそろう以前の早期の段階では,しばしば診断が困難なことがあり,診断基準の作成が重要である.Crow-Fukase症候群は依然として難治性の疾患であるが,最近,強力な化学療法と自己末梢血幹細胞移植の併用による緩解例の報告が見られるようになり,今後は我が国での検討も必要である

  • 【救急医療】救急医療に必要な基礎知識 緊急検査と評価

    大山 陽子, 橋口 照人, 丸山 征郎

    診断と治療   91 ( Suppl. )   35 - 43   2003.4

     More details

    Language:Japanese   Publisher:(株)診断と治療社  

  • Adult T-cell leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the central nervous system

    Internal Medicine   41(1):34-38.   2002

     More details

  • 【血栓症に関するQ&A】成因・危険因子 潰瘍性大腸炎の血栓傾向について教えて下さい

    橋口 照人

    血栓と循環   9 ( 4 )   425 - 426   2001.12

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

  • 神経免疫性疾患をめぐって Crow-Fukase症候群の発症機序とVEGF

    有村 公良, 橋口 照人, 納 光弘

    臨床神経学   41 ( 12 )   1144 - 1146   2001.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

  • 【生活習慣病 分子メカニズムと治療】動脈硬化 血栓形成の分子機構と動脈硬化

    橋口 照人, 丸山 征郎

    Molecular Medicine   38 ( 臨増 生活習慣病分子メカニズムと治療 )   81 - 85   2001.8

     More details

    Language:Japanese   Publisher:(株)中山書店  

  • 【血管新生-update】VEGFとCrow-Fukase症候群

    橋口 照人, 丸山 征郎, 有村 公良, 納 光弘

    Biomedical Perspectives   10 ( 1 )   23 - 27   2001.5

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    VEGF(血管内皮増殖因子)は分泌型の糖タンパク質であり,強力な血管透過性亢進作用をもち,血管新生の全過程との関わりが深い重要な血管新生因子である.低酸素状態でVEGF mRNAが誘導され,内皮細胞の増殖や管腔形成を促進する.また正常の血管新生のみでなく,腫瘍内血管新生,糖尿病網膜症,動脈硬化層,側副血行路,創傷治癒,慢性関節リウマチ等の病態の血管新生にも,VEGFは特に重要な役割を果たすとされている.Crow-Fukase症候群は,VEGFそのものが疾患と一次的に密接に関連している最も代表的な疾患である

  • 【ニューロパチー】主なニューロパチーの最近の知見 Crow-Fukase症候群

    橋口 照人, 有村 公良, 納 光弘

    Clinical Neuroscience   19 ( 1 )   50 - 52   2001.1

     More details

    Language:Japanese   Publisher:(株)中外医学社  

  • Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome

    Neurology   56(6):807-810   2001

  • Elevation of N-(carboxymethyl)valine residue in hemoglobin of diabetic patients. Its role in the development of diabetic nephropathy

    Diabetes Care   24(5):891-896.   2001

  • Frameshift mutation in the collagen VI gene causes Ullrich's disease

    Annals of Neurology   50(2):261-265.   2001

     More details

  • Frameshift mutation in the collagen VI gene causes Ullrich's disease

    Annals of Neurology   50(2):261-265.   2001

     More details

  • Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome

    Neurology   56(6):807-810   2001

  • 【ニューロパチーの病態と治療 最近の進歩】Crow-Fukase症候群 病因としてのVEGF

    有村 公良, 橋口 照人

    医学のあゆみ   195 ( 10 )   745 - 748   2000.12

     More details

    Language:Japanese   Publisher:医歯薬出版(株)  

  • 【血管新生】VEGFと疾患とのかかわり

    橋口 照人, 丸山 征郎

    臨床検査   44 ( 13 )   1617 - 1621   2000.12

     More details

    Language:Japanese   Publisher:(株)医学書院  

    VEGFは,血管内皮特異的増殖因子で分泌型の糖蛋白である.強力な血管透過性亢進作用を有し,血管新生の全過程とのかかわりが深い重要な血管新生因子である.低酸素状態でVEGF mRNAが誘導され,内皮細胞の増殖や管腔形成を促進する.また正常の血管新生のみでなく,腫瘍内血管新生,糖尿病性網膜症,動脈硬化層,側副血行路,創傷治癒,慢性関節リウマチ等の病態の血管新生にも,VEGFは特に重要な役割を果たすことが推定されている.抗VEGF抗体やアンチセンスVEGFを用いて病的血管新生を抑え,癌治療などへの試みもなされつつある.又,VEGFの作用を応用して,虚血性疾患への治療にと応用されつつある

  • 【免疫症候群(下巻)】Crow-Fukase(POEMS)症候群

    橋口 照人, 有村 公良, 納 光弘

    日本臨床   別冊 ( 免疫症候群(下) )   595 - 598   2000.12

     More details

    Language:Japanese   Publisher:(株)日本臨床社  

  • 【傍腫瘍性症候群の治療】Crow-Fukase症候群の新しい治療ストラテジー

    有村 公良, 橋口 照人, 渡邊 修, 納 光弘

    神経治療学   17 ( 6 )   547 - 550   2000.11

     More details

    Language:Japanese   Publisher:(一社)日本神経治療学会  

  • Highly concentrated vascular endothelial growth factor in platelets in Crow- Fukase syndrome

    MUSCLE & NERVE   23 : 1051-1056   2000

  • VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome

    Internal Medicine   39(12):1101-1104   2000

     More details

  • VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome

    Internal Medicine   39(12):1101-1104   2000

     More details

  • Highly concentrated vascular endothelial growth factor in platelets in Crow- Fukase syndrome

    MUSCLE & NERVE   23 : 1051-1056   2000

  • 【糖尿病性神経障害の臨床像とその対策】特殊な病型の病態と治療法 Diabetic amyotrophy

    有村 公良, 橋口 照人, 奥 寛子, 出口 尚寿, 徳永 久理子

    Complication: 糖尿病と血管   4 ( 2 )   231 - 236   1999.11

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

  • 分泌異常による先天性凝固線溶因子欠乏症 先天性XIII因子欠損症を惹起した異常bサブユニットの分泌障害

    橋口 照人, 一瀬 白帝

    血液・腫瘍科   33 ( 5 )   371 - 378   1996.11

     More details

    Language:Japanese   Publisher:(有)科学評論社  

  • 各種の凝固第XIII因子欠乏症の分子病態学的解析

    一瀬 白帝, 泉 友則, 橋口 照人

    日本血栓止血学会誌   7 ( 3 )   193 - 198   1996.6

     More details

    Language:Japanese   Publisher:(一社)日本血栓止血学会  

  • 凝固検査のためのサンプルの取り扱い 凝固検査検体取り扱い標準化ワーキンググループの2020年の提言

    小宮山 豊, 家子 正裕, 松田 将門, 橋口 照人

    日本検査血液学会雑誌   22 ( 1 )   136 - 141   2021.2

     More details

    Publisher:(一社)日本検査血液学会  

    凝固検査検体取扱い標準化ワーキンググループでは、院内検査用の凝固検査検体取り扱いのコンセンサスの英文改訂版作成と外注検査用コンセンサスに必要な実験に取り組んだ。院内検査用コンセンサスでは「血漿中残存血小板数が10×10^9/L未満」であれば高速遠心が許容できるかの検証実験を実施した。その結果turnaround time短縮のため、推奨(1,500xg)以上の高速遠心(3,500xg)を実施すると検体血漿中でトロンビン-アンチトロンビン複合体で検出される凝固活性が高まることを明らかにし、凝固検査検体取り扱いとして高速遠心を推奨できないことを追記した。この内容は英語版にも追記した。また外注検査用コンセンサスについては、家子らの報告をもとに長時間搬送MIMIC系での実験を行った。その結果、全血長時間搬送では、4℃静置での変化がより顕著で第VIII因子低下を伴うAPTT延長を認め、血友病と誤診されるレベルであった。凝固因子測定のほとんどを受託施設に頼る本邦の現状を考えると注意が必要である。なお、自施設用コンセンサスの認知度調査も最近報告され、それらを解析すると自施設用コンセンサスの周知には、院内検査室が保持する遠心分離機の複数化や技師会を通じて広いアナウンスの必要性などが改善方法として有用であることを確認した。(著者抄録)

  • 【2つのルーチン検査値で患者の病態を考えてみよう】フィブリノゲンとD-dimer

    橋口 照人

    治療   103 ( 1 )   74 - 78   2021.1

     More details

    Publisher:(株)南山堂  

  • バイオマーカーを理解する 凝固カスケード温故知新

    橋口 照人

    Cardio-Coagulation   7 ( 3 )   162 - 165   2020.10

     More details

    Publisher:(株)メディカルレビュー社  

  • バイオマーカーを理解する 抗凝固療法を受けている患者の周術期に測定すべきマーカー TAT、FMC、Dダイマー、FDP

    橋口 照人

    Cardio-Coagulation   6 ( 2 )   113 - 116   2019.6

     More details

    Publisher:(株)メディカルレビュー社  

  • 【検査項目と異常値からみた-緊急・重要疾患レッドページ】(1章)全身疾患 血栓傾向

    橋口 照人

    臨床検査   63 ( 4 )   364 - 365   2019.4

     More details

    Publisher:(株)医学書院  

    <文献概要>血栓傾向を診断する最も代表的なバイオマーカーはDダイマー,フィブリノゲン・フィブリン分解産物(FDP)である.その考え方の基本は,"凝固が起これば線溶が起こる"という二次線溶反応の機序である.凝固反応の結果,フィブリンが生成されると,フィブリンに親和性の高いプラスミノゲンアクチベータとプラスミノゲンがこのフィブリンに結合して,フィブリン上でプラスミノゲンからプラスミンの生成が効率よく起こり,プラスミンはフィブリンを分解してDダイマーが生成される.

  • Intra-platelet serotonin as a biomarker in HCC recurrence: When time matters

    Aryal B.

    Journal of Cancer   10 ( 11 )   2384 - 2385   2019

     More details

    Publisher:Journal of Cancer  

    DOI: 10.7150/jca.30696

    Scopus

    PubMed

  • 【血栓止血の臨床-研修医のために[第2版]】検査 採血から検査結果の解釈まで

    橋口 照人

    日本血栓止血学会誌   29 ( 6 )   545 - 549   2018.12

     More details

    Publisher:(一社)日本血栓止血学会  

    <ポイント>・採血は、日本臨床検査標準協議会(Japanese Committee for Clinical Laboratory Standards:JCCLS)の「標準採血法ガイドライン第2版(GP4-A2)」に則って実施されなければならない。その上で結果の正しい解釈が可能である。・凝固系は「溶けない分子」への変換であり、線溶系は「溶ける分子」への再変換というダイナミックな反応系である。・凝固反応はカスケード(増幅)反応であり、カルシウムイオンを必要とする。・凝固系は血小板のリン脂質膜上、線溶系はフィブリンの分子上にて効率よくプロセスされる反応である。・日常臨床における凝固系検査の多くに凝固時間検査が用いられている。(著者抄録)

  • 【ポストゲノムダイナミクスと検査医学への展望】検査医学へつながるmiRNA研究

    山口 宗一, 橋口 照人

    臨床化学   47 ( 3 )   229 - 236   2018.7

     More details

    Publisher:(一社)日本臨床化学会  

  • 2017 Hot Topics 血管分野

    橋口 照人, 山田 典一, 島岡 要

    日本血栓止血学会誌   29 ( 1 )   52 - 54   2018.2

     More details

    Publisher:(一社)日本血栓止血学会  

  • 【血栓傾向を示す患者データの読み方】直接経口抗凝固薬のモニタリング検査

    橋口 照人

    Medical Technology   46 ( 1 )   47 - 51   2018.1

     More details

    Publisher:医歯薬出版(株)  

    直接経口抗凝固薬(DOAC)の内服症例に対する凝固検査の際は、服薬からの時間・腎機能など全身状態の把握とともに、施設ごとの試薬のDOACに対する感受性を考慮に入れて結果を判断することが必要である。予後の改善を目的とした抗凝固療法を積極的に行うためには、過度の抗凝固状態あるいは残存凝固活性測定法の確立が必須の時代となったといえる。(著者抄録)

  • 凝固・線溶データのみかたと考え方

    橋口 照人

    臨床血液   58 ( 10 )   2096 - 2103   2017.10

     More details

    Publisher:(一社)日本血液学会-東京事務局  

    凝固・線溶データを解釈する上で大切なことは「フィブリンは血液中に溶けない分子である」ことを再認識することであろう。凝固系は可溶性から不溶性への変換であり線溶系は不溶性から可溶性への再変換というダイナミックな反応系である。フィブリンは溶けないからこそ分子としての意味をもち,FDP・Dダイマーは溶けるからこそ分子としての意味をもつ。この大きな概念の中に凝固反応はカスケード(増幅)反応であること,カルシウムイオンを必要とすること,凝固系は血小板のリン脂質膜上,線溶系はフィブリンの分子上にて効率良くプロセスされる反応が含まれる。日常臨床における凝固系検査の多くに凝固時間検査が応用されている。その一つである凝固因子活性測定法(一段法)は生体内の凝固因子は過剰に存在していることがその基本原理である。DICの病態においてはプロテアーゼの活性化により血中に無数のペプチド断片が出現している。(著者抄録)

  • 2016 Hot Topics 血管分野

    小亀 浩市, 橋口 照人, 山田 典一

    日本血栓止血学会誌   28 ( 1 )   89 - 91   2017.2

     More details

    Publisher:(一社)日本血栓止血学会  

  • CPCでR-CPCの重要性を再認識しよう

    金井 信一郎, 松本 剛, 佐野 健司, 上田 和彦, 藤澤 紳哉, 大林 光念, 橋口 照人, 柳原 克紀, 森吉 美穂, 北川 清樹, 和田 英夫, 森信 暁雄, 和田 隆志, 本田 孝行

    臨床病理   60 ( 5 )   449 - 457   2012.5

     More details

    Publisher:(一社)日本臨床検査医学会  

▼display all

Presentations

  • 森岡 洋史, 橋口 照人   HIV抗体陽性が判明した学生の支援を経験して  

    CAMPUS HEALTH  2008.10  (公社)全国大学保健管理協会

  • 古川 良尚, 橋口 照人   HIV治療中断とともに貧血の増悪を認めたβサラセミアの一例  

    日本エイズ学会誌  2013.11  (一社)日本エイズ学会

  • 大塚 麗華, 有村 公良, 林 茂昭, 橋口 照人, 冨満 久教, 園田 至人, 長堂 竜維, 納 光弘   Isaacs症候群における抗VGKC抗体の標的認識部位の検討  

    臨床神経学  2001.11  (一社)日本神経学会

  • 竹中 大喜, 山口 宗一, 竹之内 和則, 大山 陽子, 清水 利昭, 郡山 豊泰, 古城 剛, 橋口 照人   miR-22の血管内皮細胞での役割の検討  

    臨床病理  2016.9  (一社)日本臨床検査医学会

  • 山口 宗一, 郡山 豊泰, 向原 公介, 重久 喜哉, 古城 剛, 清水 利昭, 竹之内 和則, 大山 陽子, 井本 浩, 橋口 照人   miRNAによる自然免疫制御機構の解明  

    臨床病理  2016.9  (一社)日本臨床検査医学会

  • 政元 いずみ, 谷口 眞由美, 竹之下 友寿, 田畑 仁美, 古園 千里, 松下 昌風, 橋口 照人, 八牧 愉二, 河野 嘉文   MLL再構成を有し混合形質白血病を疑った1症例  

    Cytometry Research  2013.6  (一社)日本サイトメトリー学会

  • 竹之下 友寿, 政元 いずみ, 谷口 眞由美, 田畑 仁美, 松下 昌風, 橋口 照人, 西川 拓郎, 河野 嘉文   NG2(neural-glial antigen2)使用によりMLLと報告できた1症例  

    Cytometry Research  2014.6  (一社)日本サイトメトリー学会

  • 橋口 照人   NOAC(DOAC)に学ぶ凝固学  

    日臨技九州支部医学検査学会  2015.11  日臨技九州支部医学検査学会

  • 竹之内 和則, スレスタ・ビニタ ビ, 山口 宗一, 橋口 照人   non-β細胞由来VEGF-Aはisletを構成しないインスリン産生細胞のsmall clustersを増加させる  

    臨床化学  2014.8  (一社)日本臨床化学会

  • 政元 いずみ, 竹之下 友寿, 高味 聡子, 谷口 眞由美, 田畑 仁美, 松下 昌風, 橋口 照人   FCMによるnormal pathwayとの比較から見える骨髄球系細胞の質的異常  

    日本検査血液学会雑誌  2015.6  (一社)日本検査血液学会

  • 高口 剛, 樋口 雄二郎, 林 大輔, 市來 征仁, 東 桂子, 出口 尚寿, 渡邊 修, 橋口 照人, 高嶋 博   HAART導入により神経症状の改善および髄液HIV-RNA量の減少を確認し得たHIV脳症の一例  

    臨床神経学  2011.8  (一社)日本神経学会

  • 梅原 藤雄, 白濱 ゆう子, 橋口 照人   HAM脊髄活動性炎症部にはIL-17が発現している  

    臨床神経学  2009.12  (一社)日本神経学会

  • スレスタ・ビニタ , 橋口 照人, 伊藤 隆史, 三浦 直樹, 竹之内 和則, 吉永 成就, 川原 幸一, 佐藤 正弘, 坂本 泰二, 丸山 征郎   血管増殖因子VEGF-Aは獲得免疫環境を制御する  

    臨床病理  2009.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 山口 宗一, 上田 英昭, 向原 公介, 松本 和久, 大川 政士, 竹之内 和則, 大山 陽子, 東 貞行, 藤崎 知園子, 井本 浩, 橋口 照人   血管平滑筋細胞石灰化のmiRNA依存性制御機構の検討  

    日本血栓止血学会誌  2021.5  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 橋口 照人   血管年齢を診断する  

    日本予防医学会雑誌  2008.4  (一社)日本予防医学会

     More details

    Language:Japanese  

  • 橋口 照人, 丸山 征郎   血餅形成における凝固系と血小板の相互作用 血管血栓における血小板VEGF-Aの役割(Interaction of coagulation system and platelets in clot formation Role of platelet VEGF-A in vascular thrombosis)  

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集  2010.12  (公社)日本生化学会

     More details

    Language:English  

  • 中村 政敏, 竹之下 友寿, 佐藤 香奈子, 松下 昌風, 内門 泰斗, 夏越 祥次, 橋口 照人   術後創傷治癒過程における凝固・線溶系の動態解析  

    生物試料分析  2012.2  (NPO)生物試料分析科学会

     More details

    Language:Japanese  

  • 喜井 裕哉, 山切 啓太, 園田 恭志, 土居 範仁, 坂本 泰二, 橋口 照人, 丸山 征郎   裂孔原性網膜剥離におけるHigh mobility group box 1 proteinの病態形成への関与  

    日本眼科学会雑誌  2007.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 大塚 寛樹, 有村 昇, 山切 啓太, 橋口 照人, 丸山 征郎, 坂本 泰二   裂孔原性網膜剥離におけるStromal cell drived factor-1の関与  

    日本眼科学会雑誌  2010.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 中島 篤人, 山口 宗一, 吉村 明子, 古城 剛, 小濱 祐行, 竹之内 和則, 大山 陽子, 政元 いずみ, 高嶋 博, 橋口 照人   親子間で病型の異なるフォン・ヴィレブランド病の一家系  

    日本血栓止血学会誌  2019.5  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 高味 聡子, 政元 いずみ, 竹之下 友寿, 田畑 仁美, 松下 昌風, 橋口 照人, 西川 拓朗, 河野 嘉文   診断に苦慮した免疫不全症の1症例  

    日本検査血液学会雑誌  2016.7  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 内村 友則, 橋口 照人, 山口 宗一, 奥浦 正弘, 丸山 征郎, 岩本 久彦, 三浦 圭介, 吉村 佳典, 本宮 善恢   赤血球ヘモグロビンβ鎖N末バリン残基カルボキシメチル化蛋白測定系の確立,糖尿病における臨床的意義  

    臨床病理  2001.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 内村 友則, 橋口 照人, 水上 尚子, 野口 慶久, 森田 俊裕, 松下 昌風, 黒木 辰雄, 村永 文学, 森永 健一郎, 今門 莞爾, 丸山 征郎   超音波情報システムの構築 HIS,LIS情報とのintegration  

    超音波医学  2003.4  (公社)日本超音波医学会

     More details

    Language:Japanese  

  • 園田 理子, 中野 文, 牧 美充, 兒玉 憲人, 武井 潤, 平松 有, 田代 雄一, 荒田 仁, 橋口 照人, 高嶋 博   辺縁系脳炎として治療中にHIV陽性が判明したHIV脳症の一例  

    臨床神経学  2020.4  (一社)日本神経学会

     More details

    Language:Japanese  

  • 内村 友則, 本宮 善恢, 橋口 照人, 山口 宗一, 王 寅, 丸山 征郎   透析患者におけるアナンダマイド(ANA)の測定  

    日本腎臓学会誌  2001.4  (一社)日本腎臓学会

     More details

    Language:Japanese  

  • 内村 友則, 本宮 善恢, 丸山 征郎, 三浦 雅一, 岩本 久彦, 東 拓也, 山口 宗一, 橋口 照人   透析患者における動脈硬化進展リスクファクターの検討 Carbonyl Stressの重要性  

    日本透析医学会雑誌  2001.5  (一社)日本透析医学会

     More details

    Language:Japanese  

  • 新山 尚仁, 樋口 逸郎, 橋口 照人, 迫田 俊一, 納 光弘, 園田 至人, 中江 めぐみ, 児玉 知子, 宇都 正, 福永 秀敏   進行性筋ジストロフィー患者の皮膚組織におけるジストロフィン・ジストロフィン関連蛋白の発現  

    臨床神経学  2001.11  (一社)日本神経学会

     More details

    Language:Japanese  

  • 今釜 逸美, 上野 哲哉, 川原 幸一, 荒田 憲一, 岩下 龍史, 牛島 孝, 久 容輔, 山本 裕之, 橋口 照人, 井畔 能文, 丸山 征郎, 井本 浩   遺伝子組み換えトロンボモジュリン(recombinant human soluble thrombomodulin:rTM)の脊髄虚血による対麻痺への保護効果  

    脈管学  2011.9  (一社)日本脈管学会

     More details

    Language:Japanese  

  • 橋口 照人, 李 良子, 田中 憲次, 丸山 征郎   重症病態における低分子量フラグメント(ペプチドーム/プロテオーム)解析  

    臨床病理  2008.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 出口 尚寿, 徳永 久理子, 堀之内 秀治, 新名 清成, 奥 寛子, 橋口 照人, 有村 公良, 納 光弘   長期にわたりインスリン抵抗性を呈する肥満slowly progressive IDDMの一例  

    糖尿病  2001.10  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 中村 政敏, 舞木 公子, 高手 恵美, 高味 聡子, 竹之下 友寿, 佐藤 香奈子, 政元 いずみ, 大山 陽子, 竹之内 和則, 山口 宗一, 橋口 照人   電子カルテ(HIS)更新時における検査部情報システム(LIS)を用いた結果報告の検討  

    日本臨床検査自動化学会会誌  2018.9  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 佐々木 健, 橋口 照人, 田中 憲次, 李 良子, 野中 大輔, 奥村 浩, 内門 泰斗, 喜多 芳昭, 大脇 哲洋, 夏越 祥次   食道扁平上皮癌患者における血清α1-アンチトリプシンペプチド断片の測定意義  

    日本食道学会学術集会プログラム・抄録集  2012.6  (NPO)日本食道学会

     More details

    Language:Japanese  

  • 内門 泰斗, 奥村 浩, 松本 正隆, 大脇 哲洋, 喜多 芳昭, 佐々木 健, 尾本 至, 橋口 照人, 石神 純也, 夏越 祥次   食道癌からサイエンスを考える 食道癌診断に血清中N型糖鎖を利用した新規腫瘍マーカーとしての可能性  

    日本食道学会学術集会プログラム・抄録集  2012.6  (NPO)日本食道学会

     More details

    Language:Japanese  

  • 本部 卓志, 内村 友則, 橋口 照人, 大西 敏之, 丸山 征郎, 小宮 節郎   骨セメント使用時の血圧低下におけるAnandamide,2-Arachionylglycerolの影響  

    日本整形外科学会雑誌  2002.8  (公社)日本整形外科学会

     More details

    Language:Japanese  

  • 橋口 照人, 李 良子, 濱戸 宣昭, 有村 公良, 田中 憲次, 丸山 征郎   高VEGF-A血症をきたすCrow-Fukase(POEMS)症候群の病態解析  

    日本癌学会総会記事  2005.9  (一社)日本癌学会

     More details

    Language:Japanese  

  • 橋口 照人, 李 良子, 田中 憲次, 丸山 征郎   高VEGF血症をきたすCrow-Fukase(POEMS)症候群の病態解析 各病態ステージにおける血清バイオマーカーの探索・同定  

    日本癌学会総会記事  2006.9  (一社)日本癌学会

     More details

    Language:Japanese  

  • 山口 宗一, 橋口 照人, 内村 友則, 奥浦 正弘, 丸山 征郎   高グルコース下のマクロファージの遺伝子変化-SAGE法による解析  

    糖尿病  2001.3  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 永里 朋香, 尾田 悠, 細川 和也, 橋口 照人, 丸山 征郎   高血圧ラットの血小板機能の推移 血流下血栓形成能解析装置T-TASを用いた解析  

    日本血栓止血学会誌  2014.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 出口 尚寿, 奥 寛子, 徳永 久理子, 有村 公良, 納 光弘, 川村 美輪子, 堀之内 秀治, 橋口 照人   高血糖性舞踏病を併発した未治療若年2型糖尿病の一例  

    糖尿病  2002.5  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 中村 政敏, 舞木 公子, 福山 竜子, 小濱 祐行, 川畑 恵, 佐藤 香奈子, 政元 いずみ, 茂見 茜里, 川村 英樹, 西 順一郎, 橋口 照人   鹿児島感染制御サーベイランスによる鹿児島県の薬剤耐性菌の動向調査  

    医療検査と自動化  2021.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 川村 英樹, 藺牟田 直子, 茂見 茜里, 西 順一郎, 舞木 公子, 福山 竜子, 橋口 照人   鹿児島感染制御サーベイランスシステムによるMRSAの検出状況  

    日本化学療法学会雑誌  2020.9  (公社)日本化学療法学会

     More details

    Language:Japanese  

  • 川村 英樹, 郡山 豊泰, 古城 剛, 大山 陽子, 橋口 照人, 西 順一郎   鹿児島感染制御サーベイランスシステムによる鹿児島県の薬剤耐性菌検出状況  

    日本臨床微生物学雑誌  2017.12  (一社)日本臨床微生物学会

     More details

    Language:Japanese  

  • 中村 政敏, 宮内 恵美, 佐藤 香奈子, 政元 いずみ, 松下 昌風, 橋口 照人   鹿児島県での凝固検査精度管理調査導入の検討とフィブリノゲン試薬間の直接トロンビン阻害薬の影響の検証  

    臨床化学  2016.10  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 中村 政敏, 宮内 恵美, 佐藤 香奈子, 政元 いずみ, 松下 昌風, 橋口 照人   鹿児島県での凝固検査精度管理調査導入検討とフィブリノゲン測定試薬間の直接トロンビン阻害薬の影響の検証  

    日本臨床検査自動化学会会誌  2016.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 山下 ひとみ, 中島 隆宏, 伊藤 隆史, 濱田 祐樹, 大山 徹也, 脇田 政之, 永里 朋香, 橋口 照人, 丸山 征郎, 松岡 秀樹   血流下血栓形成能解析システム(T-TAS)による血小板増多を伴う脳梗塞の血栓形成能評価  

    臨床神経学  2015.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 永里 朋香, 細川 和也, 大西 朋子, 鮫島 寿代, 橋口 照人, 丸山 征郎   血流下血栓形成能解析装置T-TASを用いた血栓傾向の解析 冠危険因子は血栓形成能を高めるか?  

    日本血栓止血学会誌  2013.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 橋口 照人   血液凝固第13因子bサブユニット完全欠損症患者の2つの遺伝子異常  

    International Journal of Hematology  1993.4  (一社)日本血液学会

     More details

    Language:Japanese  

  • 橋口 照人   血液凝固第13因子bサブユニット欠損症の分子機序  

    日本血栓止血学会誌  1993.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 大山 陽子, 竹之内 和則, 古城 剛, 郡山 豊泰, 福山 竜子, 山口 宗一, 橋口 照人   血液培養陽性データよりみる検出菌とその臨床背景  

    臨床病理  2016.9  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 大山 陽子, 竹之内 和則, 古城 剛, 郡山 豊泰, 福山 竜子, 川畑 恵, 山口 宗一, 橋口 照人   血液培養陽性データよりみる真菌検出とその臨床背景  

    臨床病理  2017.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 笠畑 拓志, 高味 聡子, 佐々木 ゆかり, 餅原 愛, 山崎 澪, 政元 いずみ, 橋口 照人   血液細胞分類装置を用いた血液検査室の運用  

    医療検査と自動化  2020.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 徳永 久理子, 出口 尚寿, 橋口 照人, 堀之内 秀治, 奥 寛子, 川村 美輪子, 有村 公良, 納 光弘, 瀬戸山 史郎   血清VEGFと生活習慣病  

    糖尿病  2002.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 出口 尚寿, 堀之内 秀治, 宇都 正, 堂地 ゆかり, 中島 雅恵, 奥 寛子, 橋口 照人, 有村 公良, 納 光弘   血清VEGFは糖尿病性多発神経障害の症状期前期から中期に高値を呈する  

    糖尿病  2005.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 大川 政士, 山口 宗一, 竹之内 和則, 東 貞行, 井上 恵一, 山田 晋吾, 橋口 照人   血清、血漿、血小板におけるVEGF-A 121、165アイソフォームの比較定量  

    日本検査血液学会雑誌  2021.8  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 李 良子, 橋口 照人, 佐貫 展也, 丸山 征郎, 田中 憲次   血清バイオマーカーの体系的探索・同定システムの構築  

    日本癌学会総会記事  2006.9  (一社)日本癌学会

     More details

    Language:Japanese  

  • 川原 幸一, 阿辺山 和浩, 橋口 照人, 山口 宗一, 丸山 征郎, 川上 雅之   血管内皮・凝固障害 血小板とその他の細胞の相互作用  

    エンドトキシン血症救命治療研究会誌  2003.12  (株)自然科学社

     More details

    Language:Japanese  

  • 前之園 隆一, 橋口 照人, 大野 佳子, 丸山 征郎   血管内皮細胞機能と動脈硬化危険因子との関係について新機検査法を用いた検証  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 山路 加津代, シャーカー・クリシェナ・パダ , 川原 幸一, 橋口 照人, 阿辺山 和浩, 丸山 征郎   血管内皮細胞障害 TTP,HUSにおける内皮細胞障害のメディエーターの一つは内因性カンナビノイド,アナンダマイドである その分子細胞機構とシグナル伝達について  

    エンドトキシン血症救命治療研究会誌  2004.11  (株)自然科学社

     More details

    Language:Japanese  

  • 橋口 照人   血栓症と血管機能、血管細胞生物学内科学 疲労と血管機能  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 山崎 哲, 家子 正裕, 橋口 照人, 金子 誠, 小宮山 豊, 矢島 智志, 静 怜子, 内藤 澄悦, 由木 洋一, 叶内 和範, 福武 勝幸, 日本検査血液学会/標準化委員会/血栓止血検査標準化小委員会   血栓止血検査標準化に関する2018年度の提言  

    日本検査血液学会雑誌  2018.6  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 橋口 照人, 丸山 征郎   血小板性VEGFの生理学的意義の考察  

    日本血栓止血学会誌  2006.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 橋口 照人   血小板VEGFの機能解析 血管修復とモデリングへの関与  

    先進医薬年報  2002.9  (公財)先進医薬研究振興財団

     More details

    Language:Japanese  

  • 橋口 照人, 宇都 伸枝, 永里 朋香, 鮫島 寿代, 塗木 千鶴, 徳満 貴子, 二反田 隆夫, 北島 信一, 有村 公良, 丸山 征郎   血小板性VEGFの概念の提唱(Crow-Fukase症候群の病態解析から)  

    臨床化学  2005.10  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 竹之内 和則, 児玉 祐一, 上野 健太郎, 清水 利昭, 中村 政敏, 松下 昌風, 河野 嘉文, 橋口 照人   血小板VEGF-Aの病態バイオマーカーとしての可能性の解析  

    日本血栓止血学会誌  2013.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 大山 陽子, 内村 友則, 川原 幸一, Biswas Kamal Krishna, 橋口 照人, 小玉 拓郎, 早田 正和, 地頭方 良江, 梅北 善久, 塗木 千鶴, 徳満 貴子, 二反田 隆夫, 北島 信一, 吉田 浩己, 丸山 征郎   腎結石形成モデルにおける腎不全発症機構についての研究  

    臨床化学  2005.10  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 有水 琢朗, 神田 直昭, 篠原 和也, 橋口 照人   脳静脈洞血栓症をきたしたアンチトロンビン欠損症例  

    臨床神経学  2011.9  (一社)日本神経学会

     More details

    Language:Japanese  

  • 松崎 敏男, 新名主 宏一, 有里 敬代, 東 桂子, 松本 秀也, 大勝 洋祐, 橋口 照人, 中川 正法, 納 光弘   脳血管障害における抗HTLV-I抗体陽性者と陰性者の頸部血管エコー所見の比較検討  

    臨床神経学  2000.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 菊池 清志, 宮城 尚久, 川原 幸一, 森元 陽子, 三浦 直樹, 橋口 照人, 丸山 征郎, 徳富 孝志, 重森 稔   脳脊髄外傷の基礎的研究(神経損傷の基礎シンポジウム) 無酸素無糖条件下での神経様細胞におけるミノサイクリンのHMGB1に対する効果  

    日本脳神経外傷学会プログラム・抄録集  2010.3  (一社)日本脳神経外傷学会

     More details

    Language:English  

  • 菊池 清志, 川原 幸一, 森元 陽子, 伊藤 隆史, 清水 利昭, 大山 陽子, 竹之内 和則, 有村 真一郎, 岩田 政宏, 名和 由布子, 孟 暁潔, 吉田 義弘, 橋口 照人, 丸山 征郎   脳梗塞後神経細胞死のメディエーター HMGB1のダイナミズムとその制御  

    日本血栓止血学会誌  2006.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • Kikuchi Kiyoshi, Kawahara Ko-ichi, Miyagi Naohisa, Morimoto Yoko, Miura Naoki, Matsuda Fumiyo, Yoshida Yoshihiro, Uchikado Hisaaki, Hashiguchi Teruto, Maruyama Ikuro, Shigemori Minoru   脳梗塞ラットにおけるHMGB1に対するedaravoneの効果(Effects of Edaravone on HMGB1 in Rats with Cerebral Infarction)  

    Circulation Journal  2011.3  (一社)日本循環器学会

     More details

    Language:English  

  • 有村 愛子, 中野 晶子, 稲留 さおり, 奥 寛子, 堀之内 秀治, 出口 尚寿, 橋口 照人, 神田 直昭, 有村 公良, 納 光弘   脳主幹動脈高度狭窄を認めた抗リン脂質抗体陽性2型糖尿病の1例  

    糖尿病  2007.1  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • Aryal Bibek, Shimizu Toshiaki, Kadono Jun, Starlinger Patrick, Furoi Akira, Komokata Teruo, Yamakuchi Munekazu, Hashiguchi Teruto, Imoto Yutaka   肝部分切除後の血小板内セロトニン HCC再発の予測因子候補(Intra-Platelet Serotonin After Partial Hepatectomy: A Candidate Predictor of HCC recurrence)  

    Journal of Hepato-Biliary-Pancreatic Sciences  2017.5  John Wiley & Sons Australia, Ltd

     More details

    Language:English  

  • 岡本 好司, 金光 秀一, 日暮 愛一郎, 橋口 照人, 丸山 征郎, 山口 幸二   肝切除術後に産生される内因性マリファナの術後せん妄発症への影響  

    日本肝胆膵外科学会・学術集会プログラム・抄録集  2009.6  (一社)日本肝胆膵外科学会

     More details

    Language:Japanese  

  • Aryal Bibek, 清水 利昭, 竹之内 和則, 郡山 豊泰, 古城 剛, 門野 潤, 菰方 輝夫, 風呂井 彰, 松下 昌風, 山口 宗一, 橋口 照人, 井元 浩   肝再生中での血小板の血管新生作用(Platelet' s angiogenic role during liver regeneration)  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:English  

  • 阿部 正治, 池田 加奈子, 政元 いずみ, 石井 千佳子, 有村 恵美, 桶谷 薫, 橋口 照人, 堀内 正久   職域健診における尿蛋白検査の検討  

    日本腎臓学会誌  2018.8  (一社)日本腎臓学会

     More details

    Language:Japanese  

  • 池田 加奈子, 中村 政敏, 佐藤 香奈子, 石井 千佳子, 舞木 公子, 阿部 正治, 有村 恵美, 政元 いずみ, 桶谷 薫, 橋口 照人, 堀内 正久   職域健診における尿たんぱく検査精度の検討  

    産業衛生学雑誌  2018.5  (公社)日本産業衛生学会

     More details

    Language:Japanese  

  • 徳永 久理子, 出口 尚寿, 奥 寛子, 橋口 照人, 有村 公良, 納 光弘, 瀬戸山 史郎   耐糖能異常及び生活習慣病と血清VEGFとの関連について  

    糖尿病  2001.3  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 郡山 豊泰, 福山 竜子, 舞木 公子, 川畑 恵, 政元 いずみ, 藺牟田 直子, 川村 英樹, 西 順一郎, 橋口 照人   耐性Acinetobacter属を目的とした環境培養時におけるCROMagar mSuperCarba培地の性能評価  

    日本臨床微生物学会雑誌  2018.12  (一社)日本臨床微生物学会

     More details

    Language:Japanese  

  • タンジャルーン・サランヤー , サイウィーチャイ・タウィー , サンガランカン・バニダ , 川原 幸一, 名和 由布子, 大山 陽子, 永里 朋香, 宇都 伸枝, 橋口 照人, 丸山 征郎   緑茶抽出物サプリメントはタバコ煙曝露ラットにおけるHMGB1放出を抑制する(Green tea extract supplement inhibits HMGB1 release in rats exposed to cigarette smoke)  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 内村 友則, 橋口 照人, 松下 昌風, 黒木 辰雄, 村永 文学, 森永 健一郎, 今門 莞爾, 丸山 征郎   総合画像診断システム-GALIREO-の構築 情報統合サーバー導入による情報のシームレス管理の実現  

    臨床病理  2003.9  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 有村 昇, 喜井 裕哉, 野田 佳宏, 山切 啓太, 土居 範仁, 橋口 照人, 丸山 征郎, 志村 雅彦, 坂本 泰二   網膜静脈閉塞症患者硝子体中のSDF1、VEGF、炎症性サイトカイン濃度の評価  

    日本眼科学会雑誌  2007.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 有村 昇, 喜井 裕哉, 橋口 照人, 川原 幸一, 中村 誠, 園田 恭志, 山切 啓太, 大久保 明子, 丸山 征郎, 坂本 泰二   網膜剥離におけるHigh-mobility group box 1 proteinの関与  

    日本眼科学会雑誌  2009.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 内村 友則, 本宮 善恢, 橋口 照人, 阿辺山 和浩, 井上 恵一, 山田 信吾, 丸山 征郎   維持透析者における偽陽性P-ANCAの対応抗原としてのHMGB1  

    日本透析医学会雑誌  2005.5  (一社)日本透析医学会

     More details

    Language:Japanese  

  • 内村 友則, 本宮 善恢, 井上 恵一, 矢ヶ部 恵子, 山田 晋吾, 橋口 照人, 丸山 征郎   維持透析患者における血中HMGB-1(high mobility group box chromosomal protein1)の測定,透析合併症への関与  

    日本透析医学会雑誌  2003.5  (一社)日本透析医学会

     More details

    Language:Japanese  

  • 大山 陽子, 橋口 照人, 谷口 昇, タンジャルーン・サランヤー , 内村 友則, ビシュワズ・クリシュナ・カマル , 川原 幸一, 二反田 隆夫, 梅北 善久, ロッツ・マーティン , 丸山 征郎   結晶誘発腎炎の炎症遷延化はHMGB1とMCP-1の相互放出による悪循環が関与する  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 奥 寛子, 橋口 照人, 有村 由美子, 有村 公良, 納 光弘, 徳永 久理子, 出口 尚寿   糖尿病患者における神経伝導検査の異常率についての検討  

    糖尿病  2000.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 出口 尚寿, 徳永 久理子, 新名 清成, 奥 寛子, 橋口 照人, 有村 公良   糖尿病患者における手根管症候群の機序に関する検討  

    糖尿病  2000.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 出口 尚寿, 徳永 久理子, 新名 清成, 奥 寛子, 橋口 照人, 有村 公良, 納 光弘   糖尿病性筋萎縮症2例の臨床的検討  

    糖尿病  2000.8  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 有村 公良, 橋口 照人, 出口 尚寿   糖尿病性神経障害の成因の新しい展開と治療への指針 神経障害におけるVEGFの役割と治療への展望  

    糖尿病  2002.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 奥 寛子, 橋口 照人, 有村 由美子, 有村 公良, 納 光弘, 徳永 久里子, 出口 尚寿, 新名 清成   糖尿病性末梢神経障害における臨床症状と電気生理学的所見の比較検討  

    糖尿病  1999.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 出口 尚寿, 橋口 照人, 宇都 正, 徳永 久理子, 奥 寛子, 堀之内 秀治, 有村 公良, 納 光弘   糖尿病性多発神経障害における血清VEGF,MMP,TIMPの動態  

    糖尿病  2003.4  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 樋口 逸郎, 白石 匡史, 新山 尚仁, 中川 正法, 有村 公良, 納 光弘, 末原 雅人, 橋口 照人, 丸山 征郎   筋疾患における各種コラーゲンの発現に関する免疫組織化学的,遺伝子学的検討  

    臨床神経学  2001.11  (一社)日本神経学会

     More details

    Language:Japanese  

  • 樋口 逸郎, 新山 尚仁, 堀切 尚, 内田 裕一, 白石 匡史, 胡 静, 有村 公良, 納 光弘, 末原 雅人, 橋口 照人, 丸山 征郎   筋ジストロフィーに関連する疾患の病態解明と治療法の開発に関する研究 コラーゲンVI欠損を伴うUllrich病患者における骨格筋内血管の病理学的検討  

    厚生労働省精神・神経疾患研究委託費研究報告集  2003.6  国立精神・神経センター

     More details

    Language:Japanese  

  • 川村 英樹, 松元 一明, 茂見 茜里, 郡山 豊泰, 徳田 浩一, 橋口 照人, 西 順一郎, 川畑 直也, 善明 美千久, 小宮 節郎   積極的監視培養・術後感染予防抗菌薬適正使用を中心とした整形外科領域MRSA手術部位感染対策の効果  

    感染症学雑誌  2012.3  (一社)日本感染症学会

     More details

    Language:Japanese  

  • 白澤 誠, 有村 昇, 大塚 寛樹, 園田 祥三, 橋口 照人, 坂本 泰二   硝子体出血における血管内皮細胞増殖因子についての検討  

    眼科臨床紀要  2012.10  眼科臨床紀要会

     More details

    Language:Japanese  

  • Kawano Hiroki, Ito Takashi, Maruyama Ikuro, Hashiguchi Teruto, Sakamoto Taiji   硝子体は細胞外ヒストンの毒性を中和する(Vitreous Body Neutralize the Toxicity of Extracellular Histones)  

    眼科臨床紀要  2014.9  眼科臨床紀要会

     More details

    Language:English  

  • 有村 昇, 喜井 裕哉, 園田 恭志, 山切 啓太, 橋口 照人, 丸山 征郎, 坂本 泰二   眼内炎におけるHigh-Mobility Group Box 1 Proteinの発現  

    日本眼科学会雑誌  2008.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 山口 宗一, 清水 利昭, 竹之内 和則, 大山 陽子, 郡山 豊泰, 伊藤 隆史, 橋口 照人   直腸がんの血管新生を制御するマイクロRNAの検討  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 園田 至人, 新山 尚仁, 樋口 逸郎, 橋口 照人, 松村 剛, 前村 和俊, 西郷 隆二, 福永 知, 宇都 正, 児玉 知子, 中江 めぐみ, 迫田 俊一, 福永 秀敏, 納 光弘   皮膚生検によるジストロフィノパチーの診断  

    厚生労働省精神・神経疾患研究委託費研究報告書 筋ジストロフィーの遺伝相談法及び病態に基づく治療法の開発に関する研究  2002.3  厚生労働省精神・神経疾患研究班

     More details

    Language:Japanese  

  • 副島 健太郎, 山口 宗一, 橋口 照人, 川島 清美, 杉原 一正, 丸山 征郎   癌病変における温熱療法の効果性の検討  

    日本癌治療学会誌  2001.10  (一社)日本癌治療学会

     More details

    Language:Japanese  

  • 郡山 豊泰, 大山 陽子, 川畑 恵, 小濱 祐行, 福山 竜子, 舞木 公子, 中村 政畝, 藤崎 知園子, 東 貞行, 田上 聖徳, 竹之内 和則, 山口 宗一, 政元 いずみ, 橋口 照人   病院検査室におけるM aviumの偽陽性例の検討  

    日本臨床検査医学会誌  2021.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 大山 陽子, 竹之内 和則, 郡山 豊泰, 山口 宗一, 橋口 照人   病態解析情報を含む感染症データベースシステムの構築  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 竹岡 啓子, 日高 洋, 菱沼 昭, 池田 勝義, 大久保 滋夫, 土屋 達行, 橋口 照人, 堀田 多恵子, 古田 耕, 松下 一之, 松本 祐之, 村上 正巳, 前川 真人, 日本臨床検査医学会標準化委員会   甲状腺刺激ホルモン(TSH)測定値のハーモナイゼーション  

    日本内分泌学会雑誌  2015.11  (一社)日本内分泌学会

     More details

    Language:Japanese  

  • 竹岡 啓子, 日高 洋, 菱沼 昭, 池田 勝義, 大久保 滋夫, 土屋 達行, 橋口 照人, 堀田 多恵子, 古田 耕, 松下 一之, 松本 祐之, 村上 正巳, 前川 真人, 日本臨床検査医学会標準化委員会   甲状腺刺激ホルモン(TSH)測定値のハーモナイゼーション  

    臨床病理  2015.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 橋口 照人, 前之園 隆一, 丸山 征郎   生活習慣病と和漢薬 漢方『脈診』の科学化の試み  

    Journal of Traditional Medicines  2006.8  (一社)和漢医薬学会

     More details

    Language:Japanese  

  • Binita Shrestha, 伊藤 隆史, 竹之内 和則, Sushil Panta, 郡山 豊泰, 古城 剛, 山口 宗一, 丸山 征郎, 橋口 照人   生体において免疫系を微調整する過程としての生理的な血球貪食作用(Physiological hemophagocytosis as a process of fine tuning immune system in vivo)  

    日本血栓止血学会誌  2015.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 笠畑 拓志, 高味 聡子, 政元 いずみ, 西川 拓朗, 橋口 照人   混合表現型急性白血病(MPAL、T/B)の1例  

    日本検査血液学会雑誌  2020.6  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • Yamakuchi Munekazu, Takenouchi Kazunori, Oyama Yoko, Hashiguchi Teruto   注目すべき病態と抗血栓療法の進歩-Notable pathophysiology and progress in antithrombotic therapy- 内皮細胞におけるvon Willebrand因子放出の調節(Regulation of von Willebrand factor release in endothelial cells)  

    日本血栓止血学会誌  2019.5  (一社)日本血栓止血学会

     More details

    Language:English  

  • 政元 いずみ, 谷口 眞由美, 田畑 仁美, 古園 千里, 松下 昌風, 橋口 照人, 児玉 祐一, 岡本 康裕, 河野 嘉文   治療経過中に細胞形質変化した小児白血病の1症例  

    Cytometry Research  2011.6  (一社)日本サイトメトリー学会

     More details

    Language:Japanese  

  • 外室 喜英, 舞木 弘幸, 尾前 歩, 原口 安江, 古川 良尚, 政元 いずみ, 松下 昌風, 橋口 照人, 堂地 勉, 折田 有史   母児間輸血症候群により血液型判定が困難となった症例  

    日本輸血細胞治療学会誌  2014.2  (一社)日本輸血・細胞治療学会

     More details

    Language:Japanese  

  • タンジャルーン・サランヤー , 松山 孝司, 川原 幸一, 名和 由布子, 橋口 照人, 和泉 雄一, 丸山 征郎   歯周炎症におけるアクアポリン3の役割(The Role of Aquaporin 3 in the Periodontal Inflammation)  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 橋口 照人   止血機能検査の理論的背景と臨床応用  

    日本血栓止血学会誌  2021.5  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 橋口 照人   止血機構オーバービュー  

    日本臨床検査自動化学会会誌  2012.9  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 橋口 照人   止血反応に仕組まれた初期設定(デフォルト)機構  

    日本検査血液学会雑誌  2017.6  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 池田 勝義, 大久保 滋夫, 松本 祐之, 松下 一之, 土屋 達行, 日高 洋, 康 東天, 橋口 照人, 前川 真人, 古田 耕   検査目的に適合した検体の質を確保するための検体保存評価法の検討【臨床検査医学会標準委員会】  

    臨床病理  2012.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 中島 一壽, 小森園 康二, 迫 勝巳, 柴藤 俊彦, 北薗 正樹, 田中 貞夫, 東 貞行, 大山 陽子, 竹之内 和則, 山口 宗一, 橋口 照人   未破裂肝細胞癌に対しマイクロスフィア塞栓後(DEB-TACE後)に肝切除を行った症例の病理学的検討  

    臨床化学  2019.8  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 細川 和也, 永里 朋香, 橋口 照人, 丸山 征郎   新規開発の血流下血栓形成能診断システム(T-TAS)を用いた血栓症の予知・予防への試み  

    臨床病理  2012.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 菊池 清志, 川原 幸一, Salunya Tancharoen, 松田 史代, 伊藤 隆史, Biswas Kamal K., 竹之内 和則, 大山 陽子, 名和 由布子, 三浦 直樹, 有村 昇, 孟 暁潔, Binita Shrestha, 田島 裕, 倉本 晃一, 中山 顕児, 重森 稔, 吉田 義弘, 橋口 照人, 丸山 征郎   新規脳梗塞のマーカー;HMGB1  

    臨床病理  2009.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 橋口 照人   新しい血栓止血関連検査と治療法への応用 自己免疫性後天性凝固因子欠乏症の診断と治療  

    日本検査血液学会雑誌  2021.8  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 橋口 照人, 竹之内 和則, 川原 幸一, 丸山 征郎   敗血症における血小板-白血球複合体とexhausted platelets  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 川原 幸一, 橋口 照人, 山口 宗一, 丸山 征郎, 川上 雅之   敗血症では好中球周囲に血小板が粘着して循環する Platelet Satellitismと2-AGの役割  

    エンドトキシン血症救命治療研究会誌  2002.12  (株)自然科学社

     More details

    Language:Japanese  

  • 中村 政敏, 佐藤 香奈子, 伊藤 隆史, 山口 桂司, 松下 昌風, 垣花 泰之, 橋口 照人   救急検査におけるTAT、total PAI-1の有用性の検討  

    日本臨床救急医学会雑誌  2016.4  (一社)日本臨床救急医学会

     More details

    Language:Japanese  

  • 川原 幸一, 橋口 照人, 菊池 清志, 森元 陽子, 名和 由布子, スレスタ・ビニタ , タンジャルーン・サランヤー , 大山 陽子, 丸山 征郎   拒絶反応制御の新たな標的分子 HMGB1  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 谷口 昇, 川原 幸一, 橋口 照人, 山口 宗一, 井尻 幸成, 松永 俊二, 小宮 節郎, 丸山 征郎   慢性関節リウマチの病態とHMG-1の役割  

    整形外科と災害外科  2002.5  西日本整形・災害外科学会

     More details

    Language:Japanese  

  • 本部 卓志, 谷口 昇, 平嶋 正樹, 橋口 照人, 内村 友則, 山口 宗一, 丸山 征郎, 小宮 節郎   慢性関節リウマチにおけるセレノプロテインPの関与  

    整形外科と災害外科  2001.5  西日本整形・災害外科学会

     More details

    Language:Japanese  

  • 大山 陽子, 郡山 豊泰, 川村 英樹, 徳田 浩一, 西 順一郎, 橋口 照人   患者情報を立体的かつ一元的に捉える感染症データベースシステムの構築  

    感染症学雑誌  2015.3  (一社)日本感染症学会

     More details

    Language:Japanese  

  • 橋口 照人   急性膵炎を併発したと思われる有機りん中毒の1症例  

    麻酔  1990.7  克誠堂出版(株)

     More details

    Language:Japanese  

  • 水上 尚子, 中村 幸美, 大園 七瀬, 小林 沙織, 湯之上 真吾, 前之園 隆一, 湯浅 敏典, 大山 陽子, 橋口 照人   心血管エコーと臨床検査 より価値ある診療支援を考える 肺塞栓症 心エコーおよび下肢静脈検査と血液凝固検査  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 松井 宏樹, 小島 聡子, 窪園 琢郎, 波野 史典, 前之園 隆一, 政元 いずみ, 大石 充, 橋口 照人   心疾患患者における握力と関連する生理機能検査項目の検討  

    日臨技九州支部医学検査学会  2018.10  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 大野 佳子, 山下 秀俊, 山下 義人, 蓑輪 一文, 平良 行雄, 前之園 隆一, 橋口 照人, 丸山 征郎   心理社会的因子が血管内皮細胞機能へ及ぼす影響評価とフォローアップ  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 波野 史典, 入来 泰久, 前之園 隆一, 市來 仁志, 桶谷 直也, 松下 昌風, 大石 充, 橋口 照人   心房細動基質に対するアブレーションにおけるCFAE鑑別ソフトウェアの至的設定  

    日臨技九州支部医学検査学会  2015.11  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 波野 真伍, 波野 史典, 小濱 祐行, 古城 剛, 前之園 隆一, 政元 いずみ, 山口 宗一, 橋口 照人   心房細動アブレーション治療における長期予後予測バイオマーカーの検討 血管内皮機能関連マーカーの可能性  

    日本検査血液学会雑誌  2020.6  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 波野 史典, 山口 宗一, 前之園 隆一, 入來 泰久, 二宮 雄一, 市來 仁志, 政元 いずみ, 大石 充, 堀内 正久, 橋口 照人, 丸山 征郎   心房細動アブレーション治療における可溶性トロンボモジュリンと循環miRNAの動態  

    臨床病理  2019.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 波野 史典, 山口 宗一, 前之園 隆一, 入來 泰久, 奥井 英樹, 市來 仁志, 大石 充, 橋口 照人   心房細動アブレーションにおける血管内皮機能変化と血清primary microRNAの関連究明  

    日本循環器学会学術集会抄録集  2018.3  (一社)日本循環器学会

     More details

    Language:Japanese  

  • Osaki Tsukasa, Souri Masayoshi, Ogawa Yoshiyuki, Kobayashi Keiko, Ieko Masahiro, Hashiguchi Teruto, Yamakuchi Munekazu, Ichinose Akitada, Japanese Collaborative Research Group on Autoimmune Hemorrhaphilia(supported by the Japanese Ministry of Health,Labor,and Welfare)   後天性血友病A(自己免疫性FVIII/8欠乏症)における抗第VIII/8因子(FVIII/8)自己抗体(Anti-factor VIII/8(FVIII/8) autoantibodies in acquired hemophilia A(autoimmune FVIII/8 deficiency))  

    臨床血液  2016.9  (一社)日本血液学会-東京事務局

     More details

    Language:English  

  • 有村 敏明, 迫田 晃郎, 橋口 照人   当院における有機リン中毒症例の検討  

    救急医学  1990.3  (株)へるす出版

     More details

    Language:Japanese  

  • 竹之下 友寿, 中村 政敏, 高手 恵美, 小濱 祐行, 田嶋 彩香, 政元 いずみ, 橋口 照人   当院における効率的な検査室運用を目指した総合臨床検査システム更新とその導入効果について  

    日本臨床検査自動化学会会誌  2019.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 川村 英樹, 郡山 豊泰, 古城 剛, 茂見 茜里, 大山 陽子, 徳田 浩一, 橋口 照人, 西 順一郎   当院におけるカルバペネム耐性腸内細菌科細菌の検出状況  

    感染症学雑誌  2015.3  (一社)日本感染症学会

     More details

    Language:Japanese  

  • 餅原 愛, 高味 聡子, 笠畑 拓志, 佐々木 ゆかり, 政元 いずみ, 橋口 照人, 鎌田 勇平, 石塚 賢治   当院で経験した芽球形質細胞様樹状細胞腫瘍(BPDCN)の一例  

    日臨技九州支部医学検査学会  2021.11  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 笠畑 拓志, 政元 いずみ, 高味 聡子, 田畑 仁美, 竹之下 友寿, 松下 昌風, 橋口 照人   当院で経験した組織球類縁疾患の2症例  

    日臨技九州支部医学検査学会  2016.10  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 笠畑 拓志, 高味 聡子, 田畑 仁美, 竹之下 友寿, 政元 いずみ, 橋口 照人   当院で経験した急性好塩基球性白血病の1例  

    日臨技九州支部医学検査学会  2017.10  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 中村 政敏, 宮内 恵美, 佐藤 香奈子, 伊藤 隆史, 山口 宗一, 政元 いずみ, 橋口 照人   当院でクロスミキシングテストが有用であった波形/数値 判定パターン解析について  

    日本臨床検査自動化学会会誌  2017.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 川村 英樹, 郡山 豊泰, 福山 竜子, 舞木 公子, 川畑 恵, 折田 美千代, 有村 尚子, 中村 隼人, 児玉 祐一, 藺牟田 直子, 政元 いずみ, 橋口 照人, 西 順一郎   当院ICUで発生した薬剤耐性Acinetobacter baumannii多発事例における検出菌株の解析  

    日本臨床微生物学会雑誌  2018.12  (一社)日本臨床微生物学会

     More details

    Language:Japanese  

  • 上野 健太郎, 野村 裕一, 益田 君教, 橋口 照人, 森田 康子, 櫨木 大祐, 江口 太助, 河野 嘉文   川崎病重症度評価における血小板血管内皮細胞増殖因子の有用性  

    日本小児循環器学会雑誌  2009.5  (NPO)日本小児循環器学会

     More details

    Language:Japanese  

  • 上野 健太郎, 野村 裕一, 櫨木 大祐, 江口 太助, 河野 嘉文, 橋口 照人, 益田 君教, 森田 康子   川崎病重症度評価における血小板血管内皮細胞増殖因子の有用性  

    日本小児科学会雑誌  2009.4  (公社)日本小児科学会

     More details

    Language:Japanese  

  • 上野 健太郎, 櫨木 大祐, 江口 太助, 野村 裕一, 河野 嘉文, 橋口 照人, 政元 いずみ, 益田 君教, 森田 康子   川崎病回復期における好中球減少症発症機序の検討  

    日本小児科学会雑誌  2009.1  (公社)日本小児科学会

     More details

    Language:Japanese  

  • 江口 太助, 野村 裕一, 荒田 道子, 櫨木 大祐, 上野 健太郎, 河野 嘉文, 橋口 照人, 丸山 征郎, 益田 君教   川崎病におけるHigh mobility group box 1値の検討  

    Progress in Medicine  2008.1  (株)ライフ・サイエンス

     More details

    Language:Japanese  

  • 江口 太助, 櫨木 大祐, 荒田 道子, 上野 健太郎, 野村 裕一, 河野 嘉文, 益田 君教, 橋口 照人, 丸山 征郎   川崎病におけるHigh mobility group box 1(HMGB-1)値の検討  

    日本小児科学会雑誌  2007.12  (公社)日本小児科学会

     More details

    Language:Japanese  

  • Kosai Kenichiro, Nagano Satoshi, Ijichi Nobuhiro, Futagawa Toshitaka, Sumi Eriko, Yamaguchi Munekazu, Nakajo Masanori, Hashiguchi Teruto, Takeda Yasuo, Yoshiura Takashi, Shimizu Akira, Takatani Muneo, Komiya Setsuro   小児固形腫瘍に対する遺伝子細胞療法の新展開 独自開発の腫瘍溶解性ウイルスSurv.-m-CRAのFirst-in-human医師主導治験と実用化の展望  

    日本小児血液・がん学会雑誌  2018.10  (一社)日本小児血液・がん学会

     More details

    Language:Japanese  

  • 古城 剛, 郡山 豊泰, 川村 英樹, 大山 陽子, 茂見 茜里, 徳田 浩一, 久保田 知洋, 児玉 祐一, 山遠 剛, 藺牟田 直子, 橋口 照人, 西 順一郎   小児入院患者の血液培養で検出されたBrevibacterium caseiの検討  

    感染症学雑誌  2015.3  (一社)日本感染症学会

     More details

    Language:Japanese  

  • 丸山 英樹, 茨 聡, 加藤 英二, 丸山 有子, 池江 隆正, 前出 喜信, 丸古 慶子, 楠元 雅寛, 後藤 俊二, 吉田 瑞穂, 小池 浩文, 立石 洋子, 田畑 実香, 加藤 博美, 宇都 博文, 小林 洋子, 丸山 征郎, 橋口 照人   小児・新生児に対する血液浄化 脳室周囲白質軟化症(PVL)と臍帯血中内因性cannabinoid濃度の高値  

    エンドトキシン血症救命治療研究会誌  2003.12  (株)自然科学社

     More details

    Language:Japanese  

  • 橋口 照人, 奥 寛子, 有村 公良, 納 光弘, 徳永 久理子, 出口 尚寿, 牧角 寛郎   学校検尿にて発見されたI型糖尿病の2症例  

    糖尿病  2000.8  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 政元 いずみ, 谷口 眞由美, 田畑 仁美, 松下 昌風, 橋口 照人   好中球上のCD10の発現低下を認めた症例  

    Cytometry Research  2012.6  (一社)日本サイトメトリー学会

     More details

    Language:Japanese  

  • 上田 英昭, 山口 宗一, 松本 和久, 竹之内 和則, 大山 陽子, 橋口 照人, 井本 浩   大動脈弁狭窄症に対する大動脈弁置換術前後での末梢血、凝固系の検討  

    日本臨床検査自動化学会会誌  2019.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 上田 英昭, 山口 宗一, 竹之内 和則, 大山 陽子, 井本 浩, 橋口 照人   大動脈弁狭窄症における弁置換術前後の末梢血の推移  

    臨床化学  2018.7  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 上田 英昭, 松本 和久, 向原 公介, 重久 喜哉, 立石 直毅, 井本 浩, 山口 宗一, 橋口 照人   大動脈弁狭窄症における弁置換術前後の末梢血の推移  

    日本外科学会定期学術集会抄録集  2018.4  (一社)日本外科学会

     More details

    Language:Japanese  

  • 松室 健士, 橋口 照人, 有村 公良, 納 光弘, 丸山 征郎   培養脳微小血管内皮細胞のバリアー機能に対するvascular endothelial growth factor(VEGF)の影響  

    臨床神経学  1999.1  (一社)日本神経学会

     More details

    Language:Japanese  

  • 東 貞行, 山口 宗一, 竹之内 和則, 大山 陽子, 橋口 照人   臨床検査専門医プログラムを選択して 現在の研修風景  

    臨床病理  2019.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 中村 政敏, 竹之下 友寿, 田之上 三喜恵, 宮内 恵美, 田畑 仁美, 佐藤 香奈子, 政元 いずみ, 松下 昌風, 橋口 照人   臨床検査システムCLALISを活用したISO15189認定の維持  

    日本臨床検査自動化学会会誌  2013.9  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 橋口 照人   臨床化学の若い力で発信しつつある新たな検査、病態解析法 生体蛋白質のnon-homeostatic degradation解析による病態予知診断 次世代検査医学への応用を目指して  

    臨床化学  2009.7  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 東 貞行, 藤崎 知園子, 郡山 豊泰, 川畑 恵, 小濱 祐行, 福山 竜子, 舞木 公子, 佐藤 香奈子, 中村 政畝, 政元 いずみ, 田上 聖徳, 大山 陽子, 竹之内 和則, 山口 宗一, 橋口 照人   呼吸器糸状菌感染症の簡便な検出率改善への試み  

    日本臨床検査医学会誌  2021.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • Aryal Bibek, Shimizu Toshiaki, Kadono Jun, Furoi Akira, Gejima Kentaro, Komokata Teruo, Koriyama Chihaya, Yamakuchi Munekazu, Hashiguchi Teruto, Imoto Yutaka   周術期血清中PDGF-BB濃度により切除後HCC再発患者を明らかにする(Perioperative Serum PDGF-BB Concentrations Characterize Patients with Post- Resection HCC Recurrence)  

    日本肝胆膵外科学会・学術集会プログラム・抄録集  2018.6  (一社)日本肝胆膵外科学会

     More details

    Language:English  

  • 川村 英樹, 徳田 浩一, 宮之原 弘晃, 藺牟田 直子, 松元 一明, 茂見 茜里, 橋口 照人, 西 順一郎, 折田 美千代, 善明 美千久, 小宮 節郎   同一患者におけるMRSA術前鼻腔保菌株と術後手術部位検出株の遺伝子型の比較  

    感染症学雑誌  2011.9  (一社)日本感染症学会

     More details

    Language:Japanese  

  • 川村 英樹, 徳田 浩一, 宮之原 弘晃, 藺牟田 直子, 松元 一明, 茂見 茜里, 橋口 照人, 西 順一郎, 鹿児島大学病院インフェクションコントロールチーム   同一患者におけるMRSA術前鼻腔保菌株と術後手術部位検出株の遺伝子型の比較  

    感染症学雑誌  2011.3  (一社)日本感染症学会

     More details

    Language:Japanese  

  • Tancharoen Salunya, Sarikaphuti Ariya, Kikuchi Kiyoshi, Hashiguchi Teruto, Maruyama Ikuro   口腔癌におけるソニックヘッジホッグシグナル伝達経路に対するOryza sativa L.由来のcyanidin-3-glucosideの効果(The effect of cyanidin-3-glucoside from Oryza sativa L. on the sonic hedgehog signaling pathway in oral cancer)  

    日本癌学会総会記事  2013.10  (一社)日本癌学会

     More details

    Language:English  

  • 伊藤 隆史, 永里 朋香, 細川 和也, 橋口 照人, 丸山 征郎   単一分子、細胞レベルの血小板フィブリン血栓形成とその溶解過程を目撃しよう! 血小板血栓形成過程の可視化とその臨床的意義  

    日本生化学会大会プログラム・講演要旨集  2016.9  (公社)日本生化学会

     More details

    Language:English  

  • 川原 幸一, 橋口 照人, 山口 宗一, 阿辺山 和浩, 鮫島 由規則, 丸山 征郎   動脈硬化と血栓形成の最新のトピックス Platelet satellitism 血小板・白血球複合体と血管病  

    動脈硬化  2002.6  (一社)日本動脈硬化学会

     More details

    Language:Japanese  

  • 有村 昇, 山下 敏史, 中尾 久美子, 橋口 照人, 坂本 泰二   前房水中VEGF濃度測定を行ったPOEMS症候群の一例  

    日本眼科学会雑誌  2012.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 東 桂子, 新山 尚仁, 白石 匡史, 樋口 逸郎, 有村 公良, 納 光弘, 橋口 照人   出血傾向・知能低下を伴うミオパチーに認めた線維芽細胞のthrombomodulin(TM)発現亢進  

    臨床神経学  2004.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 家子 正裕, 小宮山 豊, 橋口 照人   凝固検査検体取扱いに関するコンセンサスの重要性の再確認と問題点  

    日本検査血液学会雑誌  2021.8  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 川原 幸一, 橋口 照人, 丸山 征郎   凝固制御研究の新展開 致死性因子HMGB1はDICのポテンシエーターとして働く  

    日本血栓止血学会誌  2006.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 竹之内 和則, 永里 朋香, 清水 利明, 丸山 征郎, 橋口 照人   内臓平滑筋human VEGF-A発現マウスにおける膵インスリン陽性細胞の構築変化  

    臨床病理  2012.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • カマル・K・ビスワズ , 川原 幸一, シャーカ・K・パダ , 鵜島 雅子, 阿邊山 和浩, 橋口 照人, 丸山 征郎   内因性カンナビノイドがHMGB1の遊離を誘導する  

    Shock: 日本Shock学会雑誌  2005.4  (一社)日本Shock学会

     More details

    Language:Japanese  

  • 山路 加津代, カマル・クリシェナ・ビスワズ , シャーカー・クリシェナ・パダ , 山口 宗一, 橋口 照人, 丸山 征郎   内因性カンナビノイド アナンダマイドの向アポトーシス作用  

    エンドトキシン血症救命治療研究会誌  2002.12  (株)自然科学社

     More details

    Language:Japanese  

  • 中村 政敏, 田之上 三喜恵, 宮内 恵美, 佐藤 香奈子, 松下 昌風, 橋口 照人   免疫検査におけるマルチコントロールの有用性の評価 ISO15189を考慮した新たな挑戦  

    日本臨床検査自動化学会会誌  2014.9  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 橋口 照人, 伊藤 隆史, スレスタ・ビニタ , 三浦 直樹, 丸山 征郎   免疫B細胞発現VEGF-Aによるリンパ節リモデリングと免疫環境の機能的制御  

    日本血栓止血学会誌  2012.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 橋口 照人, 野口 慶久, 有吉 聡子, 楢原 真二, 黒木 辰雄, 丸山 征郎   健康と臨床化学 スタチン時代の高脂血症 遅れてやってきた危険因子  

    臨床化学  2001.6  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 川原 幸一, 岩田 政弘, 橋口 照人, 金蔵 哲郎, 丸山 征郎   低線量UVB照射HaCaT細胞に対するトロンボモジュリンの細胞保護作用(Thrombomodulin exerts cytoprotective effect on low-dose UVB-irradiated HaCaT cells)  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • Higashi Yuko, Yamakuchi Munekazu, Fukushige Tomoko, Hashiguchi Teruto, Kanekura Takuro   乾癬のマーカーとしての好中球中microRNA(MicroRNAs in neutrophils as markers of psoriasis)  

    日本研究皮膚科学会年次学術大会・総会プログラム  2021.12  (一社)日本研究皮膚科学会

     More details

    Language:English  

  • Higashi Yuko, Yamakuchi Munekazu, Fukushige Tomoko, Hashiguchi Teruto, Kanekura Takuro   マウスにおいて高脂肪食はイミキモドにより誘発される乾癬様皮膚病変をIL-17Aとインフラフマソームの誘導を介して悪化させる(High fat diet exacerbates psoriasis-like skin lesion induced by imiquimod through inducing IL-17A and inflammasomes in mice)  

    日本研究皮膚科学会年次学術大会・総会プログラム  2016.12  (一社)日本研究皮膚科学会

     More details

    Language:English  

  • 山口 宗一, 清水 利昭, 竹ノ内 和則, 大山 陽子, 橋口 照人   マイクロRNAによる直腸がん細胞の低酸素応答制御  

    臨床病理  2013.9  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 山口 宗一, 清水 利昭, 竹ノ内 和則, 大山 陽子, 伊藤 隆史, 丸山 征郎, Lowenstein Charles, 橋口 照人   マイクロRNAによる直腸がんの血管新生制御機構の解明  

    日本血栓止血学会誌  2014.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 上田 英昭, 山口 宗一, 大川 政士, 松本 和久, 向原 公介, 今釜 逸美, 重久 喜哉, 豊川 建二, 橋口 照人, 曽我 欣治   マイクロRNA-218はFOXO3を介し血管平滑筋細胞を石灰化に誘導する  

    日本胸部外科学会定期学術集会  2021.10  (一社)日本胸部外科学会

     More details

    Language:Japanese  

  • 末竹 真子, 中村 政敏, 宮内 恵美, 谷口 眞由美, 佐藤 香奈子, 松下 昌風, 橋口 照人   プロカルシトニンの基礎的検討と血液培養の一致率の検証について 24時間運用に向けて  

    日臨技九州支部医学検査学会  2016.10  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 菊池 清志, 川原 幸一, 松田 史代, Tancharoen Salunya, 森元 陽子, 伊藤 隆史, 名和 由布子, 山下 伸, 折戸 公彦, 宮城 知也, 広畑 優, 徳富 孝志, 重森 稔, 吉田 義弘, 橋口 照人, 丸山 征郎   フリーラジカルスカベンジャーの効果と新規治療法の可能性  

    日本脳神経外科学会総会CD-ROM抄録集  2007.10  (一社)日本脳神経外科学会

     More details

    Language:Japanese  

  • 名和 由布子, 升田 好樹, 今泉 均, 巽 博臣, 吉田 真一郎, 北 飛鳥, 藤本 俊一, 後藤 京子, 川原 幸一, 橋口 照人, 丸山 征郎   ヒト組み換え型トロンボモジュリンによる敗血症性DIC治療効果の検討  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 池田 勝義, 大久保 滋夫, 松下 一之, 松本 祐之, 日高 洋, 康 東天, 橋口 照人, 土屋 達行, 古田 耕, 前川 真人   ヒト液性試料の質 検査や解析に適正な試料を得るために 検査目的に適合した検体の質を確保するための検体保存評価法の検討 標準化委員会プロジェクト報告  

    臨床病理  2013.9  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 池田 勝義, 大久保 滋夫, 松下 一之, 松本 祐之, 日高 洋, 康 東天, 橋口 照人, 土屋 達行, 古田 耕, 前川 真人   ヒト液性試料の質 検査や解析に適正な試料を得るために 検査目的に適合した検体の質を確保するための検体保存評価法の検討 標準化委員会プロジェクト報告  

    臨床病理  2015.1  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 川原 幸一, 菊池 清志, 岩田 政宏, 伊藤 隆史, 瀬戸山 健太郎, 上村 亮三, 大山 陽子, 竹之内 和則, カマル・クリシュナン・ビシュワズ , 清水 利昭, 名和 由布, 孟 暁潔, サランヤータンジャロン , ビニタスレスタ , 有村 昇, 三浦 直樹, 高尾 尊身, 橋口 照人, 丸山 征郎   ヒトリンパ細胞はブタ内皮細胞を標的・活性化しHigh Mobility Group Box 1(HMGB1)を発現誘導する  

    移植  2007.6  (一社)日本移植学会

     More details

    Language:Japanese  

  • 川原 幸一, 菊池 清志, 岩田 政弘, 名和 由布子, スレスタ・ビニタ , 橋口 照人, 高尾 尊身, 丸山 征郎   ヒトリンパ細胞はブタ内皮細胞を標的・活性化しHigh Mobility Group Box 1(HMGB1)を発現誘導する  

    臨床病理  2009.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 米良 健太郎, 川原 幸一, 橋口 照人, 河井 一浩, 丸山 征郎, 金蔵 拓郎   ヒトケラチノサイトを環境線量UVBから保護するためのERシグナル活性化(ER signaling is activated to protect human keratinocytes from environmental doses of UVB)  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • Aryal Bibek, Shimizu Toshiaki, Kadono Jun, Furoi Akira, Yamakuchi Muneazu, Komokata Teruo, Hashiguchi Teruto, Imoto Yutaka   ヒトの部分肝切除後の肝再生中における血小板介在性血管新生(Platelet Mediated Angiogenesis During Liver Regeneration After Partial Hepatectomy in Humans)  

    日本肝胆膵外科学会・学術集会プログラム・抄録集  2015.6  (一社)日本肝胆膵外科学会

     More details

    Language:English  

  • 有村 真一郎, 川原 幸一, 伊藤 隆史, 田畑 雅士, ビシュワズ・クリシュナ・カマル , 尾込 大介, 松崎 典弥, 加藤 真哉, 杉原 一正, 明石 満, 橋口 照人, 丸山 征郎   ハイドロキシアパタイト/アガロースゲル(HA/agarose)の止血効果について  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 名和 由布子, 川原 幸一, タンジャルーン・サランヤー , 橋口 照人, 丸山 征郎   ヌクレオフォスミンはalarminか?  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 名和 由布子, 川原 幸一, 橋口 照人, 今泉 均, 丸山 征郎   ヌクレオフォスミンはalarmins/DAMPsか?!  

    日本救急医学会雑誌  2008.8  (一社)日本救急医学会

     More details

    Language:Japanese  

  • 岩田 政宏, 川原 幸一, 川畑 久, 橋口 照人, 丸山 征郎, 金蔵 拓郎   トロンボモジュリンは低用量UVB照射から表皮角化細胞を保護する  

    日本研究皮膚科学会年次学術大会・総会プログラム  2007.4  (一社)日本研究皮膚科学会

     More details

    Language:Japanese  

  • 岩田 政宏, 川原 幸一, 川畑 久, 東 裕子, 金蔵 拓郎, 伊藤 隆史, 菊池 清志, 橋口 照人, 丸山 征郎   トロンボモジュリンは低用量UVB照射から表皮角化細胞を保護する  

    西日本皮膚科  2008.10  日本皮膚科学会-西部支部

     More details

    Language:Japanese  

  • Iwata Masahiro, Kawahara Ko-ichi, Kawabata Hisashi, Hashiguchi Teruto, Maruyama Ikuro, Kanekura Takuro   トロンボモジュリンは低用量UVBに対してヒト表皮ケラチノサイトを保護する(Thrombomodulin protects human epidermal keratinocytes against low dose UVB)  

    Journal of Dermatological Science  2007.7  エルゼビア・ジャパン(株)

     More details

    Language:English  

  • 伊藤 隆史, 川原 幸一, 岡本 好司, 橋口 照人, 丸山 征郎   トロンボモジュリンの新しい抗炎症作用 HMGB1の分画と分解(The novel anti-inflammatory mechanism of thrombomodulin: sequestration and degradation of HMGB1)  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 川原 幸一, 伊藤 隆史, 岡本 好司, 安田 峰次, 橋口 照人, 丸山 征郎   トロンビン-トロンボモジュリン複合体によるHMGB1(High Mobility Group Box 1)の蛋白質分解的切断(Proteolytic Cleavage of High Mobility Group Box 1 by Thrombin-Thrombomodulin Complexes)  

    日本血栓止血学会誌  2008.10  (一社)日本血栓止血学会

     More details

    Language:English  

  • Tada Ko-ichi, Kawahara Ko-ichi, Matsushita Shigeto, Mera Kentaro, Hashiguchi Teruto, Kawai Kazuhiro, Maruyama Ikuro, Kanekura Takuro   トリテルペノイドを含有するウメ抽出物MK615は悪性黒色腫細胞と悪性黒色腫患者においてアポトーシスを誘導する(MK615, a Japanese apricot extract containing triterpenoids, induces apoptosis in malignant melanoma cells and a patient with malignant melanoma)  

    日本研究皮膚科学会年次学術大会・総会プログラム  2009.12  (一社)日本研究皮膚科学会

     More details

    Language:English  

  • 伊藤 隆史, 山田 晋吾, 橋口 照人, 丸山 征郎   ダメージ関連分子パターン(DAMPs)の解析と応用展開  

    臨床病理  2020.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 出口 尚寿, 宇都 正, 徳永 久理子, 奥 寛子, 有村 公良, 納 光弘, 橋口 照人, 堀之内 秀治   ステロイド糖尿病に対するナテグリニドの有用性  

    糖尿病  2003.2  (一社)日本糖尿病学会

     More details

    Language:Japanese  

  • 山本 英彦, 名取 省一, 阿部 紀代美, 橋口 照人, 丸山 征郎, 田中 宏暁   ステップ運動を用いた生活習慣病予防・改善プログラム  

    人間ドック  2006.8  (公社)日本人間ドック学会

     More details

    Language:Japanese  

  • 白石 匡史, 樋口 逸郎, 橋口 照人, 末原 雅人, 丸山 征郎, 有村 公良   コラーゲンVI欠損UCMD患者の皮膚線維芽細胞に対するthrombomodulinの作用  

    臨床神経学  2009.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 菅野 光俊, 松本 剛, 橋口 照人   ウィズコロナ社会における臨床検査医学教育の重要性 SARS-CoV-2検査室の最前線から求める医学教育への期待  

    日本臨床検査医学会誌  2021.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 中島 結実子, 森元 陽子, 古市 保志, 橋口 照人, 川原 幸一, 丸山 征郎, 和泉 雄一   アナンダマイド/CB1,CB2レセプターシステムによる歯周病態制御  

    炎症・再生  2005.7  (一社)日本炎症・再生医学会

     More details

    Language:Japanese  

  • 橋口 照人, 前之園 隆一, 大野 佳子, 川原 幸一, 斉藤 和人, 丸山 征郎   『NO抵抗性の概念』の提案  

    日本血栓止血学会誌  2008.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 永里 朋香, 尾田 悠, 細川 和也, 橋口 照人, 丸山 征郎   「血栓傾向の診断は可能か?」血流下血栓形成能解析システムT-TASを用いた試み  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 橋口 照人, 前之園 隆一, 大野 佳子, 川原 幸一, 斉藤 和人, 丸山 征郎   「NO抵抗性」の概念  

    臨床病理  2009.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 岩城 宏之, 樋口 逸郎, 中川 正法, 大窪 隆一, 迫田 俊一, 橋口 照人, 有村 公良, 納 光弘   γ-Sarcoglycan(LGMD2C)欠損症における分子遺伝学的及び免疫組織化学的検討  

    臨床神経学  2000.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 渡邊 修, 橋口 照人, 有村 公良, 松室 健士, 納 光弘, 西 順一郎, 丸山 征郎   VEGFのisoform Crow-Fukase症候群とCastleman病の比較検討  

    臨床神経学  1999.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • スレスタ・ビニタ , 橋口 照人, 伊藤 隆史, 三浦 直樹, 竹之内 和則, 大山 陽子, 川原 幸一, タンジャルーン・サランヤー , 貴井 裕哉, 有村 昇, 吉永 就正, 野間 聖, 二反田 隆夫, 北島 信一, 有村 公良, 佐藤 正宏, 坂本 泰二, 丸山 征郎   VEGF-Aの免疫調節的役割(Immunomodulatory role of VEGF-A)  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 中村 政敏, 宮内 恵美, 佐藤 香奈子, 松下 昌風, 橋口 照人   STACIA専用試薬「ステイシアCLEIA TAT」「LPIA・tPAIテスト」「エルピアF-XIII」の性能評価と有用性の検討  

    生物試料分析  2016.1  (NPO)生物試料分析科学会

     More details

    Language:Japanese  

  • 川上 雅之, 垣花 泰之, 上村 裕一, 川原 幸一, 山口 宗一, 橋口 照人, 丸山 征郎   Septic shockにおけるPlatelet Satellitismとendocannabinoidsの役割  

    日本救急医学会雑誌  2002.9  (一社)日本救急医学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 川原 幸一, 中村 隆広, 山田 晋吾, 阿辺山 和浩, 橋口 照人, 丸山 征郎   Sepsis治療研究の最先端 死のメディエーター HMGB1は凝固反応を加速させ、DICを増悪させる  

    エンドトキシン血症救命治療研究会誌  2006.12  (株)自然科学社

     More details

    Language:Japanese  

  • 山口 宗一, 副島 健太郎, 奥浦 正弘, 橋口 照人, 丸山 征郎   SAGE法を用いた高血糖下の単球,マクロファージの遺伝子発現の検討  

    臨床病理  2001.7  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 花田 浩一, 徳永 秀明, 成迫 智子, 法化図 陽一, 徳永 久理子, 橋口 照人, 有村 公良   POEMS症候群に対する長期的MP療法の有用性の検討  

    神経治療学  2002.5  (一社)日本神経治療学会

     More details

    Language:Japanese  

  • Umehara Fujio, Michizono Kumiko, Hashiguchi Teruto, Arimura Kimiyoshi, Fujimoto Noboru, Okada Yasunori, Osame Mitsuhiro   POEMS症候群においてMMP-1,-2,-3,-9及びTIMP-1の血中レベルは上昇する(Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome)  

    The Keio Journal of Medicine  2001.10  慶應義塾大学医学部

     More details

    Language:English  

  • 道園 久美子, 梅原 藤雄, 橋口 照人, 渡邊 修, 有村 公良, 納 光弘   POEMS syndromeにおけるマトリックスメタロプロテイナーゼ(Matrix Metalloproteinase;MMP)の検討  

    臨床神経学  2000.12  (一社)日本神経学会

     More details

    Language:Japanese  

  • 道園 久美子, 梅原 藤雄, 橋口 照人, 有村 公良, 岡田 保典, 藤本 昇, 納 光弘   POEMS syndromeでは血中VEGFとTIMP-1は相関する  

    臨床神経学  2001.11  (一社)日本神経学会

     More details

    Language:Japanese  

  • 荒畑 創, 西浦 義博, 佐藤 賀昭, 千原 純一, 池田 喜彦, 大島 孝一, 菊池 昌弘, 橋口 照人, 有村 公良, 中村 龍文   POEMS syndrome1例における腹水中VEGFの検討  

    臨床神経学  1999.4  (一社)日本神経学会

     More details

    Language:Japanese  

  • 橋口 照人, 川原 幸一, 丸山 征郎, 李 良子, 田中 憲次   PMX-DHPによる炎症制御機序のUp-date Degradation of non-hemostatic molecules in the state of DIC/MOF  

    エンドトキシン血症救命治療研究会誌  2008.10  (株)自然科学社

     More details

    Language:Japanese  

  • 大塚 寛樹, 有村 昇, 喜井 裕哉, 山切 啓太, 土居 範仁, 橋口 照人, 丸山 征郎, 坂本 泰二   PDRに対するBevacizumab、TA投与による硝子体中サイトカイン濃度  

    日本眼科学会雑誌  2008.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 菊池 清志, 宮城 尚久, 川原 幸一, 倉本 晃一, 森元 陽子, 三浦 直樹, 橋口 照人, 丸山 征郎, 重森 稔   PC12細胞におけるHMGB1の効果(The effect of HMGB1 in PC12 cells)  

    Brain Tumor Pathology  2011.5  日本脳腫瘍病理学会

     More details

    Language:Japanese  

  • 菊池 清志, 川原 幸一, ビシュワズ・クリシュナ・カマル , 伊藤 隆史, 三浦 直樹, 森元 陽子, 田島 裕, 倉本 晃一, 中山 顕児, 橋口 照人, 丸山 征郎, 重森 稔   PC12細胞におけるHMGB1に対するミノサイクリンの作用(The effect of Minocycline on HMGB1 in PC12 cells)  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 吉永 就正, 有村 昇, 大塚 寛樹, 竹之内 和則, 貞村 ゆかり, 野間 聖, 川原 幸一, 園田 祥三, 橋口 照人, 丸山 征郎, 坂本 泰二   NSAIDs点眼による脈絡膜血管新生抑制  

    日本眼科学会雑誌  2011.4  (公財)日本眼科学会

     More details

    Language:Japanese  

  • 吉永 就正, 有村 昇, 園田 祥三, 竹之内 和則, 野間 聖, 川原 幸一, 橋口 照人, 丸山 征郎, 坂本 泰二   NSAIDsによる網膜色素上皮株における抗酸化タンパク質誘導  

    日本眼科学会雑誌  2010.3  (公財)日本眼科学会

     More details

    Language:Japanese  

  • Koriyama Toyoyasu, Yamakuchi Munekazu, Kojo Tsuyoshi, Fukuyama Ryuko, Matsushita Masakaze, Hashiguchi Teruto   Legionella pneumophila感染症におけるマイクロRNAの測定の意義(The significance of miRNA measurement in Legionella pneumophilia infection)  

    医学検査  2015.5  (一社)日本臨床衛生検査技師会

     More details

    Language:English  

  • 郡山 豊泰, 山口 宗一, 竹之内 和則, 大山 陽子, 清水 利昭, 松下 昌風, 橋口 照人   L.pneumophila感染単核球系細胞におけるmiRNA解析  

    臨床病理  2015.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 山口 宗一, 郡山 豊泰, 古城 剛, 竹之内 和則, 清水 利昭, 大山 陽子, 松下 昌風, 橋口 照人   L.pneumophila感染マクロファージ系細胞におけるmiRNAの役割  

    日本血栓止血学会誌  2016.5  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • Binita Shrestha, 伊藤 隆史, 郡山 豊泰, 竹之内 和則, 大山 陽子, 清水 利昭, 山口 宗一, 丸山 征郎, 橋口 照人   in vivoにおける免疫系のきめ細かな調節過程としての血球貪食(Hemophagocytosis as a process of fine tuning immune system in vivo)  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 川原 幸一, Biswas Kamal K., 菊池 清志, 橋口 照人, 丸山 征郎   HMGB1研究の最前線 HMGB1-CRP枢軸 細胞壊死アラーミンから急性反応性シグナルへのシフト  

    エンドトキシン血症救命治療研究会誌  2008.10  (株)自然科学社

     More details

    Language:Japanese  

  • 清水 利昭, 竹之内 和則, 郡山 豊泰, 古城 剛, 山口 宗一, 橋口 照人   HMGB1は炎症性のアディポサイトカインでインスリンシグナルを阻害する  

    臨床病理  2014.10  (一社)日本臨床検査医学会

     More details

    Language:Japanese  

  • 清水 利昭, 山口 宗一, 竹之内 和則, 丸山 征郎, 橋口 照人   HMGB1は大型脂肪細胞から分泌される炎症性のアディポサイトカインでありインスリン抵抗性を誘導する  

    臨床化学  2015.10  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 川原 幸一, 中村 隆広, 阿辺山 和浩, 山田 晋吾, 有村 真一郎, 橋口 照人, 丸山 征郎   HMGB1はトロンボモジュリン・プロテインC経路を抑制し、DIC促進因子として働く  

    臨床血液  2006.9  (一社)日本血液学会-東京事務局

     More details

    Language:Japanese  

  • 菊池 清志, 川原 幸一, びしゅわず・かまるくりしゅなん , 伊藤 隆史, 三浦 直樹, たんじぇろん・さらんやー , 森元 陽子, 田島 裕, 倉本 晃一, 中山 顕児, 橋口 照人, 丸山 征郎, 重森 稔   HMGB1に対するミノサイクリンの効果  

    日本生化学会大会プログラム・講演要旨集  2009.9  (公社)日本生化学会

     More details

    Language:Japanese  

  • 川原 幸一, 橋口 照人, 伊藤 隆史, 菊池 清志, 森元 陽子, 清水 利昭, 大山 陽子, 竹之内 和則, 有村 真一郎, 岩田 政宏, 名和 由布子, 孟 暁潔, 丸山 征郎   HMGB1によるVEGF産生刺激 シグナル伝達と敗血症病態への関与  

    日本血栓止血学会誌  2006.10  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • 川原 幸一, 橋口 照人, 伊藤 隆史, 菊池 清志, 森元 陽子, カマル・K・ビスワス , 大山 陽子, 清水 利昭, 竹之内 和則, 喜井 裕哉, 有村 真一郎, 丸山 征郎   HMGB1 HMGB1によるVEGF産生刺激 シグナル伝達と敗血症病態への関与  

    エンドトキシン血症救命治療研究会誌  2006.12  (株)自然科学社

     More details

    Language:Japanese  

  • カマル・K・ビジュアズ , 川原 幸一, シャーカ・K・パダ , 鵜島 雅子, 阿邊山 和浩, 橋口 照人, 丸山 征郎   HMGB-1 内因性カンナビノイドによるHMGB-1の遊離とそのシグナル伝達機構  

    エンドトキシン血症救命治療研究会誌  2005.12  (株)自然科学社

     More details

    Language:Japanese  

  • 川原 幸一, Biswas Kamal Krishna, 伊藤 隆史, 橋口 照人, 丸山 征郎   HMGB-1 CRPはp38 MAPKを介してHMGB-1を放出する  

    エンドトキシン血症救命治療研究会誌  2005.12  (株)自然科学社

     More details

    Language:Japanese  

  • 森岡 洋史, 橋口 照人   HIV抗体陽性が判明した学生の支援を経験して  

    CAMPUS HEALTH  2009.2  (公社)全国大学保健管理協会

     More details

    Language:Japanese  

  • 川原 幸一, カマル・K・ビスワズ , 伊藤 隆史, 橋口 照人, 丸山 征郎   CRPはp38MAPKを介してHMGB1を放出する  

    Shock: 日本Shock学会雑誌  2005.4  (一社)日本Shock学会

     More details

    Language:Japanese  

  • 川原 幸一, Biswas Kamal Krishna, 伊藤 隆史, 清水 利昭, 大山 陽子, 森元 陽子, 菊池 清志, 橋口 照人, 丸山 征郎   CRPがp38MAPKを介してHMGB1を細胞外に放出する  

    臨床化学  2005.10  (一社)日本臨床化学会

     More details

    Language:Japanese  

  • 今村 智美, 柳 正和, 柚木 健太朗, 橋口 照人   HIV感染症患者に発症した急速増大を呈したG-CSF産生性右上葉巨大腫瘤の1例  

    肺癌  2021.6  (NPO)日本肺癌学会

     More details

    Language:Japanese  

  • ビベック・アリアル , 清水 利昭, 山口 宗一, 門野 潤, 菰方 輝夫, 風呂井 彰, 橋口 照人, 井本 浩   HCCと肝再生における血小板由来VEGF-Aの両義的機能(A bidirectional role of platelet sequestered VEGF-A in HCC and liver regeneration)  

    臨床病理  2015.10  (一社)日本臨床検査医学会

     More details

    Language:English  

  • 政元 いずみ, 谷口 眞由美, 田畑 仁美, 松下 昌風, 橋口 照人   FCMによるnormal pathwayとの比較から見える骨髄異型成  

    日本検査血液学会雑誌  2012.6  (一社)日本検査血液学会

     More details

    Language:Japanese  

  • Mera Kentaro, Kawahara Ko-ichi, Hashiguchi Teruto, Kawai Kazuhiro, Maruyama Ikuro, Kanekura Takuro   ERシグナル伝達はヒトケラチノサイトをUVB誘発性ERストレスから保護するために活性化される(ER signaling is activated to protect human keratinocytes from UVB-induced ER stress)  

    日本研究皮膚科学会年次学術大会・総会プログラム  2009.12  (一社)日本研究皮膚科学会

     More details

    Language:English  

  • 菊池 清志, 川原 幸一, 宮城 尚久, 倉本 晃一, 森元 陽子, 三浦 直樹, 橋口 照人, 丸山 征郎, 重森 稔   虚血条件下での神経様細胞におけるエダラボンのHMGB1に対する効果  

    日本脳神経外傷学会プログラム・抄録集  2011.3  (一社)日本脳神経外傷学会

     More details

    Language:English  

  • 山口 宗一, 向原 公介, 上田 英昭, 大川 政士, 松本 和久, 竹之内 和則, 大山 陽子, 東 貞行, 藤崎 知園子, 井本 浩, 橋口 照人   血中microRNA-126と血小板VEGF-Aの相互関連性についての検討  

    医療検査と自動化  2021.8  (一社)日本医療検査科学会

     More details

    Language:Japanese  

  • 中村 政敏, 竹之下 友寿, 佐藤 香奈子, 松下 昌風, 竹之内 和則, 大山 陽子, 佐々木 健, 内門 泰斗, 夏越 祥次, 橋口 照人   血小板VEGF-Aの推計による血小板の質の評価 血小板の質は凝集能以外の側面からもダイナミックに変化する  

    生物試料分析  2013.1  (NPO)生物試料分析科学会

     More details

    Language:Japanese  

  • Yamakuchi Munekazu, Shimizu Toshiaki, Takenouchi Kazunori, Oyama Yoko, Hashiguchi Teruto   臨床データからみた癌患者における血栓研究のすすめ 本邦での未検討領域を明確に マイクロRNAによる発癌の調節 マイクロRNAは癌関連血栓症と関連しているのか?(Regulation of Tumor Development by microRNAs: Do microRNAs link to cancer-associated thrombosis?)  

    日本血栓止血学会誌  2015.4  (一社)日本血栓止血学会

     More details

    Language:English  

  • 野邊 紗耶香, 小濱 祐行, 中村 政敏, 政元 いずみ, 山口 宗一, 橋口 照人   Cobas Liatの当院における性能評価  

    日臨技九州支部医学検査学会  2022.11  日臨技九州支部医学検査学会

     More details

    Language:Japanese  

  • 伊藤 隆史, 川原 幸一, 橋口 照人, 丸山 征郎   自然免疫と血栓形成 アラーミン:HMGB1の凝固促進活性とトロンボモジュリンによる制御機構  

    日本血栓止血学会誌  2009.4  (一社)日本血栓止血学会

     More details

    Language:Japanese  

  • アリアル・ビベック , 清水 利昭, 門野 潤, 風呂井 彰, 槐島 健太郎, 菰方 輝夫, 郡山 千早, 山口 宗一, 橋口 照人, 井本 浩   PDGF-BB低値はHCC切除後再発のリスク因子なのか、単なる指標なのか?(Depleted PDGF-BB Kinetic In Post-Resection HCC Recurrence: A Risk Factor or Merely an Indicator?)  

    臨床病理  2018.10  (一社)日本臨床検査医学会

  • 大山 陽子, 竹之内 和則, 舞木 公子, 郡山 豊泰, 福山 竜子, 川畑 恵, 古城 剛, 山口 宗一, 政元 いずみ, 橋口 照人   24時間体制で血液培養陽性検体のサブカルチャーを可能にしたことによる患者アウトカムの検討  

    臨床病理  2018.10  (一社)日本臨床検査医学会

  • 中村 幸美, 水上 尚子, 大園 七瀬, 湯之上 真吾, 前之園 隆一, 野口 慶久, 堀添 善尚, 湯浅 敏典, 林 完勇, 瀬之口 輝寿, 大石 充, 橋口 照人   Aneurysmal typeの腎動静脈瘤の2症例  

    脈管学  2018.9  (一社)日本脈管学会

  • 古城 剛, 山口 宗一, 吉村 明子, 竹之内 和則, 清水 利昭, 大山 陽子, 郡山 豊泰, 波野 史典, 高嶋 博, 橋口 照人   CalDAG-GEFI分子異常による血小板機能異常症  

    日本検査血液学会雑誌  2017.6  (一社)日本検査血液学会

  • 笠畑 拓志, 政元 いずみ, 高味 聡子, 佐藤 香奈子, 橋口 照人, 山崎 家春, 西川 拓朗, 河野 嘉文   Hermansky-Pudlak syndrome 2型(HPS2)の1症例  

    日本検査血液学会雑誌  2019.6  (一社)日本検査血液学会

  • 山口 宗一, 高木 弘一, 松山 崇弘, 近藤 清貴, 内田 章文, 大山 陽子, 清水 利昭, 竹之内 和則, 井上 博雅, 橋口 照人   IL-13はmiR-424/503を介して肺動脈血管内皮細胞の遊走能を亢進する  

    臨床病理  2017.10  (一社)日本臨床検査医学会

  • 山口 宗一, 上田 英昭, 大川 政士, 向原 公介, 重久 善哉, 松本 和久, 竹之内 和則, 大山 陽子, 東 貞行, 藤崎 知園子, 井本 浩, 橋口 照人   microRNAによる血管平滑筋石灰化制御の検討  

    臨床病理  2020.10  (一社)日本臨床検査医学会

  • 波野 史典, 前之園 隆一, 入來 泰久, 奥井 英樹, 市來 仁志, 政元 いずみ, 山口 宗一, 橋口 照人   NT-proBNPを用いた心房細動アブレーション治療後の長期洞調律維持予測  

    日臨技九州支部医学検査学会  2017.10  日臨技九州支部医学検査学会

  • 橋口 照人, 李 良子, 田中 憲次, 丸山 征郎   DIC/MOFにおける非ホメオスタシス分子の分解(Degradation of non-homeostatic molecules in the state of DIC/MOF)  

    日本血栓止血学会誌  2007.10  (一社)日本血栓止血学会

  • 奥 寛子, 出口 尚寿, 新名 清成, 橋口 照人, 有村 公良, 納 光弘   CRP高値を呈したDiabetic Amyotrophyの1例  

    糖尿病  1999.8  (一社)日本糖尿病学会

  • 奥 寛子, 橋口 照人, 有村 公良, 丸山 征郎, 納 光弘   Crow-Fukase症候群患者由来血小板VEGFは高度の血管内皮細胞増殖活性を示す  

    臨床神経学  2001.11  (一社)日本神経学会

  • 橋口 照人, 有村 公良, 松室 健士, 大塚 麗華, 渡邊 修, 城之園 学, 納 光弘, 丸山 芳一, 丸山 征郎   Crow-Fukase症候群患者の血小板には過剰のvascular endothelial growth factor(VEGF)が含まれ凝集反応において放出される  

    臨床神経学  1999.12  (一社)日本神経学会

  • 有村 公良, 徳永 久理子, 奥 寛子, 出口 尚寿, 納 光弘, 橋口 照人, 丸山 征郎   Crow-Fukase症候群の診断と血清VEGF濃度測定  

    臨床神経学  2002.12  (一社)日本神経学会

  • 橋口 照人, 有村 公良, 渡邊 修, 大塚 麗華, 奥 寛子, 栄楽 信隆, 梅原 藤雄, 納 光弘   Crow-Fukase症候群の臨床診断と血清VEGF濃度との関連について  

    臨床神経学  2000.12  (一社)日本神経学会

  • 岩崎 博恵, 橋口 照人, 城之園 学, 梅原 藤雄, 有村 公良, 納 光弘   Crow-Fukase症候群の治療法とその機序についての検討  

    神経治療学  1999.9  (一社)日本神経治療学会

  • 橋口 照人, 渡嘉敷 崇, 有村 公良, 西垂水 和隆, 渡邊 修, 納 光弘   Crow-Fukase症候群の播種性血管内凝固症候群においては多量のVEGFが血小板より放出される(本症候群における抗血小板療法の重要性について)  

    神経治療学  2000.9  (一社)日本神経治療学会

  • 有村 公良, 上原 明子, 橋口 照人, 納 光弘, 吉良 潤一   Crow-Fukase症候群の全国疫学調査2004  

    臨床神経学  2005.12  (一社)日本神経学会

  • 小池 文彦, 酒井 徹雄, 安徳 恭演, 田中 薫, 橋口 照人, 有村 公良   Crow-Fukase症候群の一例  

    臨床神経学  2002.10  (一社)日本神経学会

  • 渡嘉敷 崇, 橋口 照人, 有村 公良, 渡邊 修, 西垂水 和隆, 榮楽 信隆, 納 光弘   Crow-Fukase症候群における血小板の関与について  

    臨床神経学  2000.12  (一社)日本神経学会

  • 樋口 逸郎, 新山 尚仁, 堀切 尚, 内田 裕一, 白石 匡史, 胡 静, 有村 公良, 納 光弘, 末原 雅人, 橋口 照人, 丸山 征郎   Collagen VI欠損を伴うUllrich病患者における骨格筋内血管の病理学的検討  

    臨床神経学  2003.12  (一社)日本神経学会

  • 徳永 久理子, 出口 尚寿, 新名 清成, 奥 寛子, 橋口 照人, 梅原 藤雄, 有村 公良, 納 光弘   CIDP類似の神経所見を呈した糖尿病の1症例  

    糖尿病  2000.8  (一社)日本糖尿病学会

  • 古城 剛, 山口 宗一, 吉村 明子, 竹之内 和則, 伊藤 隆, 清水 利昭, 大山 陽子, 郡山 豊泰, Panta Sushil, 松下 昌風, 丸山 征郎, 高嶋 博, 橋口 照人   CalDAG-GEFI分子異常により血小板機能異常を呈した一症例  

    臨床病理  2016.9  (一社)日本臨床検査医学会

  • 古城 剛, 山口 宗一, 吉村 明子, 竹之内 和則, 伊藤 隆史, 清水 利昭, 大山 陽子, 郡山 豊泰, Sushil Panta, 松下 昌風, 丸山 征郎, 高嶋 博, 橋口 照人   CalDAG-GEFI分子異常により血小板機能異常を呈した一症例  

    日本血栓止血学会誌  2016.5  (一社)日本血栓止血学会

  • 鈴木 雄大, 三浦 直樹, Binita Shrestha, 伊藤 隆史, 竹之内 和則, 山口 宗一, 桃井 康行, 橋口 照人   B細胞特異的VEGF-A過剰発現マウスのリンパ組織の構造変化、免疫応答と脾臓のトランスクリプトーム(mRNA & microRNA)解析  

    日本獣医学会学術集会講演要旨集  2013.8  (公社)日本獣医学会

  • 古城 剛, 政元 いずみ, 田畑 仁美, 谷口 眞由美, 竹之下 友寿, 古園 千里, 松下 昌風, 橋口 照人, 吉満 誠, 有馬 直道   AML治療経過中の末梢血液像に出現した封入体様物質  

    日本検査血液学会雑誌  2013.6  (一社)日本検査血液学会

  • 古城 剛, 山崎 家春, 政元 いずみ, 田畑 仁美, 谷口 眞由美, 竹之下 友寿, 松下 昌風, 橋口 照人, 吉満 誠, 有馬 直道   AML治療経過中に末梢血液像に出現した封入体様物質(第二報) 電顕の結果を踏まえて  

    日本検査血液学会雑誌  2014.6  (一社)日本検査血液学会

  • 前之園 隆一, 竹之内 和則, 大山 陽子, 清水 利昭, 伊藤 隆史, 山口 宗一, 丸山 征郎, 橋口 照人   AIとRH-PAT測定による血管老化プロセスの考察  

    臨床病理  2014.10  (一社)日本臨床検査医学会

  • 谷口 尚太郎, 橋口 照人, 小野 智子, 竹之内 和則, 中山 宏仁, 川野 貴久, 加藤 香, 松下 隆司, 長友 優尚, 中村 周治, 中島 知徳, 丸山 征郎   ADAMTS13減少と糖尿病性腎症との関連(Association between reduced ADAMTS13 and diabetic nephropathy)  

    日本血栓止血学会誌  2010.4  (一社)日本血栓止血学会

  • 橋口 照人   17α-hydroxylase欠損症の一症例  

    日本内分泌学会雑誌  1989.9  (一社)日本内分泌学会

  • 橋口 照人   13因子bサブニットの異常分子の解析  

    東北止血・血栓研究会会誌  1994.11  東北止血・血栓研究会

  • 向原 公介, 山口 宗一, 松本 和久, 上田 英昭, 重久 喜哉, 大川 政士, 橋口 照人, 井本 浩   冠動脈バイパス術周術期における血小板内VEGFの推移  

    日本外科学会定期学術集会抄録集  2020.8  (一社)日本外科学会

  • 山口 宗一, 向原 公介, 上田 英昭, 重久 善哉, 大川 政士, 松本 和久, 竹之内 和則, 大山 陽子, 井本 浩, 橋口 照人   冠動脈バイパス術周術期における血小板内VEGF-Aの変化についての検討  

    臨床化学  2020.10  (一社)日本臨床化学会

  • 山口 宗一, 向原 公介, 上田 英昭, 重久 善哉, 大川 政士, 松本 和久, 竹之内 和則, 大山 陽子, 東 貞行, 藤崎 知園子, 井本 浩, 橋口 照人   冠動脈バイパス術周術期におけるmicroRNA-126についての検討  

    臨床病理  2020.10  (一社)日本臨床検査医学会

  • 山口 宗一, スシル・パンタ , 郡山 豊泰, 清水 利昭, 大山 陽子, 竹之内 和則, 橋口 照人   低グレードの炎症はVEGF誘発性のHUVECsの遊走をp53依存的な様式で阻害する(Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner)  

    日本血栓止血学会誌  2017.4  (一社)日本血栓止血学会

  • 上田 英昭, 山口 宗一, 松本 和久, 大川 政士, 向原 公介, 重久 喜哉, 橋口 照人, 井本 浩   マイクロRNAが血管平滑筋の石灰化に与える影響の解析  

    日本外科学会定期学術集会抄録集  2020.8  (一社)日本外科学会

  • 郡山 豊泰, 山口 宗一, 竹之内 和則, 大山 陽子, 政元 いずみ, 橋口 照人   ヒト巨核芽球細胞株における高血糖時のGLP-1受容体発現と機能の解析  

    臨床病理  2018.10  (一社)日本臨床検査医学会

  • 小戝 健一郎, 永野 聡, 伊地知 暢広, 二川 俊隆, 角 栄里子, 山口 宗一, 中條 正典, 橋口 照人, 武田 泰生, 吉浦 敬, 清水 章, 高谷 宗男, 小宮 節郎   トランスレーショナルリサーチの現状と展望 次世代の腫瘍溶解性ウイルス・免疫遺伝子治療の独自開発と実用化を目指したFirst-in-human医師主導治験(Current status and prospects in translational research Development of next-generation oncolytic viro-immuno-therapy and investigator-initiated first-in-human clinical trial)  

    日本癌学会総会記事  2018.9  (一社)日本癌学会

  • 落合 龍史, 渡辺 卓也, 橋口 照人   クロロゲン酸は健常人の食後の血管機能低下を抑制する  

    日本高血圧学会総会プログラム・抄録集  2018.9  (NPO)日本高血圧学会

  • 中村 政敏, 高手 恵美, 神宮司 真子, 小濱 祐行, 竹之下 友寿, 政元 いずみ, 伊藤 隆史, 大山 陽子, 竹之内 和則, 山口 宗一, 橋口 照人   クロスミキシングテストを施行した28症例の考察  

    日本臨床検査自動化学会会誌  2018.9  (一社)日本医療検査科学会

  • 上田 英昭, 重久 喜哉, 向原 公介, 井本 浩, 山口 宗一, 橋口 照人   せん断応力が大動脈弁狭窄における血小板分布幅に及ぼす影響(The Impact of Shear Stress on Platelet Distribution Width in Aortic Stenosis)  

    日本循環器学会学術集会抄録集  2018.3  (一社)日本循環器学会

▼display all

Research Projects

  • Platelet-VEGFという概念の提唱(Crow-Fukase症候群の解析から)

    2001 - 2003

    科学研究費補助金 

      More details

    Grant type:Competitive

  • Role of platelet-VEGF in Crow-Fukase syndrome

    2001 - 2003

    Grant-in-Aid for Scientific Research 

      More details

    Grant type:Competitive